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ABSTRACT  
A NEUROBIOLOGICAL PATHWAY THAT MEDIATES STRESS-INDUCED DRUG 
USE 
 
 
Oliver Vranjkovic B.S.  
 
Marquette University, 2015 
 
 
Cocaine addiction represents a tremendous health and financial burden on our 
society and the high rate of relapse to cocaine use in abstinent addicts represents a major 
barrier to effective therapy.  Thus, understanding the factors that contribute to relapse and 
the underlying neurobiological processes is important for guiding the development of 
treatment for addiction.   Stressful life events often trigger drug use in recovering addicts.  
The contribution of stress to drug use is problematic due to the unpredictable and often 
uncontrollable nature of stress.  A growing literature indicates that norepinephrine and 
corticotropin releasing factor (CRF) in the brain play key roles in stress interactions with 
motivational neurocircuitry that mediate stress-induced drug seeking. Previous work from 
our lab has demonstrated that activation of the CRFR1 receptor within the ventral 
tegmental area (VTA) is both necessary and sufficient for drug-seeking behavior during 
periods of stress. However, the afferent CRF projection into the VTA, and how CRF 
affects the neurocircuitry of VTA to evoke stress-induced relapse are poorly understood.  
 
We report that stress-induced cocaine use involves a beta-2 adrenergic receptor-
regulated CRF pathway from the ventral bed nucleus of the stria terminalis to the VTA 
and a CRFR1 receptor-regulated dopaminergic pathway to the prelimbic cortex.  It is 
hypothesized that dopamine released into the prelimbic cortex activates dopamine D1 
receptors on pyramidal neurons that comprise a glutamatergic projection to the nucleus 
accumbens core that is critical for relapse to drug use in abstinent cocaine addicts.  It is 
also reported that the ability of stressors to trigger drug use is determined by the amount 
and pattern of prior drug use.  Findings suggesting that excessive cocaine use establishes 
susceptibility to stress-induced relapse by recruiting CRF regulation of this key stressor-
responsive mesocortical dopaminergic pathway through increased CRFR1 expression are 
described. 
 
This dissertation defines a key pathway through which stress can promotes 
relapse and describes its recruitment as result of repeated excessive drug use.  
Understanding the processes through which stress contributes to cocaine seeking in these 
rodent models should facilitate translational work aimed targeting these mechanisms 
clinically and therefore the development of new medications or approaches managing for 
addiction.
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Chapter I 
 
 
General Introduction  
 
Risk factors for cocaine addiction 
 
The total cost of drug abuse and addiction due to use of tobacco, alcohol, and 
illegal drugs is estimated at $524 billion a year, while illicit drug use alone, such as 
cocaine, accounts for $181 billion in health care, productivity loss, crime, incarceration 
and drug enforcement (NIDA). Addiction to cocaine and other illicit drugs, is a 
chronically relapsing disorder in which drug use progresses from its initial stages of 
limited, non-dependent intake to later stages of uncontrolled abuse (Koob & Volkow 
2010, Volkow et al 2003). The major risk factors for developing cocaine abuse disorders 
or relapse to cocaine are bipolar disorder, schizophrenia, antisocial personality disorder, 
and other substance abuse disorders (DSM-V). Cocaine use amongst youth can be 
attributed to prenatal cocaine exposure, postnatal cocaine use by parents, and exposure to 
community violence during childhood (DSM-V).   
 
Cellular mechanisms of cocaine 
 
 
The positive reinforcing value of drugs drives the initials periods of drug use, 
while later stages of addiction are driven, in part, by negative reinforcement such as the 
relief of withdrawal which is induced by negative affective states (Koob & Volkow 
2010). The primary reinforcing effects of drugs such as cocaine are thought to occur by 
increased dopamine (DA) signaling that leads to enhanced activity of the brain’s pleasure 
pathway which in turn leads to increased craving. Cocaine physically inhibits the 
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dopamine transporters within the synapse and therefore increases extracellular dopamine 
levels due to decreased reuptake into the presynaptic terminal. Chronic drug use and over 
activation of this pathway is thought to devaluate natural rewards, diminish cognitive 
control of behaviors, and increase salience of drug-related stimuli (Edwards & Koob 
2010, Volkow et al 2003). One major factor that plagues drug users is the high rate of 
relapse, as 70-90% of people have reported periods of relapse.   
 
Stress promotes drug use and relapse 
  
Numerous studies suggest that stress plays a crucial role in addiction. 
Specifically, stress has long been considered an important factor contributing to drug 
craving and relapse of drug use in humans (Kreek & Koob 1998). Interestingly, clinical 
reports indicate that individuals with a history of drug use attribute episodes of relapse to 
stressful life events (Sinha 2001, Wang et al 2001). Consistent with these results, 
controlled clinical experiments in cocaine- and alcohol-dependent patients report a 
significant increase in drug craving following exposure to a personalized stressor (Fox et 
al 2009, Sinha et al 1999). Furthermore, population-based and clinical studies support a 
strong correlation between addiction, chronic distress, and negative affect (Sinha 2008). 
These studies have shown that stressors such as physical or sexual abuse, parental neglect 
and poor family structure increase the likelihood of substance abuse, or relapse of drug 
use (Sinha 2008). While stress and drug use are strongly correlated, the precise 
mechanism by which stress contributes to drug use remains unclear, and in many cases 
involves an interaction between stressful life events, cocaine-related cures, and the effect 
of cocaine itself. In addition, the effects of drug use may vary across different 
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subpopulations of addicts (Preston and Epstein, 2011), making it clear that management 
and treatment of stress-related drug use may need to be individualized.     
  In addition, anxiety and depression are often cited by recovering addicts as key 
contributors of drug craving and relapse (Sinha 2007). Intriguingly, epidemiological 
studies have shown that cocaine dependence is highly correlated with numerous stress-
related disorders such as depression, anxiety, and post-traumatic stress disorder 
(Rounsaville et al 1991). Lifetime cocaine use is strongly correlated with PTSD and 
suicide risk; depressive symptoms with suicidal connotations are generally thought of the 
most serious problems (Narvaez et al 2014). However, studies have also indicated that 
the severity of traumatic events may predate cocaine use (Back et al 2001, Brady et al 
2001). While it is clear that stress-related disorders and cocaine use (the initiation, 
escalation or relapse) go hand in hand, developing and treating stress-related cocaine use 
remains difficult because the appearance of stressors is unpredictable and in most cases 
unavoidable. Therefore, understanding the neurobiological pathways that mediate stress-
related drug use remains an important goal for preventing relapse, the development of 
therapeutics for the management of drug use, and the prevention of stress-related drug 
seeking. To investigate the factors that contribute to stress-induced relapse observed in 
clinical studies, preclinical animal models of relapse, or reinstatement procedures, have 
been developed.       
 
Methods in studying stress-induced cocaine use: Conditioned Place Preference 
 
 
Several different animal models of addiction have been developed to better 
understand the changes in neuronal chemistry, physiology, and behavior that lead to drug 
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seeking during periods of stress. In general, these methods can be grouped into two 
categories based on the method of drug delivery. Non-contingent models involve the 
delivery of drugs by the experimenter; an example of a non-contingent model is 
conditioned place preference. Conditioned place preference (CPP) examines the ability of 
drugs of abuse to establish positive enforcement with learned contextual cues; these cues 
can acquire additional appetitive properties when paired with cocaine or other drugs of 
abuse (Tzschentke 2007). In the CPP model, different compartments of a two, or three 
compartment chamber are paired with either cocaine or saline. CPP first consists of 
determining natural preference, termed preconditioning. To define preconditioning 
preference, the experimenter evaluates the natural value to each compartment by placing 
the rodent in the center compartment of the chamber and allow free access to all three 
compartments for 30 min in the absence of cocaine or saline and the time spent in each 
compartment is compared, and one compartment is designated as the cocaine 
compartment, and the other as the saline compartment. Three methods are used to 
determine preference: in a biased approach, the compartment that was not preferred in the 
preconditioning test is paired with the drug, while an un-biased protocol randomly pairs 
the compartment with the drug, in particular when animals have no general preference 
during preconditioning. Finally, a balanced protocol assigns the chamber so that no group 
as a whole has a preference for a particular chamber (Aguilar et al 2009). After 
preference has been established, the rodent enters the conditioning phase. During the 8-
day conditioning phase of the experiment, mice receive cocaine (15 mg/kg, i.p.) on the 
odd days and saline injections on the even days. Immediately after the injection, mice 
confined (guillotine door closed) to the drug-appropriate compartment for 30 min. A day 
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after the final conditioning session, the mice are tested for the expression of cocaine-
induced CPP by placing them in the center compartment and allowing them full access to 
the apparatus for 30 min. A conditioned place preference is defined as the change in time 
spent (in seconds) in the cocaine-paired compartment after conditioning compared with 
the initial preconditioning session. Mice are determined to exhibit a conditioned place 
preference if they spend more time in the cocaine-paired compartment during the post-
conditioning session compared to the preconditioning session. 
Next, animals are allowed to explore the CPP chamber freely in order to measure, 
and induce extinction behavior, using an approach that involves assessment of the 
incentive motivation properties of the drug-paired environment, until there is no 
significant difference between the times spent in the drug-paired compartment during 
preconditioning. This usually occurs for an average of five to eight days at which, once 
extinction criterion is met, animals undergo reinstatement testing. 
 
Methods in studying stress-induced cocaine use: Self-Administration 
 
Another model of addiction is a contingent model in which the animal requires an 
operant response, such as activating a lever, or activating photobeams through a nose-
poke to receive an intravenous infusion of cocaine; this is coined the self-administration 
model (SA). To study the neurobiological mechanisms involved in reinstatement, studies 
have utilized the reinstatement of drug seeking model following SA. In this model, 
rodents are trained to self-administer a drug of abuse (such as cocaine), followed by an 
extinction phase in which the cocaine is replaced with saline, or they are forced into 
abstinence in which the rodents have no more exposure to the drug of abuse and the 
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environment paired with drug use, and are sequestered in their home cage. If a rodent 
undergoes abstinence, exposure to the drug-paired environment will trigger a robust drug-
seeking behavior phenotype from days to months after the last drug-administration 
session (Conrad et al 2008). In the case of extinction, lever responding will progressively 
diminish. Following extinction training, rats may be exposed to either a cue, non-
contingent infusion of the drug of abuse, or a stressor (such as a mild-non noxious 
footshock) to elicit previous drug seeking behavior, and therein overcoming the 
extinction training and increasing lever responding. The SA model allows for the analysis 
of the neurobiological mechanism in drug-seeking behavior because it directly measures 
intake behavior.   
 
Stress as a trigger for relapse 
 
 
Since stress has been cited as a major factor that contributes to drug use in 
humans, studies examining the neurobiological mechanism involved have been 
developed; these studies involve the assessment of stress-induced reinstatement. Stress-
induced reinstatement may involve different types of stressors such as a cold forced swim 
(Conrad et al 2010), or food restriction (Chen et al 2014, Shalev et al 2003); the most 
common type of a stressor utilized for self-administration experiments is an 
uncontrollable intermittent electric-footshock delivered throughout the steel floors of the 
self-administration chamber (Ahmed & Koob 1997, Erb et al 1996). Reinstatement 
testing, more specifically stress-induced reinstatement, is most commonly tested in the 
CPP model by either a forced-swim stressor (Figure 1.1 A-C (Mantsch et al 2010). 
Stress-induced reinstatement in most cases significantly increases the time spent in the 
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cocaine-paired compartment compared to the previous extinction day, and the 
preconditioning day. Once stress-induced reinstatement has been established, different 
neuropharmacological agents may be employed in order to prevent, or in some cases 
evoke, stress-induced drug seeking, allowing for a better understanding of the different 
neurobiological mechanisms that contribute to drug seeking during periods of stress. This 
is important because stress is known to influence the rewarding effects of drugs of abuse 
(Cleck & Blendy 2008, Der-Avakian et al 2005), and stress has a prominent role in 
relapse to drugs of abuse (Sinha 2001).  
 
  
 
 
In the case of SA, the conditions under which stress evokes reinstatement 
involves animals with a specific history of self-administration;  animals that undergo self-
administration for 2 hours will not show reinstatement to an electric footshock stressor, 
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Stress-induced reinstatement in rats following cocaine self- administration and extinction is shown in 
Figs. D–F. Following training, rats (n = 5) self- administered cocaine (1.0 mg/kg/inf) by pressing a lever 
during daily 6-h sessions for 14 days (D) prior to undergoing extinction over a 10-day period during 
daily 2-h sessions (E) and reinstatement testing (F). Stress-induced reinstatement was observed as the 
ability of footshock stress (0.5 mA; 0.5” duration delivered an ave. of 40-s apart over a 15-min session) 
to increase responding on the cocaine lever (*P < 0.05 vs. Bas). 
Figure 1.1 Models of studying 
stress-induced relapse in rodents: 
Stress-induced cocaine seeking in 
mouse (A–C) and rat (D–F) models. 
Stress-induced reinstatement of 
extinguished cocaine-induced CPP is 
shown in Figs. A-C. Preference for a 
cocaine-paired compartment (4 ! 15 
mg/kg, ip) was established (A; 
increase in time spent post-
conditioning vs. pre-conditioning) 
and extinguished (B) in C57BL/6 
mice (n = 4) prior to reinstatement of 
preference by pre-exposure to a 
forced swim session (C; 6-min swim 
in 22 °C water; *P < 0.05 vs. Bas).  !
A. 
D. 
B. C. 
E. F. 
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while animals that undergo self-administration for  6 hours (Figure 1.1 D-F) or more will 
show reinstatement (Mantsch et al 2008a, Mantsch et al 2008b). Preliminary studies have 
indicated that elevated glucocorticoids during 6-hr SA are involved in establishing 
susceptibility to stress-induced drug seeking (Mantsch et al 2008b) though more research 
needs to be conducted to better understand the neurobiological mechanism involved in 
this relapse susceptibility. The Mantsch lab has shown that animals with 6hr access to 
cocaine also show an escalating pattern of cocaine self-administration. In addition, these 
animals are more susceptible to reinstatement by cocaine, footshock, or intra 
cerebroventricular injections of corticotropin releasing factor -( Mantsch et al., 2008a). In 
addition, surgical adrenalectomy, which eliminates corticosterone production, slows the 
escalation, and prevents the establishment of stress-induced reinstatement when 
conducted prior to but not after repeated daily 6-hr cocaine self-administration (Mantsch 
et al., 2008b). This suggests that corticosterone, and other adrenal hormones, may induce 
neuroplastic changes, possibly in the mesocortical system to make rats more susceptible 
to stress-induced relapse.  These neuroplastic changes have been proposed to promote 
drug use during periods of stress through actions of corticotropin releasing factor (an 
important peptide in stress-induced reinstatement) or its receptor which may be up-
regulated by drug use. Both factors are explored in this body of work.  
Using the approaches mentioned above has allowed us to better understand the 
neurobiological mechanisms that contribute to drug use during stress. The CPP model has 
allowed us to explore which noradrenergic receptors mediate this process; this is 
important because clonidine, an agonist at the alpha-2 adrenergic receptor (AR) has been 
shown to decrease drug craving during periods of stress (Jobes et al 2011, Shaham et al 
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2000b). Our studies have also shown that the beta-2 AR is both necessary and sufficient 
in promoting drug use during periods of stress (Mantsch et al. 2010, Vranjkovic et al. 
2012). Using this information, we moved our studies into the SA model and showed that 
activation of the beta-2 AR within the ventral bed nucleus of the stria terminalis 
mobilizes a corticotropin releasing factor pathway projection into the ventral tegmental 
area (Vranjkovic 2014; this data is presented in this dissertation). 
 
Neurocircuitry involved in stress-induced cocaine seeking 
 
Using the self-administration/reinstatement approach in rats, we have focused on 
defining the neurocircuitry (Figure 1.2) involved in stress-evoked drug seeking. 
Particularly, stress-induced reinstatement appears to involve a glutamatergic projection 
from the prelimbic cortex to the nucleus accumbens core (Kalivas and McFarland, 2003), 
which likely regulates motor outputs to produce drug-seeking behavior. This pathway 
may be regulated by glutamate release from the prefrontal cortex, because studies have 
shown that inhibition of the nucleus accumbens core with GABA receptor agonist 
cocktail blocks footshock-induced reinstatement in rats (McFarland et al., 2004) while 
other groups have found that dopamine release within the prelimbic cortex is required for 
stress-induced drug seeking (Capriles et al., 2003, McFarland et al., 2004). Specifically, 
administration of fluphenazine into the prelimbic, but not the core of the nucleus 
accumbens blocked footshock-induced reinstatement; the same study showed that a 
footshock stressor increased both glutamate and dopamine release within the prelimbic 
cortex, however, only glutamate but not dopamine was increased within the nucleus 
accumbens core (McFarland et al., 2004). In addition studies have shown that AMPA 
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administration within the core induced reinstatement while an AMPA antagonist was able 
to block cocaine primed reinstatement (Cornish and Kalivas., 2000) . This dopamine 
likely acts on pyramidal D1 receptors to increase the excitability of pyramidal neurons 
that specifically project to the nucleus accumbens core (Lewis and O’Donnell, 2000; 
Seamans et al., 2001).  
 
 
 
The aim of this body of work is to identify the stress-related neurocircuitry that 
acts up-stream from the cortical-accumbens pathway. Here we will examine the actions 
of the neuropeptide corticotropin releasing factor (CRF) in different stress-related brain 
nuclei, most notably the bed nucleus of the stria terminalis; specifically we will examine 
its interaction with the noradrenergic system within the bed nucleus. We will also 
!"#
"$%#
&'(#()$*#
+,&-.#
!.'#
!*/0$12#/)$13$*/*$45(##
67/32*#
&)$13$*/125/*#
8)91:5/*#
;<=#
>2701:10*#
>','#
 Neuroanatomical projections involved in stress-induced cocaine seeking: An electric footshock stressor will activate a 
noradrenergic projection from the ventral noradrenergic bundle into the ventral bed nucleus of the stria terminalis. Here 
norepinephrine will activate beta-2AR receptors and release corticotropin releasing factor (CRF). CRF will increase the drive 
on CRF ventral tegmental area (VTA)  projecting neurons. A CRF projection from the vBNST into the VTA will be activated, 
and CRF will be released within the VTA. CRF will activate CRFR1 on VTA dopamine neurons that project into the 
prelimbic cortex. DA within the prelimbic cortex will activate D1R and increase the firing rate of pyramidal neurons that 
project into the core of the nucleus accumbens. This will activate sub-motor circuits to engage in drug seeking behavior. 
(Figure adapted from Mantsch et al., 2015)     
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examine its actions within the VTA and how it engages CRFR1 to promote drug seeking 
by activating a dopaminergic projection to the prelimbic cortex.   
 
Bed Nucleus of the Stria Terminalis: General Introduction and anatomy 
 
 
 
 
The bed nucleus of the stria terminalis (BNST) is considered the central 
coordinator between stress-responsive regions such as the amygdala, the paraventricular 
nucleus of the hypothalamus, and the brainstem and motivation systems such as the 
ventral tegmental area (VTA), and the nucleus accumbens (Georges & Aston-Jones 2001, 
Jalabert et al 2009). Structurally, the BNST is a rostral forebrain structure that is enclosed 
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Figure 1.3: The BNST can be divided into three subregions 
Based on the location of the lateral ventricle and the anterior 
commissure; the BNST is divided into a dorsal part: medial of 
the lateral ventricle and lateral f the lateral ventricle, and 
below the anterior commissure or the ventral BNST. Each of 
these subregions comprise of nearly 20 subnuclei.  
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by the lateral ventricles, lateral septum, fornix, the nucleus accumbens, the preoptic area, 
and the hypothalamus (Crestani et al 2013).  
It is made up of 20 different subregions based on cyto- and chemo-architectonic 
studies; the BNST has been subdivided along an anterior to posterior axis. The anterior 
BNST is involved in autonomic control, while the posterior division is involved in 
controlling neuroendocrine responses (Bayer 1987, Ju & Swanson 1989, Ju et al 1989). In 
addition, the BNST can be divided into the dorsal medial, dorsal lateral, and ventral 
subregions (figure 1.3) though some early anatomical studies have suggested that the 
dorsal lateral and ventral portions of the BNST are a continuous structure (Swanson 
1989). Recently, studies have shown that both the dorsal and ventral lateral divisions of 
the BNST are critical in bridging the pathway between stress and reward. The role of the 
dorsal BNST in stress-related drug use has been extensively studied by the Winder group 
(Flavin & Winder 2013, McElligott & Winder 2009). The current body of work will 
examine the ventral portion because studies have suggested that it has a direct 
involvement in stress-induced drug seeking as inhibition of the ventral BNST by a 
GABA agonist cocktail has been shown to prevent footshock-induced drug seeking 
(McFarland et al., 2004). 
 
Bed Nucleus of the Stria Terminalis: Stress-Related Connectivity 
  
The BNST is a critical modulator of stress-induced relapse of drug seeking 
(Aston-Jones et al 1999, Aston-Jones & Druhan 1999, Leri et al 2002, Rodaros et al 
2007) partly due to its connectivity with different limbic brain structures. The BNST 
receives dense glutamatergic projections from the infralimbic cortex, prelimbic cortex, 
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insular cortex, entrorhinal cortex, and the orbital frontal cortex (McDonald 1998) and a 
dense GABAergic projection from the amygdaloidal nuclei (Dong & Swanson 2006). 
Interestingly, the BNST sends both GABAergic and glutamatergic projections to the 
VTA, a region critical in motivated behavior. These projections synapse in part onto 
putative VTA GABA neurons, indicating that the BNST can directly modulate VTA 
firing (Dumont & Williams 2004, Jalabert et al 2009, Kudo et al 2012, Silberman et al 
2013). Specifically, recent data has shown that stimulation of the ventral portion of the 
BNST (vBNST) potently and consistently activates VTA dopamine neurons (Georges & 
Aston-Jones 2001, Massi et al 2008). This may indicate that dopamine firing within the 
VTA is, in part, dependent upon BNST-mediated inhibition of local VTA GABA 
neurons. In addition, other studies have shown that activation of the ventral BNST have 
an excitatory input on to VTA DA neurons (Georges and Aston Jones 2002). It is also 
important to note that both the ventral pallidum (Mahler et al 2014), and the tail of the 
VTA (tVTA or RMTg) have been shown to send GABA inputs to the VTA that are 
prominent during reinstatement behaviors (Barrot et al 2012, Sanchez-Catalan et al 
2014). This indicates that multiple GABAergic inputs into the VTA, and possibly 
glutamatergic inputs, may regulate dopamine release in terminal regions. In this body of 
work, we have focused on the interaction between the vBNST and the VTA.  
 
The Role of Norepinephrine in stress-related drug use 
 
Norepinephrine is an important stress-related neuromodulator that is released 
within the BNST in response to aversive stimuli (Park et al 2012), and during periods of 
stress (Pacak et al., 1995) and has been suggested to promote drug use during times of 
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stress (Brown et al., 2009). Central noradrenergic (NE) neurons are activated by stress 
and play an important role in the stress response. Noradrenergic projections in the brain 
originate from seven distinctive cell bodies in the brainstem (A1-A7) (Dahlstrom & Fuxe 
1964). These projections are divided into the dorsal noradrenergic bundle, which 
provides sole NE projections to the cortex, hippocampus, thalamus, and cerebellum; or 
the ventral noradrenergic bundle, which provides sole NE projections to the 
hypothalamus, and regions of the limbic forebrain such as the amygdala and the BNST.  
These projections are thought to be largely ipsilateral, and innervate a majority of the 
CNS (Moore & Bloom 1979). Importantly, the ventral forebrain bundles sends NE from 
the A2 region into the BNST (Wang et al 2001). Interestingly, it was determined that the 
ventral, but not the dorsal, NE pathway is responsible for footshock-induced 
reinstatement. For example, animals were given 6-hydroxydopamine (6-OHDA; a 
neurotoxin that enters the neuron through monoamine transporters) lesions in either the 
dorsal or ventral forebrain bundle and subsequently tested for footshock-induced 
reinstatement of heroin seeking; only lesions in the ventral NE pathway significantly 
attenuated the effects of footshock on reinstatement for heroin (Shaham et al 2000b), 
morphine (Wang et al 2001), and opioids (Aston-Jones et al 1999). Taken together, this 
suggests that the innervation of NE from the ventral forebrain bundle to the BNST is 
crucial in mediating reinstatement to drugs during times of stress.  
In addition to the ventral forebrain bundle, the locus coeruleus (A6 group) is 
another major NE input into limbic forebrain structures such as the prefrontal cortex, and 
the BNST. The locus coeruleus has a major role in mediating the sleep-wake cycle, 
attention and memory, cognitive flexibility, and stress responses (Schwartz & Roth 
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2008). Recent studies have suggested that the kappa-opioid system interacts with the LC 
to contribute to drug-induced cocaine seeking (Al-Hasani et al 2013, McCall et al 2015, 
Siuda et al 2015). 
 
Noradrenergic receptors and their involvement in stress-related drug use: alpha-2  
Adrenergic receptors 
 
 
Norepinephrine can activate five distinct adrenoceptor (-AR) subtypes: alpha-1 
AR (Gq), alpha-2 AR (Gi), beta-1 AR, beta-2 AR, and beta-3 AR (all Gs), all of which are 
coupled to a G-protein and activate unique secondary messenger signals. All of the 
receptors are distributed throughout the central nervous system (Asanuma et al 1991, 
Bing et al 1992, Levin 1982, Young & Kuhar 1980). Both alpha-1 AR and the beta-ARs 
are largely located on post-synaptic cells; whereas alpha-2 ARs mainly assert their effects 
on the presynaptic cell to serve as auto/heteroreceptor: to function as a negative feedback 
system for neurotransmitter release. However, it has also become evident that many 
alpha-2 ARs are postsynaptic and may regulate brain function in a manner that can 
contribute to drug-seeking behavior (see e.g., (Zhang et al 2009)). Importantly, many 
studies examining the role of norepinephrine in stress have used the alpha-2 AR agonist 
clonidine and related drugs to prevent further NE release, and therefore block stress-
induced reinstatement; importantly, clonidine has been shown to block stress-induced 
cocaine seeking in humans (Jobes et al 2011). The alpha-2 AR antagonist yohimbine and 
related agents, which stimulate NE release, have been used to mimic a stressor in 
preclinical settings and has been shown to induce cocaine-seeking behavior (Mantsch et 
al 2010, Shepard et al 2004).      
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Stress-induced reinstatement studies show that activation of noradrenergic 
receptors plays a crucial role in either forced swim or footshock stress induced 
reinstatement of drug seeking. For example, we have used the alpha-2 AR antagonists 
yohimbine, and BRL4408 (Kiss et al 1995) to induce reinstatement of extinguished 
cocaine CPP (Mantsch et al 2010) and yohimbine has been shown to reinstate drug 
seeking following self-administration (Shepard et al 2004). Systemic injections of the 
alpha-2 AR agonist clonidine have been shown to block footshock-induced reinstatement 
of cocaine seeking (Erb et al 2000), and forced swim-induced reinstatement of CPP 
(Mantsch et al 2010). In addition, central injections of clonidine into the lateral or fourth 
ventricles blocks footshock-induced reinstatement of heroin seeking (Shaham et al 
2000b). While using these drugs has implied that the noradrenergic system plays a major 
role in stress-induced drug seeking, their use has some limitations. For example, 
yohimbine has other targets besides the alpha-2 AR; yohimbine has been shown to 
enhance turnover of dopamine and serotonin (Millan et al 2000), so this promiscuous 
effect of yohimbine makes it difficult to pinpoint its mechanism of action. However, 
work from the Erb lab has shown that central injections of norepinephrine induced 
reinstatement of cocaine seeking (Brown et al 2011), suggesting that norepinephrine does 
indeed have a prominent role in promoting drug seeking by ARs in the brain.    
 
Noradrenergic receptors and their involvement in stress-related drug use: alpha-1 
adrenergic receptors 
 
 
Studies have examined the role of alpha-1 ARs on stress-induced reinstatement. 
These studies have produced mixed results: some studies found that the alpha-1 AR 
antagonist prazosin can block yohimbine-induced reinstatement of food, and alcohol 
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seeking, as well as footshock-induced reinstatement of alcohol seeking (Le et al 2011), 
whereas we observed a failure of prazosin to block forced-swim induced reinstatement of 
cocaine CPP (Mantsch et al 2010). More studies need to be performed to fully understand 
the role of alpha-1 ARs in stress-induced reinstatement, in part because it may have 
indirect effects through modulation of BNST activity. For example, application of an 
alpha-1 AR agonist induced a long-term depression in excitatory neurons of the BNST 
(McElligott & Winder 2008), which might be involved in promoting mood disorders and 
could regulate drug seeking. However, research on the role of the alpha-1 ARs in stress-
related drug use has been overshadowed by the positive results with the beta-ARs.  
 
Noradrenergic receptors and their involvement in stress-related drug use: 
beta adrenergic receptors 
 
 
Studies have indicated that the beta-ARs play a crucial role in stress-induced 
reinstatement. Studies from our lab have found that pretreatment with the nonspecific 
beta-AR antagonist propranolol blocks stress-, but not cocaine-induced reinstatement 
(Mantsch et al 2010). Furthermore, we have shown this to be specific to beta-2 ARs as 
the beta-2 AR antagonist ICI 118,551, and not the beta-1 AR antagonist betaxolol, 
blocked forced swim-induced reinstatement (Mantsch et al 2010). Further studies from 
our lab have shown that beta-ARs, specifically beta-2 ARs, are both necessary and 
sufficient for stress-induced reinstatement because 1) the non-specific beta-AR agonist 
isoproterenol is sufficient to induce reinstatement; 2) beta-AR knockout mice failed to 
reinstate following forced swim; 3) the beta-2 AR agonist clenbuterol is sufficient to 
induce reinstatement (Vranjkovic et al 2012). Interestingly, other studies have indicated 
that beta-ARs are necessary for footshock-induced reinstatement in both the central 
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nucleus of the amygdala, and the vBNST, as a cocktail of betaxolol and ICI 118,551 
(beta-1 AR, and beta-2 AR antagonist respectively) prevented reinstatement when 
injected into either of the two structures (Leri et al 2002). Taken together, these studies 
indicate that beta-AR activation within the central nucleus of the amygdala and the 
vBNST might be a key contributor to stress-induced reinstatement. Furthermore, studies 
have suggested that the noradrenergic system directly interacts with, and may stimulate 
the release of corticotropin releasing factor to induce cocaine seeking because central 
injections of NE causes reinstatement, and this is blocked by pretreatment with a 
nonspecific CRF receptor antagonist (Brown et al 2009).    
 
Introduction to Corticotropin Releasing Factor 
 
Corticotropin Releasing Factor (CRF) is a 41-amino acid peptide that has been 
found to play a critical role in the behavioral and neuroendocrine responses to stress. 
CRF binds to the 7-domain transmembrane receptors CRFR1 and CRFR2. CRFR1 and 
CRFR2 share approximately 70% amino acid identity, however, CRF has a greater 
affinity for CRFR1 compared to CRFR2 (Bale & Vale 2004). In addition, CRF interacts 
with the CRF-binding protein (CRF-BP). The CRF-BP has a high affinity for CRF, and it 
most likely prevents CRF from activating its receptors by directly binding CRF, and 
promoting its clearance and degradation (Woods et al 1999).  
Genetically, CRFR1 and CRFR2 are produced from distinct genes with several 
splice variants (Bale and Vale, 2004). Both CRFR1 and CRFR2 are expressed throughout 
the central nervous system; CRFR1 is expressed more abundantly than CRFR2 (Steckler 
& Holsboer 1999).  There is a 70% sequence homology between CRFR1 and CRFR2, 
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with an 8% homology at the transmembrane and intracellular domain levels (Lovenberg 
et al., 1995).  
 
 
 
CRF: Endocrine Function 
  
In its endocrine role, CRF initiates a cascade of events that activates the 
hypothalamic-pituitary-adrenocortical axis (HPA). Specifically, CRF is released from 
parvocellular neurosecretory cells in the paraventricular nucleus (PVN) of the 
hypothalamus via the median eminence in response to a stressors. CRF travels to the 
anterior pituitary gland where it acts on CRFR1 to initiate the production and release of 
adrenocorticotropic hormone (ACTH), which travels into the circulation and in turn 
promotes the release of corticosterone from the adrenal cortex. In addition to its 
plasticity and adapts to the demands of the environment.
Thus, a variety of stressors have been shown to up-
regulate CRH1, but not CRH2!, mRNA in the rat PVN
(Lacroix and Rivest 1996; Lee and Rivier 1997; Mansi et
al 1996), which suggests that functional adaptation of the
HPA axis to stress may be primarily mediated through
increased CRH1 and not CRH2!, although the l t r
seems to be the prime receptor subtype expressed at the
level of the PVN under basal conditions. Likewise, stress
increased CRH1 expression in various cortical areas in
C57BL/6 but not in DBA/2 mice (Giardino et al 1996). On
the other hand, CRH1 binding in the BLA is reduced
following chronic exposure to cocaine (Ambrosio et al
1997), suggesting that CRH1 at the level of the BLA may
play a role in the modulation of behavior associated with
drug withdrawal, which will be discussed in greater detail
below.
CRH2! has also been shown to exhibit plasticity,
however, albeit to a different set of stimuli. For example,
CRH2!mRNA in the VMH is reduced following maternal
dep ivation in infan rats (Eg bal-Ahmadi et al 1997 and,
more recently, this effect has been shown to be reversed by
mimicking maternal contact and licking of maternally
deprived pups, but not by merely restoring food intake
(Eghbal-Ahmadi et al 1999). This is of particular rele-
vance, as it has been shown that VMH CRH2! mRNA
also decreased in response to food deprivation in rats
(Makino t al 1998; Timofeeva and Richard 1997). Thus,
there is evidence suggesting that CRH2! might play a role
in social types of behavior—or at least in stress-related
changes induced by maternal deprivation—and feeding.
CRH1 and CRH2! Mediate Di fer nt Types
of Behavior
Based on these findings, a range of neuroendocrine and
behavioral effects can be predicted for these two receptor
subtypes. First, the action of CRH on the HPA axis may be
predominantly CRH1-mediated (at least in the rodent),
whereas the central effects leading to this activation, via
CeA, BNST, PVN and the hippocampus, may involve both
receptor subtypes. A role for CRH1 in the regulation of
Figure 1. Schematic illustration of the distribution of CRH1 and CRH2! in the brain. Red circles represent CRH1, whereas blue
squares illustrate the distribution of CRH2!. Although there is limited overlap in the distribution of the two receptor subtypes, CRH1
and CRH2! are frequently expressed in distinct brain areas. It should be noted that the exact expression pattern in the pedunculopontine
tegmental nucleus is not clear at present. The suggestion of CRH1 expression in the locus coeruleus is based on primate data. AON,
anterior olfactory nucleus; APit, anterior pituitary; BLA, basolateral amygdala; BNST, bed nucleus of the stria terminalis; CA1-CA4,
hippocampal areas CA1 to CA4; CeA, central nucleus of the amygdala; Cereb, cerebellum; CoA, cortical nuclei of the amygdala;
CingCx, cingulate cortex; DBB, diagonal band of Broca; DG, dentate gyrus; FrCx, frontal cortex; IC, inferior colliculus; IO, inferior
olive; LC, locus coeruleus (based on primate data); LDTg, laterodorsal tegmental nucleus; LS, lateral septum; MA, medial amygdala;
MS, medial septum; NV, trigeminal nuclei; OB, olfactory bulb; OccCx, occipital cortex; PAG, periaqueductal gray; ParCx, parietal
cortex; PPTg, pedunculopontine tegmental nucleus; PVN, paraventricular hypothalamic nucleus; R, red nucleus; RN, raphe nuclei; SC,
superior colliculus; SN, substantia nigra; Thal, thalamus; VMH, ventromedial hypothalamus.
CRH Receptor Subtypes and Emotion 1483BIOL PSYCHIATRY
1999;46:1480–1508
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Figure 1.3: Representatio  of CRFR1 ( r d) and CRFR2 ( blue) ar  
expressed throughout the CNS. Both receptors overlap in key brain areas 
such as the ventral tegmental ar  and th  ed nucleus of the stria 
terminalis that regul te drug- seeking during periods of stress. These 
areas are depicted with a star (adapted from Steckler and Holsboer 1999).   
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endocrine role, CRF acts within the brain. Within the central nervous systems, CRF, and 
other neuropeptides in general, have a very unique role.  
 
Neuropeptide Signaling 
  
Neuropeptides act differently compared to small amino acids transmitters such as 
glutamate, GABA, or glycine. In general, these neurotransmitters (i.e., glutamate, GABA, 
and glycine) are rapidly released at a presynaptic active zone; they diffuse across a 
synapse, which is only a few nanometers in length, and rapidly activate their receptors, 
and are then rapidly degraded or transported within an astrocyte or the presynaptic 
terminal (van den Pol 2012). In contrast, neuropeptides are contained in dense-core 
vesicles and may be released at multiple sites along the neuron. Once released, the 
neuropeptide can travel a significantly greater distance (in the order of microns; volume 
transmission) and therefore can diffuse throughout a specific brain area. Neuropeptides 
are not degraded quickly so they remain within a synapse longer and diffuse vast 
distances (Nassel 2009, Palkovits 1995). Binding proteins may interact with the 
neuropeptides to inhibit their actions (Kormos & Gaszner 2013). 
  Classical neurotransmitters are often synthesized within the presynaptic terminal. 
The enzymes required to convert the precursors for classical neurotransmitters are 
synthesized in the cell body; they travel down the axon and convert the precursor 
molecule to the proper neurotransmitter, which is then loaded into the vesicle at the 
presynaptic site. In contrast, neuropeptides are synthesized as pre-propeptides and are 
modified within the endoplasmic reticulum to pro-peptides. Subsequently, they travel to 
the Golgi apparatus and are packaged into dense-core vesicles. Within the vesicles, pro-
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peptides are modified by hydrolysis, glycosylation, phosphorylation, and disulfide bond 
formation to produce the final product (van den Pol 2012). 
In addition, compared to classical neurotransmitters, neuropeptides exclusively 
activate G-protein coupled receptors; these G-protein receptors usually have a high 
affinity for their peptides (it would take nanomoles to activate CRFR1 by CRF, as 
compared to micromoles of glutamate for NMDA receptors).  
 
 
 
Furthermore, all neuropeptides are thought to be co-released with classical 
neurotransmitters or neuromodulators. G-protein activation of neuropeptides will change 
many aspects of the cell’s physiology; importantly, they have been shown to modulate 
receptor trafficking, and alter the  conductance of different ion channels (van den Pol 
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Fig. 3.
Comparison of fast amino acid synaptic transmission (left) and slower neuropeptide
transmission (right).
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Figure 1.6 Actions of Neuropeptides: Neuropeptides display volume 
transmission in which they can act locally, or affect neurons that are a long 
distance away. They have no reuptake mechanism, and they are not degraded 
within the synapse, allowing for a unique signaling mechanism. They are 
released from the same terminal such as GABA or glutamate, but at different 
locations. Figure adapted from van den Pol 2012) 
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2012). Importantly, neuropeptides are produced throughout the central nervous system, 
where they can act locally, or project vast distances. These characteristics allow for 
neuropeptides such as CRF to act on multiple different synapses to both promote, and 
inhibit the activity of the same cell population.  
 
The role of Corticotropin Releasing Factor in stress-induced reinstatement of drug 
seeking 
 
 
 
 
In addition to the PVN, other brain nuclei produce CRF as a neuromodulator in 
response to various physiological and emotional stressors. Accordingly, CRF cell bodies 
and receptors are widely distributed throughout the brain (Chen et al 2015, De Souza et al 
1985, Perrin & Vale 1999). Importantly, CRF has been found in the BNST, both the 
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dorsal and the ventral subdivision (Chen et al 2015), and expression of CRFR1 and 
CRFR2 have been reported within the BNST and VTA (Justice et al 2008, Sawchenko et 
al 1993). 
  Given the importance of CRF in stress, early neurobiological investigations of 
stress-induced reinstatement focused on the role of CRF. Experiments found that 
intracerebroventricular pretreatment with the non-selective CRF receptor antagonists D-
Phe CRF, and alpha-helical CRF9-41, significantly attenuates, or blocks, footshock-
induced reinstatement of heroin, cocaine, and alcohol seeking (Erb et al 1998, Le et al 
2000, Liu & Weiss 2002, Zislis et al 2007). Conversely, central injections of CRF itself 
reinstate drug seeking (Erb & Brown 2006, Mantsch et al 2008a). These studies strongly 
suggest that CRF plays an important role in reinstatement of drug seeking during periods 
of stress. However, the site of action of CRF and the receptor that CRF acts on was just 
recently discovered. 
 The effects of CRF on footshock-induced reinstatement have been attributed to 
actions at the CRFR1 receptor. Administration of the selective CRFR1 receptor 
antagonist, CP-154, 526, prior to footshock stress blocked reinstatement of cocaine and 
heroin seeking (Blacktop et al 2011, Gehlert et al 2007, Shaham et al 2000a). In contrast, 
pretreatment with the selective CRFR2 receptor antagonist, antisauvagine failed to block 
footshock-induced reinstatement of extinguished nicotine seeking (Gehlert et al 2007, Lu 
et al 2000), or footshock-induced reinstatement of extinguished cocaine seeking 
(Blacktop et al., 2011). Interestingly, the actions of CRF on CRFR1 have been localized 
in part to the VTA. For example, studies have shown that CRF is released transiently in 
the VTA and that CRF release is enhanced during electric footshock (Wang et al 2005). 
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Recent data suggest that activation of CRFR1 in the VTA during electric footshock 
mediates stress-induced reinstatement of cocaine, heroin, and nicotine seeking (Blacktop 
et al 2011, Grieder et al 2014, Wang et al 2006). Therefore, from these studies, it can be 
concluded that CRFR1 activation within the VTA is an important contributing factor in 
the neurobiology of stress-mediated relapse. However, other studies have suggested that 
the CRFR2 receptor and not the CRFR1 receptor is involved in stress-induced drug 
seeking (Wise and Morales, 2010).  Additionally, several different brain areas may 
contribute to stress-related drug use in conjunction with CRF including the locus 
coeruleus (Al-Hasani et al 2013, McCall et al 2015), the central nucleus of the amygdala 
(Erb et al 2001b), and the dorsal raphe nucleus (Zorrilla et al 2012). The source of the 
CRF input into the VTA is not yet known, though the BNST has been placed as a likely 
candidate.   
 
Convergence of the noradrenergic and CRF systems within the BNST 
 
The BNST has two stress-related noradrenergic inputs that modulate its activity 
and may lead to drug seeking during periods of stress. The first stress-related input is into 
the ventral BNST (vBNST); it receives arguably the strongest NE projections from the 
ventral forebrain bundle (Forray & Gysling 2004). In addition, NE release within the 
vBNST has been shown to contribute to stress-induced reinstatement through the actions 
of the beta-adrenergic receptors (Leri et al 2002). Signaling through beta-ARs can 
increase both GABAergic and glutamatergic transmission through presynaptic 
mechanisms; beta-AR transmission increase IPSC frequency within the BNST (Dumont 
& Williams 2004, Egli et al 2005, McElligott et al 2010, Nobis et al 2011). Specifically, 
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NE can enhance, or decrease glutamate transmission in the dBNST, while its effects in 
the vBNST are less clear.  NE, via a beta-AR mechanism, has been reported to inhibit 
glutamate transmission in the vBNST (Egli et al., 2005). However, studies have shown 
that beta-1 AR activation within the BNST produces a CRF-dependent increase of 
excitatory transmission; specifically, activation of beta-AR receptors causes an increase 
in spontaneous EPSC.  However, in the presence of a CRFR1 antagonist, this effect is not 
observed, indicating that beta-AR dependent EPSCs are mediated by activation of 
CRFR1 (Nobis et al. 2011). This suggests that beta-ARs within the BNST may contribute 
to stress-dependent reinstatement, since stress-dependent norepinephrine release 
modulates BNST activity, most likely activating excitatory signaling through CRF-
dependent actions of beta-AR within the BNST. Based on our work, we believe that 
activation of the beta-2 AR (Mantsch et al 2010, Vranjkovic et al 2014) within the BNST 
modulates stress-responsive signaling in a CRF-dependent manner.     
The second stress-related input to the BNST is CRF. The BNST contains a local 
pool of CRF-positive cells that not only act within the BNST but also send CRF to other 
putative brain regions (Sakanaka et al 1986, Sink et al 2013, Wang et al 2011). Notably, 
stress exposure increases crf mRNA in the BNST (Funk et al 2006). For example, 
footshock has been shown to increase crf mRNA within the dorsal, but not ventral, BNST 
of withdrawn heroin animals (Shalev et al 2001). This suggests that CRF within the 
dBNST might act on other targets such as the vBNST to initiate reinstatement. 
Furthermore, injections of CRF within the BNST reinstates drug-seeking behavior, 
whereas CRF injections within the amygdala fail to promote the same response (Erb & 
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Stewart 1999). This further indicates that CRF signaling within the BNST is crucial for 
reinstatement.  
  Neuroanatomical evidence has shown that ventral NE projections, which are 
critical to stress-induced reinstatement, make direct synaptic contact with CRF cells 
within the ventral BNST (Hornby & Piekut 1989, Phelix et al 1994). Interestingly, within 
the BNST, CRF enhances beta-AR transmission though activation of CRFR1 (Nobis et al 
2011). In addition, activation of the beta-AR depolarizes BNST CRF neurons, and CRF 
enhances the frequency of spontaneous EPSCs in BNST neurons that project to the VTA 
(Silberman et al 2013). These findings suggest that beta-AR activation may enhance CRF 
release from local BNST CRF sources, leading to enhancement of excitatory 
neurotransmission on VTA-projecting neurons by the activation of either CRFR1 on 
VTA-projecting cells, or the activation of CRFR1 on glutamate cells that interact with 
BNST cells projecting to the VTA. These findings place the BNST as a main candidate 
for a CRF projection to the VTA. However, no studies have shown that a direct BNST to 
VTA CRF projection mediates stress-induced reinstatement. In addition, no studies have 
analyzed the role of interactions of CRF and NE within the BNST in mediating stress-
induced reinstatement. 
 
 
CRF acts within the VTA to promote drug seeking during periods of stress 
 
The VTA has been implicated as a key area where a number of pathways 
converge to regulate motivated behavior and reward to promote drug-seeking behavior 
when faced with a stressor. The VTA is the main source of dopamine within the central 
nervous system and via its two primary spokes, the mesocortical, and mesolimbic 
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systems, the VTA can coordinate drug-seeking behavior. Specifically, ~70% of VTA 
neurons are dopaminergic, ~30% of neurons are GABAergic, and about ~1-2% are 
glutamatergic (Nair-Roberts et al 2008, Walsh & Han 2014, Yamaguchi et al 2015).  
Within the VTA, drug-dependent neuroplasticity can make an addict more 
susceptible to relapse when faced with a stressor (Mantsch et al., 2014). In order to 
develop therapeutics for the treatment of stress-dependent drug seeking, we need to better 
understand the neurobiological mechanisms through which stressors trigger drug seeking.  
Actions of CRF within the VTA have been shown to promote drug use during 
periods of stress. Studies have shown that CRF administration into the VTA is sufficient 
to cause drug-seeking behavior (Blacktop et al 2011, Wang et al 2005, Wang et al 2007), 
and that the actions of CRFR1 (Blacktop et al 2011, Chen et al 2014), CRFR2 (Wang et 
al 2005, Wang et al 2007) and the CRF binding protein (Wang et al 2007) are necessary 
for stress-induced drug, and food (Chen et al 2014) seeking following cocaine self-
administration. CRF inputs into the VTA have been shown to come from the oval bed 
nucleus of the stria terminalis, the paraventricular nucleus of the hypothalamus, and the 
central nucleus of the amygdala (Rodaros et al 2007); however, only the CRF input from 
the oval bed nucleus has been shown to be involved in stress-related drug-seeking 
behavior (Erb et al 2001a, Erb & Stewart 1999, Rodaros et al 2007). Studies have shown 
footshock stress promotes CRF release within the VTA in both drug-naïve, and drug-
experienced rodents (Wang et al 2005).  
Interestingly, a recent study has suggested that chronic nicotine self-
administration upregulates local VTA CRF production, and that this CRF gets released in 
the posterior VTA in an autocrine fashion to activate CRFR1 on DA cells to promote 
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stress-induced nicotine relapse (Grieder et al 2014). This suggests that within the VTA, 
CRF may be released from terminals that originate from the amygdala, bed nucleus, or 
the paraventricular nucleus of the hypothalamus, or from VTA cell bodies during periods 
of stress where it most likely acts on CRFR1 to modulate VTA activity. 
 
CRF receptor subtypes within the VTA 
 
Polymorphisms in genes that encode CRF receptors are associated with 
exacerbated stress responses and propensity to develop drug addiction (Blomeyer et al 
2008, Clarke & Schumann 2009, De Luca et al 2007, Enoch et al 2008, Treutlein et al 
2006) indicating that CRF receptor function can contribute to substance abuse/addiction. 
CRF, and both of its receptors (CRFR1 and CRFR2) are expressed within the VTA 
(Ungless et al., 2003, Korotkova et al., 2006, (Grieder et al 2014). CRFR1 is expressed at 
much lower levels in VTA compared to other brain areas and is localized to both 
dopaminergic and GABAergic cells. Repeated drug use may increase the expression of 
CRFR1, partly; CRF binding is increased within the VTA due to chronic cocaine 
administration as assessed through receptor autoradiography (Goeders et al., 1990).  
Stress seems drive DA activation within the VTA through a CRF-dependent 
mechanism. We have shown that CRFR1 receptor activation is both necessary and 
sufficient for stress-induced drug seeking (Blacktop et al., 2011). In addition, deletion of 
CRFR1 within VTA DA neurons has been shown to be anxiogenic, and decrease DA 
release within the prelimbic cortex (Refojo et al., 2011). Moreover, a VTA viral-mediated 
knockdown of CRFR1 decreased food deprivation stress-induced reinstatement of 
cocaine seeking in mice (Chen et al., 2014). We hypothesize that stress induces an 
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activation of VTA DA neurons that project into the prelimbic cortex (Deutch et al., 1991) 
and therefore increases the release of DA within the prelimbic cortex ( Thierry et al., 
1976; Sorg and Kalivas, 1993). While some studies have suggested this is a CRFR1 
dependent process (Refojo et al., 2011), no studies have directly shown this to be the case 
as it relates to stress-induced drug seeking  
Traditional in situ hybridization methods have failed to detect CRFR2 within the 
VTA (Van Pett et al., 2000); this may indicate that CRFR2 are localized on projecting 
presynaptic terminals within the VTA. In addition, other studies have suggested that both 
CRFR1 and CRFR2 within the VTA mediated EPSC potentiation and attenuation 
respectively (Williams et al., 2014). In addition, the same study showed that CRFR2 
activation facilitated GABA release within the VTA (Williams et al., 2014). These 
studies have indicated that while CRFR1 within the VTA may directly mediate stress-
induced drug seeking, it may do so in coordination with the CRFR2 receptors in a poorly 
understood fashion. 
 
Actions of CRF on VTA neurons 
 
 
The cellular effects of CRF within the VTA are diverse and have been shown to 
include regulation of both glutamatergic and GABAergic inputs; CRF has been 
hypothesized to directly modulate VTA DA firing at presynaptic, postsynaptic, and 
extrasynaptic sites. Studies have indicated that aversive stimuli may differently act upon 
VTA DA projections to either the prelimbic cortex or the nucleus accumbens. 
Specifically many studies have indicated that aversive stimuli (through actions of CRF 
within the VTA) increase DA release within the prefrontal cortex (Abercrombie et al 
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1989, Lammel et al 2008, Lammel et al 2012, Refojo et al 2011, Wanat et al 2008), while 
within the nucleus accumbens, some aversive stimuli such as quinine, an aversive tastant, 
may decrease DA release (Twining et al 2015). This may be attributed to differential 
actions of CRF on VTA DA-projecting neurons; CRF may enhance DA signaling into the 
prelimbic cortex, while have differential effects on, possibly attenuating, the DA 
projection to the nucleus accumbens.  
Specifically, studies have shown that CRF, through activation of CRFR1 within 
the VTA, increases VTA DA Ih currents and dopamine neuron excitability through a 
PKC-dependent mechanism (Wanat et al., 2008). Other studies have shown that chronic 
cocaine use potentiates the magnitude and duration of CRF-induced NMDA currents, and 
that only mice treated with cocaine showed a CRF-dependent enhancement of AMPA 
transmission (Hahn et al., 2009). In addition, other studies have suggested that the 
potentiation of the NMDA receptor-mediated signaling is attributable to CRFR1 
activation (Sparta et al., 2013). These studies suggest that CRF within the VTA enhances 
excitatory transmission, in part through regulation of NMDA and AMPA receptors.  
Other studies have suggested that activation of CRFR1 within the VTA decreases 
VTA DA cell excitability (Beckstead et al., 2009), and dopamine release within the 
nucleus accumbens (Wanat et al., 2013;Twining et al., 2015). Specifically, Beckstead et 
al showed that CRF facilitated GIRK currents and reduced DA neuron excitability via 
activation of CRFR1.  Moreover, CRF administration into the VTA has been reported to 
cause a decrease in basal nucleus accumbens DA (Wanat et al., 2013),  while a CRFR1 
antagonist administered into the VTA blocked the drop in accumbens DA, which is 
observed with intra-oral quinine (Twining et al., 2015).  Interestingly, intra-oral quinine 
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also induces reinstatement. Therefore, these studies suggest that, during periods of stress, 
CRF may act to decrease the VTA DA projection into the accumbens (Twining et al., 
2015).              
 
Glutamate-CRF actions within the VTA promote drug use 
 
The VTA receives glutamatergic inputs from many brain regions (Geisler et al 
2007). Glutamatergic inputs to VTA DA neurons have been found to originate from the 
medial prefrontal cortex, mesopontine tegmentum nucleus, lateral habenula, 
periaqueductal gray, and the dorsal raphe (Charara et al 1996, Clements & Grant 1990, 
Omelchenko et al 2009, Omelchenko & Sesack 2007, Omelchenko & Sesack 2010, Qi et 
al 2014, Sesack & Pickel 1992). However, it is important to note that some of these 
glutamatergic regions also project to non-DA neurons within the VTA, and that 
glutamatergic inputs and outputs to the VTA can manipulate behavior in different ways. 
For example, reward-mediating inputs can come from the laterodorsal tegmental area, 
while aversion-mediating inputs can originate from the lateral habenula (Lammel et al 
2012). These observations are an important indication that isolating selective inputs to the 
VTA using current techniques, such as optogenetics, is critical in order to link specific 
behaviors to specific inputs. Therefore, using current advances in optogenetics and 
chemogenetics, specific inputs onto specific cell populations is an important future 
research objective.  
 CRF actions within the VTA have mainly focused on the interaction between 
CRF and glutamate. Studies have shown that CRF-containing neurons make 
morphologically asymmetric synapses with VTA DA neurons, suggesting that CRF-
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releasing terminals are predominantly glutamatergic (Tagliaferro & Morales 2008). CRF 
directly excites both DA and non-DA neurons within the VTA (Korotkova et al 2006, 
Wanat et al 2008). In addition, CRF increases NMDA current that uses a CRFR2-
dependent mechanism (Ungless et al 2003), while actions on CRFR1 have been shown to 
potentiate both NMDA and AMPA currents in cocaine-experienced mice (Hahn et al 
2009). VTA glutamate levels are increased by the direct administration of CRF within the 
VTA (Wang et al 2005) while administration of the AMPA/NMDA receptor antagonist 
kynurenic acid into the VTA has been reported to prevent both footshock-induced 
reinstatement and the increase in VTA DA levels (Wang et al 2005, Wise & Morales 
2010). This suggests that CRF enhances glutamatergic transmission on VTA DA cells. 
However, it is important to note that VTA DA neurons do not ubiquitously project to the 
same terminals; the balance between VTA DA projection activation and inhibition may 
coordinate a differential behavioral response based on the output of the VTA DA 
neurons; for example, studies have shown that laterodorsal tegmentum neurons 
preferentially synapse on DA neurons projecting into the nucleus accumbens lateral shell, 
while lateral habenula neurons synapse primarily on DA neurons that project to the 
medial prefrontal cortex, and GABAergic neurons located within the tail of the 
VTA(Lammel et al 2014, Lammel et al 2012). This is important because studies have 
shown that the lateral habenula is activated during aversive stimuli (Barrot et al 2012, 
Jhou et al 2013, Stamatakis & Stuber 2012) which suggests that the stress-dependent 
increase of DA release within the prefrontal cortex may be dependent on activation of 
VTA DA neurons by the lateral habenula.   
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GABA neurotransmission within the VTA during stress-induced relapse 
   
  
Much research has focused on the role of excitatory neurotransmission within the 
VTA that leads to relapse during periods of stress. However, the inhibitory 
neurotransmitter γ-aminobutyric acid (GABA) may have diverse functions in controlling 
DA cell firing within the VTA. It is important to note that the VTA is not only comprised 
of DA neurons, but also a subset of GABAergic neurons that are interneurons (Cruz et al 
2004, Steffensen et al 1998) or GABAergic-projecting neurons (Pupe & Wallen-
Mackenzie 2015, Walsh & Han 2014). Specifically, ~70% of VTA neurons are 
dopaminergic, ~30% of neurons are GABAergic, and about ~1-2% are glutamatergic 
(Nair-Roberts et al 2008, Walsh & Han 2014, Yamaguchi et al 2015). Interestingly, very 
small subsets of neurons have been found to co-release DA along with either glutamate, 
or GABA in their terminal region (Stuber et al 2010, Sulzer et al 1998, Tritsch et al 
2012). In addition, the VTA receives GABAergic input from various other brain areas 
such as: the nucleus accumbens (Bocklisch et al 2013, Yim & Mogenson 1980), the 
periaqueductal gray (Omelchenko & Sesack 2010, Zhang et al 2015), the bed nucleus of 
the stria terminals (Kudo et al 2012), the lateral septum (Luo et al 2011), laterodorsal 
tegmentum (Omelchenko & Sesack 2005), and the rostromedial tegmental area (Barrot et 
al 2012, Jhou et al 2009). Once released, GABA may act on either GABAA receptors, to 
open up a Cl- channel to hyperpolarize the cell and thus decrease the chance of firing an 
action potential, or it can activate GABAB receptors, which will also decrease the 
membrane potential by activating a potassium channel (GIRK) through a G-protein (Gi) 
that is coupled onto the GABAB receptor (Johnston 1996, Kasten & Boehm 2015). Both 
GABAA and GABAB receptors are located on VTA DA neurons where they can modulate 
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DA activity (Creed et al 2014, Enoch 2008, Lomazzi et al 2008); the diversity of these 
VTA DA neurons can contribute to the complexity of how stress-related inputs regulate 
VTA DA neurons. For example, studies have shown that CRF modulates DA and 
GABA-mediated inhibition within the midbrain by activating inhibitory postsynaptic 
currents through GIRK channels on DA cells. Specifically, CRF enhances the amplitude 
and slows the kinetics of inhibitory postsynaptic current through interactions with 
GABAB receptors and D2 receptors (Beckstead et al 2009).      
 Studies have shown that stress may “turn off the brakes” on VTA DA cells by 
blocking long-term potentiation of GABAergic neurons that synapse onto DA cells 
(Graziane et al 2013). In addition, GABA release is increased within the VTA during 
periods of stress in animals that received daily non-contingent cocaine injections 
(Sotomayor-Zarate et al 2015). Some studies have suggested that CRF interacts with 
GABA neurons; studies have shown that CRF regulates GABA release through a pre-
synaptic mechanism (Kasten & Boehm 2015, Williams et al 2014). This would suggest 
that GABA acts to disinhibit DA firing. However, other literature has suggested that 
GABA directly acts to decrease DA firing. Studies have shown that footshock excites 
VTA GABA neurons while concurrently inhibiting DA neurons (Tan et al 2012). In 
addition, footshock stressors have been shown to reduce the firing of VTA DA neurons 
(Ungless et al 2004). Interestingly, we have recently found that GABAB receptors are 
necessary for both stress-, and CRF-induced drug seeking; our data indicates that GABAB 
activation may be upstream from the actions of CRF (Blacktop et al., 2015). This 
demonstrates that VTA neurons may have a dual action in response to aversive stimuli; 
some neurons will increase their firing rate, while others will have a decrease in firing. It 
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is important to understand the projection areas of these differentially responding VTA 
neurons.  
VTA projections to the PFC 
 
Recent innovations in optogenetics and viral mediated-gene transfer have led to 
findings that DA neurons located in the medial posterior VTA selectively project to the 
medial prefrontal cortex (Lammel et al 2008). These neurons are very unique because 
they have the ability to fire at a very high frequency, have longer waveforms, and have 
significantly smaller after-hyperpolarization curves, indicating that these neurons have 
the potential to fire rapidly. Interestingly, these neurons express relatively low amounts of 
the DA transporter, and they lack somatodendritic D2 receptors and autoreceptor DA D2 
receptors on their presynaptic terminals which interact with G-protein inward rectifying 
receptors, in addition, these pyramidal neurons have been shown to lack GIRK channels 
as well (Lammel et al 2008).   
Studies have indicated that VTA DA neurons innervate pyramidal neurons (the 
principal glutamatergic neuron of the prefrontal cortex) located in layers II, and V/VI 
within the prelimbic cortex (Swanson 1982). Pyramidal neurons in this layer may be 
found in two types of state: a down-state in which the neurons display a negative resting 
membrane potential and therefore are less excitable, and an up-state which is 
characterized by a plateau depolarization and therefore are more excitable (Peters et al 
2000). Electrical stimulation of VTA DA neurons have been shown to evoke a long-
lasting transition of pyramidal neurons from the down-state to the up-state and this effect 
was blocked by administration of a D1 receptor antagonist (Lewis & O'Donnell 2000). 
The activation of D1 receptors within the prefrontal cortex is thought to increase current 
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through the NMDA receptor via a PKA-, and Ca+2-dependent mechanism (Wang & 
O'Donnell 2001). In addition, studies have suggested that activation of D1 receptors on 
pyramidal neurons also inhibits G protein-dependent inward recertifying currents 
(Witkowski et al 2008). These results suggest that VTA DA neurons control the 
probability of prefrontal pyramidal firing and/or synchronize pyramidal neuron activity. 
This is very important because the prefrontal cortex is necessary for stress-induced drug 
seeking, particularly pyramidal neurons (McFarland et al 2004), and drug seeking during 
periods of stress may be mediated by the activation of D1 receptors in this region 
(Capriles et al 2003). However, no studies have directly shown that mesocortical DA 
neurons are recruited in a CRF-dependent manner to promote drug use during periods of 
stress.   
 
The prefrontal cortex is involved in cocaine use during periods of stress 
 
Drugs of abuse decrease the value of natural reward, diminish cognitive control, and 
enhance glutamatergic drive to drug-associated stimuli within the cortico-accumbens 
pathway (Kalivas & Volkow 2005). It is well accepted that the reinforcing properties of 
cocaine and other drugs of abuse involves the activation of the mesocorticolimbic reward 
pathway, which includes DA neurons originating from the VTA and projecting to the 
ventral striatum and PFC. The PFC is involved in driving cognitive processes, and 
executive functioning by processing information from vast sensory modalities to form 
memories, perception, and decision-making (Siddiqui et al 2008). Our early 
understanding of the PFC comes from Phineas Gage who was unfortunate enough to have 
a metal rod obliterate his left PFC in an explosion. Phineas Gage developed both memory 
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problems and a change in personality. However, our understanding of the role of the PFC 
in stress-related drug use remains unclear.    
 Preclinical studies have indicated that acute cocaine administration increases the 
activity of the PFC. Studies have shown that non-contingent cocaine administration 
increases blood flow to the dorsolateral PFC and self-administration of cocaine increases 
blood flow to both the dorsolateral PFC and the anterior cingulate cortex (Howell et al 
2002, Howell et al 2010). Blood oxygen level-dependent (BOLD) responses are elevated 
in subregions of the PFC such as the dorsolateral prefrontal cortex, anterior cingulate, 
anterior orbital gyrus, orbitofrontal cortex, medial orbital gyrus, and frontopolar cortex 
(Goldstein & Volkow 2011). In addition, intracerebroventricular administration of 
cocaine resulted in a large fMRI response within the PFC, and other brain areas (Febo et 
al 2004). This increase in activity of the prefrontal cortex has been proposed to induce 
neuroplastic changes that transform drug habits from recreational to regular and even 
uncontrollable use (Goldstein & Volkow 2011). In addition, BOLD signals have 
indicated that the human PFC response is linked to both liking and wanting of cocaine 
because BOLD signals in most PFC regions are correlated with the “rush” ratings 
(Breiter et al 1997) and are increased when cocaine administration is expected (Kufahl et 
al 2008). Theses human studies make it very apparent that subregions of the PFC are 
highly involved in drug-seeking behavior.  
 
 
Cocaine intake induces hypofronatality within the prefrontal cortex 
  
It has been hypothesized that chronic cocaine intake may cause hypofrontality 
within the prefrontal cortex, which may be reversed when addicts are exposed to 
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environments that are previously associated with drug taking (Childress et al., 1999). It 
has been hypothesized that hypofrontality also occurs with repeated cocaine intake in 
rats; studies using rats trained to self-administer cocaine showed that overall firing and 
burst rates were significantly decreased after the first cocaine exposure relative to prior 
activity; these effects dissipated after 10 days of drug SA, and were replaced by a 
significant increase in burst duration and firing rate (Sun & Rebec 2006). Interestingly, 
imaging data has indicated that activity of the PFC in drug addicts is lower compared 
with controls (Volkow et al., 2003); these studies however cannot determine whether this 
hypofronatality is induced by cocaine or a pre-existing condition. In addition, BOLD 
signals cannot differentiate the activity between pyramidal neurons or interneurons. 
However, theories have proposed that while drug addiction devaluates natural rewards 
through hypofronatality, drugs, and drug-related cues, may enhance the activity of the 
prefrontal cortex (Volkow et al 2003). In addition, extensive drug use (such as our long-
access self-administration model) has been hypothesized to enhance the activity of the 
cortico-striatal pathways by priming the system to triggers such as cues or exposure to a 
stressor (Sinha 2013). Furthermore, studies have indicated that magnitude of stress-
induced craving correlates with levels of prior-drug use in humans (Fox et al 2005). This 
would suggest that a history of increased drug use might prime the prefrontal cortex to be 
more active when exposed to a stressor. However fMRI assessment of the PFC in cocaine 
addicts upon exposure to stress-related imagery has shown that BOLD signal is actually 
reduced rather than increased (Sinha et al., 2009).  
Interestingly, studies have also suggested that chronic drug use alters CRF activity 
(Sinha 2013). Therefore, it is intriguing to speculate that a CRF-dependent mechanism 
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may control the activity of the prefrontal cortex during stressful stimuli that in a manner 
that elicits relapse to drug use.             
 
Neuroanatomy of the rat prefrontal cortex 
  
In the rodent, the prefrontal cortex is comprised of three different topographical 
regions (medial, orbital, and lateral parts(Ongur & Price 2000). The medial PFC can be 
subdivided into four main structures: the medial granular, the anterior cingulate, the 
prelimbic cortex (PL), and the infralimbic cortex (IL; (Hoover & Vertes 2007). The 
medial PFC can be divided into dorsal and ventral divisions; the dorsal medial PFC is 
involved in motor behaviors (medial granular), while the ventral medial PFC is involved 
in emotional, and cognitive processing (anterior cingulate, PL, and IL; (Heidbreder & 
Groenewegen 2003). While this work focuses mainly on the VTA DA projection to the 
prelimbic cortex, this region does receive numerous projections from other areas. 
Notably, the main projections to the PL and IL are the orbital medial prefrontal, agranular 
insular, perirhinal and entorhinal cortices, the hippocampus, the claustrum, the medial 
basal forebrain, the basal nuclei of the amygdala, the midline thalamus, and the locus 
coeruleus of the brainstem (Hoover & Vertes 2007). Conversely, both the PL and IL 
cortices project to multiple brain areas, all of which may be reviewed by the works of 
Vertes; the important projections as it pertains to stress-evoked drug use, are the lateral 
septum, the bed nucleus of the stria terminalis, and the parabrachial nucleus of the 
brainstem for the IL and the nucleus accumbens, and mediodorsal nucleus of the 
thalamus for the PL (Vertes 2004). These projections suggest that the IL is involved, in 
part, in visceral/autonomic activity, while the PL is involved in cognitive function (Vertes 
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2004). The infralimbic cortex sends a glutamatergic projection to the shell of the nucleus 
accumbens that is thought to be involved in extinction learning (LaLumiere et al 2010, 
LaLumiere et al 2012). Furthermore, it has been shown that the glutamatergic projection 
from the IL to the shell of the accumbens exerts suppression of drug seeking (Peters et al 
2009, Peters et al 2008). Specifically, inactivation of the infralimbic cortex, or the shell of 
the nucleus accumbens, reinstates drug seeking in the absence of drugs, cue, or stressful 
triggers (Peters et al 2008)   
 
The prelimbic cortex is involved in stress-related cocaine use 
 
While much attention has been placed on the role of the PFC as it pertains to drug 
taking, the PFC also has a prominent role in stress-related relapse to drug use. Stress-
related drug use has been mimicked in the rodent using a mild-non-noxious footshock 
stressor. Interestingly, in 1976, Glowinski found that an electric-footshock stressor 
significantly increased DA, but not norepinephrine, release within the prefrontal cortex 
while DA release was not increased within the ventral striatum (Thierry et al 1976). In 
addition, retrograde tracing studies have shown that a restraint stressor increased Fos 
protein (a neuronal activity marker) immunoreactivity within VTA DA neurons that 
project to the PFC; however, Fos expression was not increased in any DA projections to 
the nucleus accumbens (Deutch et al 1991), in addition studies have shown that a tail-
shock increased DA reactivity by 95% within the PFC; and to much lesser extents in the 
nucleus accumbens, and other terminal areas (Abercrombie et al 1989). These studies 
pioneered the idea that stress may selectively activate DA projections from midbrain DA 
neurons to the PFC, which likely precipitate drug use during periods of stress (Capriles et 
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al 2003, McFarland et al 2004). Many studies have shown that aversive stimuli, such as  
footshock, increase DA release in terminal regions of the mesocorticolimbic DA system 
(Abercrombie et al 1989, Gresch et al 1994, Kalivas & Duffy 1995). This is also seen 
with other triggers for relapse, such as exposure to cues previously associated with the 
drug, and the drug itself (see Mantsch et al., 2015 for review).  The prefrontal cortex 
appears to process these different triggers to relapse by engaging the nucleus accumbens 
core. Electrophysiological data has suggested that prefrontal cortical DA activation is 
involved in cocaine seeking rather than the hedonic process of cocaine itself (Rebec & 
Sun 2005).  
 
Topographical organization of the DA projection from the VTA to the PFC 
 
As mentioned previously, dopamine originates from the VTA/substantia nigra (or 
A10) and projects to most limbic system structures, especially the prefrontal cortex 
(Swanson 1982). Most cells that project to the prefrontal cortex from the VTA are located 
in medial/caudal  parts of the VTA (Lammel et al 2014) and are mostly topographically 
organized wherein dorsomedial parts of the VTA project to the anterior cingulate, while 
ventromedial parts of the VTA project to the dorsomedial prefrontal cortex (Swanson 
1982).  
Interestingly, roughly 11% of cells that project to the PFC cross the midline and 
66% of cells that project to the PFC are dopaminergic (Swanson 1982). Most studies 
have examined the DA projection from the VTA to the PFC in mice using TH-cre/DAT-
cre GFP mouse line.  Combining this approach with retrograde tracers, studies have 
started to suggest that VTA DA projections differentially encode reward and aversion in 
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mice (Lammel et al., 2012) and non-human primates (Kormos & Gaszner 2013). While 
mouse and rodent brains are fairly similar, the lack of genetically modified rats has made 
it difficult to pinpoint VTA DA neurons that are 1) activated by aversive stimuli and 2) 
are topographically located within the VTA. 
Activation of DA receptors 
  
Once DA is released into the synaptic cleft, it can act on five major receptor 
subtypes, designated D1-D5. All of these receptors belong to the seven transmembrane 
domain G-protein coupled receptors. The DA receptors are commonly categorized as 
either D1-like (D1 and D5) or D2-like (D2, D3, and D4) based on sequence homology and 
G-protein coupling. Activation of D1-like receptors activates the G-protein Gsα, leading to 
activation of adenylyl cyclase, and an increase in second messengers such as cAMP, 
while activation of D2-like receptors are inhibitory through actions of the G-protein Gai.  
 
Dopamine receptor location within the PFC 
 
D1-like and D2-like receptors are found within the PFC, specifically within layers 
II-VI of the PFC with the highest density observed within layer V and VI of the 
prefrontal cortex; these layers also receive a prominent projection from the VTA as 
compared to layers II-III (Swanson 1982, Vincent et al 1993). Studies have suggested 
that D1-like receptors are located post-synaptically (Levey et al 1993) on pyramidal 
neurons (Vincent et al 1993) while D2-like receptors interface with the extrasynaptic 
space of the presynaptic projecting neurons where they act as autoreceptor to inhibit DA 
release (Goldstein et al 1990). However, some D2-like receptors have been localized to 
GABAergic interneurons and some expression has been observed on astrocytes (Vincent 
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et al 1993). Interestingly, some studies have reported that D1-like receptors are also 
present on parvalbumin-containing interneurons; these neurons control the 
synchronization of PFC pyramidal neurons (Muly et al 1998). This serves to show the 
complexity of the PFC, in that DA within the PFC can act to either increase or decrease 
the excitability of pyramidal neurons based the location of DA release and/or targeted 
receptor, and neuroplastic changes can occur in many different areas to shape the output 
of the prelimbic cortex. However, in the case of the projection from the VTA, D1-like 
receptors are preferentially expressed postsynaptically on pyramidal neurons in the PFC 
(Boyson et al 1986). Therefore, DA will act on D1-like receptors to increase the 
likelihood of firing rate of PFC pyramidal neurons (Lewis & O'Donnell 2000); these PFC 
neurons are thought to project to the core of the nucleus accumbens (NAc) whereby DA 
indirectly modulates the NAc by increasing the size of the NMDA component of an 
excitatory postsynaptic potential on these neurons (Lewis & O'Donnell 2000, Seamans et 
al 2001, Yang & Seamans 1996). The pyramidal neuron projections from the PFC to the 
NAc is glutamatergic. This suggests that during periods of stress, DA release from the 
VTA to the PFC is increased and activates D1-like receptors on pyramidal neurons, 
leading to an increase in the firing rate of glutamatergic projection neurons to the NAc, 
and therefore promoting drug seeking.  
 
Prelimbic interneurons regulate pyramidal neurons through actions of both D1 and 
D2 receptors 
 
 
While mesocortical DA fibers innervate pyramidal neurons (Goldman-Rakic et al 
1989, Verney et al 1990), they also innervate GABAergic interneurons (Sesack et al 
1995, Vincent et al 1993). These GABAergic interneurons are important in initiating and 
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maintaining rhythm and synaptic kinetics within the prefrontal cortex (Gupta et al 2000) 
through their variable intrinsic firing rates (Markram et al. 2004). Parvalbumin 
interneurons constitute the majority of interneurons within cortical layer V (Markram et 
al. 2004) where they synapse close to pyramidal neurons and other local interneurons 
(Kawaguchi and Kubota 1997, 1998). DA can increase the excitability of interneurons, as 
evidenced by the finding that bath application of the D2 agonist quinpirole or the D1 
agonist SK38393 induces an increase in the interneuron excitability (Tseng and 
O’Donnell 2007) and therefore may increase GABAergic synaptic transmission onto 
pyramidal neurons within the prefrontal cortex. At low DA levels, D1 receptors are 
activated therefore increase interneuron excitability (Gorelova et al., 2002, Trantham-
Davidson et al., 2004a,Trantham-Davidson 2004b) and D1 agonists have been shown to 
enhance spontaneous (sIPSCs) inhibitory neurotransmission, indicating that the intrinsic 
excitability of interneurons is increased (Seamans et al., 2001). By contrast, activation of 
D2 receptors during times of high DA concentrations has been shown to decrease cortical 
IPSCs via a postsynaptic mechanism on interneurons (Trantham-Davidson 2004b) and D2 
receptor agonists reduce the postsynaptic response to a GABAA agonist, indicating that 
signaling through D2 receptors may work via a postsynaptic mechanism to reduce the 
GABA tone of interneurons (Seamans et al., 2001). Other studies have shown that DA 
can decrease IPSCs in the prefrontal cortex by acting on presynaptic D1 receptors likely 
located on interneuron terminals (Gonzalez-Islas and Hablitz et al, 2001). All of these 
studies suggest that dopamine interactions with interneurons within the prefrontal cortex 
is very complex, since it can control interneuron firing, and since these interneurons can 
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coordinate pyramidal neuron firing by either synchronizing them, or inhibiting other 
interneurons.                
Evidence implicating DA in footshock-induced reinstatement of cocaine seeking 
comes from Capriles and colleagues (2003). This group showed that local administration 
of the D1-like and not the D2-like receptor antagonist into the PFC or the orbital frontal 
cortex blocked footshock-induced reinstatement (Capriles et al 2003). In addition, other 
findings have shown that either administration of fluphenazine (a D1/D2 like receptor 
antagonist) into the PFC (McFarland et al 2004) inhibits stress-induced reinstatement. 
The actions of D1 receptors on pyramidal neurons are thought to increase the excitability 
of pyramidal neurons that project to the nucleus accumbens core. Within layer V of the 
prefrontal cortex, activation of D1-like receptors has been shown to increase the size of 
the NMDA current (Seamans et al 2001). This suggests that VTA DA projections to the 
PFC are important in stress-induced reinstatement.     
 
CRF may regulate the DA projection to the prelimbic cortex 
   
Recent research suggests that stress, in part through the actions of CRF, activates 
the mesocortical DA system to induce reinstatement following footshock. This 
interaction between CRF and DA systems has been shown by both behavioral and 
neuroanatomical studies, which suggests that these systems converge in key brain regions 
known to play an important role in stress-evoked reinstatement. Early studies employed 
microdialysis to measure catecholamine release in the PFC and the medial hypothalamus 
during systemic and central administration of CRF. These studies demonstrated that 
intracerebroventricular CRF injections increase DA release in the PFC (Lavicky & Dunn 
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1993). Patch-clamp recordings from VTA slices demonstrated that CRF, through the 
actions of CRFR1, dose-dependently increased VTA dopamine firing (Wanat et al 2008). 
In addition, studies have reported that bath application of CRF to VTA DA neurons 
induces an increase in NMDA receptor-meditated excitatory postsynaptic potential 
(Ungless et al 2003). This effect is attributed to activation of CRFR2 receptors and the 
CRF-binding protein; this is interesting because many studies have suggested that drug 
seeking (Blacktop et al 2011, Boyson et al 2014, Grieder et al 2014), or food seeking 
during periods of stress (Chen et al 2014), is attributed to actions on CRFR1 and not 
CRFR2. However, some studies have suggested that CRFR2 and not CRFR1 is involved 
in drug-seeking behavior(Ungless et al 2003, Wang et al 2007). This difference may be 
attributed to different receptor localization, or it may be attributed to differences in prior 
drug-taking behavior (Mantsch et al 2015, Mantsch et al 2014). Interestingly, recent 
reports have shown that CRFR1 mediates DA release within the PFC and controls 
anxiety since a deletion of CRFR1 within midbrain DA neurons decreased DA release 
within the PFC, and increased anxiety levels in mice (Refojo et al 2011). CRF neurons 
that project to the VTA may contain, and therefore may co-release, glutamate onto VTA 
DA neurons. Electron microscopy work has shown that CRF terminals that synapse onto 
tyrosine hydroxylase-positive cells (TH; the precursor for DA) form asymmetric synapses 
and therefore most likely release glutamate (Tagliaferro & Morales 2008). This suggests 
that the presence of, and release of CRF during a footshock stressor may promote 
glutamatergic excitation of VTA DA neurons.  However, as previously noted, many 
CRF-releasing inputs are likely GABAergic. It is not clear whether stress-induced 
reinstatement is dependent on DA cells that are activated by CRF to precipitate stress-
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related drug use, since electron microscopy has only focused on CRF terminals that 
synapse onto DA neurons, and not GABAergic cells. 
 
Dopamine within the nucleus accumbens during stress-induced reinstatement 
 
 
In addition to the PFC, the nucleus accumbens receives VTA DA projections. 
Microdialysis studies have shown that stress can increase DA levels within the NAc shell 
(Kalivas & Duffy 1995, Sorg & Kalivas 1991). Temporary inactivation of the NAc core 
and shell with GABA receptor agonists prevents footshock-induced reinstatement 
(McFarland et al 2004). However, local infusion of fluphenazine (the non-specific DA 
antagonist) into the NAc core fails to block footshock-induced reinstatement, suggesting 
that activity at the DA receptors within the NAc core does not mediate relapse due to 
stress; however shock-induced reinstatement of heroin seeking has been reported to be 
blocked by a D1 receptor antagonist (Shaham et al., 1996). Moreover, it has been found 
that, in contrast to glutamate, DA levels in the NAc core are not changed during 
footshock stress-induce reinstatement of cocaine seeking (McFarland et al 2004). Taken 
together these studies suggest that stress-induced reinstatement may depend on activation 
of VTA DA neurons projecting to the PFC, which in turn stimulates glutamate release 
within the NAc, but not on elevated NAc DA. 
 
 
Anatomy of the nucleus accumbens 
 
 
Generally, the NAc, also termed the ventral striatum, is divided into two 
subregions, based on different cytoarchitecture, and unique functions. The first subregion 
is the nucleus accumbens core; this subdivision is considered an extension of the dorsal 
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striatum (motor pathway), which is involved in instrumental learning and reinstatement 
behavior, specifically during periods of stress (Cardinal & Everitt 2004, Ito et al 2000, Ito 
et al 2004). The NAc core receives glutamate input from the prelimbic cortex (PL); 
specifically layers V/VI (Gabbott et al 2005, Reynolds & Zahm 2005). This is thought to 
represent the final common pathway in mediating reinstatement of drug-seeking behavior 
in response to a cue, a stressor, or the drug itself (Kalivas & Volkow 2005). The second 
subregion is the nucleus accumbens shell, which is an extension of the extended 
amygdala; this part of the NAc is critical for the reinforcing/rewarding effects of drugs of 
abuse.  In contrast to glutamatergic projections from the PFC to the core, PFC projections 
to the shell are thought to inhibit drug-seeking behavior, especially since inhibiting these 
projections can induce reinstatement without the presence of a cue, a stressor, or a drug 
(Kalivas 2005, Pierce & Kumaresan 2006). In addition, a recent study has indicated that 
the dorsomedial shell encodes reward, while the ventromedial shell encodes aversion in a 
dynorphin-dependent manner (Al-Hasani et al 2013). The shell receives glutamatergic 
input from the infralimbic cortex (Gabbott et al 2005, Reynolds & Zahm 2005).  
Both the core and the shell have similar, but yet distinct output pathways. Both of 
these regions have a distinct topographical projection to the ventral pallidum and the 
entopeduncular nucleus (Groenewegen & Russchen 1984). The core projects to the 
dorsolateral part of the ventral pallidum while the shell projects to the medial part of the 
subcommissural ventral pallidum (Groenewegen et al 1993). The core has a midbrain 
projection to the substantia nigra pars reticulata (which sends input to the thalamus) 
(Deniau et al 1994), while the shell projects to the VTA (Ikemoto 2007). In addition, the 
core has some sparse projections to the lateral hypothalamus, while the shell projects 
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diffusely throughout the lateral hypothalamus, but mainly to the extended amygdala 
(Heimer et al 1991, Kelley 1999).  
Medium spiny neurons within the nucleus accumbens are GABAergic and can be 
subdivided into either the direct or the indirect pathway based dopamine receptor 
expression. Although the presumed organization of NAc MSN outputs has been recently 
called into question (Kupchik et al., 2015), it has been suggested that one subpopulation 
of medium spiny neurons expresses D1R and sends projections to midbrain regions, most 
notably the substantia nigra, while another subset of MSNs express D2R and putatively 
sends projections to the ventral pallidum (although projections to the SN have been 
identified). It is believed that direct and indirect pathway have complementary, and 
possibly, opposing actions on behavior that are controlled by the cortico-accumbal 
pathway (Gerfen and Sumeier 2011). Studies have shown that the D1R-regulated 
pathway increases conditioned place preference for cocaine, whereas activation of the 
D2R-regulated pathway decrease conditioned place preference for cocaine (Lobo et al., 
2010). Studies have also shown that activating glutamatergic inputs onto subpopulations 
of MSNs in the NAc determine cocaine susceptibility and AMPA/NMDA ratios can be 
differentially altered in excitatory synapses on different MSN population in mice exposed 
to cocaine (Bock et al., 2012). It has been hypothesized that the activation of the “direct” 
(D1R) pathway causes an increase in the motivation to seek cocaine, while the “indirect” 
(D2R) pathway serves to decrease cocaine-seeking behavior when activated (Bock et al., 
2012).          
The NAc is an important brain region that serves as the gateway through which 
the limbic system (basolateral amygdala, VTA, PFC, and NAc) communicates with the 
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motor subcircuit (motor cortex, dorsal striatum, and the substantia nigra; (Groenewegen 
et al 1996, Kalivas 2009). Studies have found that the NAc can act to engage and 
implement adaptive behaviors for a desired outcome by priming the motor system (Doya 
2008). For example, if a response such as activation of a lever leads to a positive outcome 
(such as delivery of a sucrose pellet) the NAc will engage the motor subcircuit to 
recognize this response. It has been proposed that as behavior becomes 
persistent/habitual, activation of the NAc diminishes, while the motor system becomes 
more organized to adapt to this behavior. However, if lever activation fails to yield an 
expected outcome, then the limbic subcircuit is strongly engaged, while the motor 
subcircuit becomes more disorganized (Kalivas 2009). This allows the limbic system to 
prime the motor system to maximize adaptive behavior through interactions of the NAc 
with the motor system. When it comes to relapse to cocaine use, the current thinking 
states “drug seeking arises from an impaired ability of the limbic subcircuit to effectively 
process and/or use the negative environmental contingencies associated with relapse” 
(Kalivas 2009); in other words, drug use can hijack the limbic system so that the learned 
behavior is never truly extinguished, and that environmental stimuli such as a footshock 
stressor may overcome the learned behavior of extinction and promote drug use through a 
mechanisms in which DA from the VTA potentiates PFC pyramidal neuron firing to 
activate the nucleus accumbens core.  
The primary neurons of the NAc are medium spiny neurons (MSN) and they are 
critical for goal-directed behavior. These MSNs are mainly GABAergic. The MSNs of 
the NAc integrate emotional salience from the amygdala, contextual cues from the 
hippocampus, and executive or motor control from the PFC to produce a response by 
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influencing motor regions that execute motivated-behavior (Groenewegen et al 1999, 
Kelley 1999). Rodent models have shown that activation of NAc MSN by AMPA 
receptors is required for cocaine-seeking behavior, a process that is facilitated by 
neuroplastic changes that occur on AMPA containing synapses of MSNs with repeated 
cocaine use (Wolf 2010). Studies have indicated that prefrontal glutamatergic innervation 
of the NAc is changed with chronic drug use, in that the compulsivity of drug use in 
addicts becomes more desirable than natural rewards (Kalivas & Volkow 2005). This 
neuroadaptation to drug use is mediated by at least three different mechanisms, 1) 
changes in AMPA receptor expression within the NAc (e.g. an increase in Ca+2 
permeable AMPA, the Glu-A2 lacking AMPA receptors); 2) impaired cysteine-glutamate 
exchange leading to a decrease in extracellular glutamate release and therefore decreased 
negative feedback through metabotropic glutamate receptors; 3) changes in the intrinsic 
excitability of MSNs (Wolf 2010). These adaptations serve to increase the excitability of 
MSNs.   However the NAc also receives a distinct DA projection from the VTA, which 
may also effect the excitability of MSNs. 
Dopamine in the nucleus accumbens is critical for the rewarding and stimulant 
effects of cocaine.  It has been shown that DA infused into the NAc core will induce an 
increase in locomotion, which can be inhibited by inactivating the globus pallidus with 
injections of GABA (Jones & Mogenson 1980).  Studies have shown that DA receptor 
agonists are self-administered by rodents, and non-human primates when given 
systemically, and when infused directly into the nucleus accumbens (Carlezon et al 1995, 
Woolverton et al 1984, Yokel & Wise 1978). Microdialysis studies have shown that both 
non-contingent, and contingent administration of cocaine (and other drugs of abuse) 
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increases dopamine levels within the NAc (Di Chiara & Imperato 1988, Di Ciano et al 
1998, Di Ciano et al 1995, Imperato et al 1992, Kalivas & Duffy 1990, Kalivas & Duffy 
1993, Wise et al 1995, Wise et al 2008). Interestingly, the same studies have shown that 
rats will administer cocaine in order to keep DA levels consistent within the NAc such 
that when DA levels start to decrease, the animal will self-administer more cocaine in 
order to keep the levels stable (Wise et al 1995). Therefore, these studies suggest that 
fluctuating DA levels within the NAc correlate with increased drug use. 
Studies have also examined the role of the nucleus accumbens core during either 
cocaine self-administration, or following extinction training during reinstatement 
behavior. Since, intra- nucleus accumbens core administration of DA receptor antagonists 
increases cocaine self-administration suggesting that inhibition of DA receptors decreases 
the rewarding properties of cocaine (Caine et al 1995, Koob et al 1994). While 
administration of wither AMPA or NMDA within the nucleus accumbens during self-
administration caused a significant leftward shift of cocaine responding which suggested 
enhancement of cocaine reward (Cornish et al 1999).  
Dopamine in the NAc core does not appear to be necessary for cocaine seeking; 
however, glutamatergic neurotransmission in the NAc is critical (Cornish and Kalivas, 
2000). Administration of either AMPA or NMDA following SA and extinction in rats 
reinstates drug seeking (Cornish et al 1999). At a cellular level, glutamatergic terminals 
originating from the prelimbic cortex, and dopamine originating from the VTA converge 
on the same medium spiny neurons; therefore the observation that intra-accumbens 
AMPA administration could reinstate cocaine-seeking behavior could be explained by 
AMPA directly activating MSN. Since numerous studies have shown that DA release is 
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increased within the prelimbic cortex during stress-related behaviors (McFarland et al 
2004, Moghaddam 1994, Refojo et al 2011, Thierry et al 1976), and that this increase in 
DA modulates pyramidal neuron fringing into the nucleus accumbens it is hypothesized 
that increases in glutamatergic transmission in the nucleus accumbens driven in part by 
elevated DA in the prelimbic cortex is an important factor for initiating relapse to drug 
taking; this has been shown to be involved in drug-primed reinstatement since an AMPA 
antagonist, and not a DA antagonist infused into the nucleus accumbens prevents 
reinstatement(Cornish & Kalivas 2000).  
 
Neurocircuitry involved in stress-induced drug seeking 
  
 
The use of a rodent reinstatement model of drug relapse is extremely important in 
understanding the neurobiological pathways that mediate drug seeking during periods of 
stress. This is especially important since the vulnerability to relapse due to a stressor 
persists years after the cessation of drug use. This dissertation will explore different 
aspects of this pathway to understand how stress triggers relapse, and hopefully provide 
aid in the development of therapeutics that can better manage or prevent drug use that is 
stress-related. Chapter 2 will test the hypothesis that beta-2 ARs are required for stress-
induced activation of CRF pathways responsible for reinstatement. Work done in our lab, 
and others, has suggested that noradrenergic receptors (Leri et al., 2002), specifically 
beta-2 ARs (Mantsch et al., 2010; Vranjkovic et al., 2012) may be critically involved in 
the interaction with the CRF system. Second, the self-administration model will be used 
to test the hypothesis that stress-induced reinstatement is dependent upon a beta-2 AR 
regulated vBNST-to-VTA CRF-releasing pathway, wherein stress-induced CRF will 
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activate CRFR1 on VTA neurons. Finally, this dissertation will explore how excessive 
cocaine use establishes susceptibility to stress-induced relapse by recruiting CRF 
regulation of a key stressor-responsive mesocortical dopaminergic pathway.  
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Chapter II 
 
  
Beta-2 adrenergic receptors mediate stress-evoked reinstatement of cocaine-
induced conditioned place preference and increases in CRF mRNA in the bed 
nucleus of the stria terminalis in mice 
 
 
Abstract 
 
 
 Rationale: Understanding the mechanisms responsible for stress-induced relapse 
is important for guiding treatment strategies aimed at minimizing the contribution of 
stress to addiction. Evidence suggests that these mechanisms involve interactions 
between noradrenergic systems and the neuropeptide corticotropin-releasing factor 
(CRF).  
Objectives: The interaction between beta-adrenergic receptors (ARs) and CRF as 
it relates to the reinstatement of cocaine-conditioned reward in response to a stressor was 
examined in mice. We hypothesized that beta 2-ARs are required for stress-induced 
activation of CRF pathways responsible for reinstatement.  
Methods: Stress-induced relapse was examined based on the re-establishment of 
cocaine-induced conditioned place preference (CPP; 4×15 mg/kg cocaine, i.p.) after 
extinction using forced swim (6 min at 22 °C) or an injection of the beta 2-AR agonist, 
clenbuterol (4 mg/kg, i.p.). The CRF-R1 antagonist antalarmin (10 mg/kg, i.p.) or the 
beta 2-AR antagonist ICI- 118,551 (1 mg/kg, i.p.) were given 30 min prior to reinstating 
stimuli. Quantitative PCR was conducted in dissected bed nucleus of the stria terminalis 
(BNST) and amygdala, putative sources of CRF that contribute to reinstatement, to 
examine the effects of ICI-118,551 on swim-induced increases in CRF messenger RNA 
(mRNA) in mice with a cocaine history.  
	   56	  
 
Results:  
Pretreatment with ICI-118,551 or antalarmin blocked swim-induced reinstatement of 
CPP. Reinstatement by clenbuterol was also blocked by antalarmin. ICI-118,551 
pretreatment prevented swim-induced increases in CRF mRNA in the BNST. Effects in 
the amygdala were not observed. Conclusions These findings indicate that, during stress, 
norepinephrine, via beta 2-ARs, either directly or indirectly activates CRF-releasing 
neurons in the BNST that interface with motivational neurocircuitry to induce 
reinstatement of cocaine conditioned reward. 
 
Introduction 
 
 
Understanding the mechanisms through which stress promotes relapse to drug use 
by cocaine addicts continues to be a critical research objective. Outcome measures for 
current treatment approaches aimed at relapse prevention remain poor, and stress is a 
pervasive trigger for relapse as it is typically unavoidable in daily life. In addition, there 
is currently no FDA-approved medication for cocaine addiction, making it a critical 
unmet need. Stress-induced relapse to cocaine use can be modeled in mice using a 
cocaine-induced conditioned place preference (CPP) approach in which, after extinction, 
preference can be re-established (i.e., reinstated) using stressors such as forced 
swim(Kreibich et al 2009, Mantsch et al 2010).  
A role for noradrenergic signaling in stress-induced reinstatement of cocaine-
conditioned reward has been established. Using the CPP/reinstatement approach in mice, 
our laboratory has found that functional antagonism of noradrenergic neurotransmission 
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via administration of the α2-adrenergic receptor (AR) agonist clonidine blocks swim-
induced reinstatement of extinguished CPP(Mantsch et al 2010), while disinhibition of 
noradrenergic activity via administration of yohimbine or the highly selective α2-AR 
antagonist BRL 44,408 is sufficient to reinstate(Mantsch et al 2010, Vranjkovic et al 
2012). These findings parallel those in rats demonstrating α2-adrenergic AR agonist 
blockade of shock-induced reinstatement following cocaine self-administration (SA;(Erb 
et al 2000)) and sufficiency of central administration of norepinephrine or systemic 
delivery of yohimbine for reinstatement of cocaine seeking (Brown et al 2011, Brown et 
al 2009, Feltenstein & See 2006). More importantly, they are consistent with reports that 
α2-AR agonists attenuate drug craving in human cocaine addicts upon presentation of 
stress-associated imagery(Jobes et al 2011). 
Stress-induced increases in noradrenergic activity appear to induce reinstatement 
of cocaine-conditioned reward in part via activation of beta-AR. We have found that 
swim-induced reinstatement of cocaine-induced CPP is blocked by the nonselective β-AR 
antagonist propranolol (Mantsch et al 2010)and is not observed in beta-AR-deficient 
mice (Vranjkovic et al 2012) while the non-selective beta-AR agonist isoproterenol 
induces reinstatement (Vranjkovic et al 2012). More specifically, our findings suggest 
that beta 2-ARs are necessary for stress-induced reinstatement of cocaine-conditioned 
reward, as swim-induced reinstatement of CPP is blocked by the selective beta 2-AR 
antagonist ICI-118,551 and administration of the selective beta 2-AR agonist clenbuterol 
is sufficient for reinstatement of CPP(Vranjkovic et al 2012). 
The sites at which stress-induced increases in beta-AR activation promote 
reinstatement behavior appear to include the bed nucleus of the stria terminalis (BNST) 
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and central amygdala (CeA), both of which receive dense noradrenergic projections 
(Ricardo & Koh 1978, Woulfe et al 1988), express beta-ARs (Asanuma et al 1991, 
Cecchi et al 2007, Rainbow et al 1984), and are required for stress-induced reinstatement 
of lever pressing following SA in rats (Erb et al 2001, Leri et al 2002, McFarland et al 
2004) or cocaine-induced CPP in mice (Briand & Blendy 2010). In rats, delivery of a 
cocktail of beta 1- and beta 2-AR antagonists directly into either the BNST or the CeA 
prevents shock-induced reinstatement of cocaine seeking following self-administration 
(Leri et al 2002). The BNST and CeA are components of the extended amygdala and 
serve as key interfaces between the stress and reward systems. Both regions are highly 
interconnected with the mesocorticolimbic system through which they likely regulate 
drug-seeking behavior and reinstatement of cocaine-conditioned reward, although the 
precise pathways and mechanisms through which this regulation occurs are not fully 
understood. 
The link between the mesocorticolimbic circuitry that has been implicated in 
relapse and beta-AR actions in the BNST and amygdala likely involves the neuropeptide, 
corticotropin releasing factor (CRF). CRF is a key mediator of stress induced 
reinstatement of cocaine seeking following SA in rats(Mantsch et al 2008) (Buffalari et al 
2012, Erb et al 2006, Erb et al 1998, Graf et al 2011, Shaham et al 1998) and has been 
reported to contribute to stress-induced reinstatement of lever pressing following SA via 
actions in the BNST (Erb et al 2001) and the ventral tegmental area (VTA;(Blacktop et al 
2011, Wang et al 2005). In the BNST, evidence suggests that stress-induced increases in 
CRF arise in part from local release from intrinsic cell populations(Silberman et al 2013). 
Moreover, CRF release into the VTA is thought to involve projections from the BNST 
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and the CeA(Rodaros et al 2007). In light of the requirement for beta-AR signaling in 
these regions for stress-induced cocaine seeking in rats following SA (Leri et al 2002) 
and evidence suggesting CRF-dependence of beta-AR actions in BNST (Nobis et al 
2011, Silberman et al 2013), we hypothesized that beta 2-AR activation is required for 
stress-induced regulation of CRF releasing neurons in one or both of these regions and 
for relapse to drug use during periods of stress. In support of this hypothesis, it has been 
reported that reinstatement in response to central norepinephrine is CRF-
dependent(Brown et al 2009). 
 Here, we further test this hypothesis by (1) investigating the ability of the CRF-R1 
receptor antagonist, antalarmin, to prevent reinstatement of cocaine-induced CPP in mice 
by a stressor, forced swim, and administration of the beta 2-AR agonist clenbuterol and 
(2) testing for the ability of the beta 2-AR selective antagonist ICI-118,551, which blocks 
swim-induced cocaine-conditioned reward, to also prevent swim-induced activation of 
CRF neurons in the BNST and amygdala, as assessed by increases in CRF mRNA 
measured using qPCR quantification in dissected tissue from mice with a prior history of 
cocaine administration. 
 
 
 
Methods 
 
 
 Subjects: A total of 116 male C57BL/6 mice (8–10 weeks old; 20 mice for CPP 
testing and 96 for qPCR testing), purchased from Harlan Laboratories, were housed 
individually in a humidity- and temperature-controlled, AAALAC-accredited animal 
facility under a 12 h/12 h light/dark cycle (lights on at 0700 hours) with food and water 
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available ad libitum, except when in the experimental chambers. All procedures were 
carried out in compliance with the NIH guidelines and the Guide for Care and Use of 
Laboratory Animals and were approved by Marquette University. 
 Conditioned place preference apparatus: Behavioral testing was conducted as 
previously described (Mantsch et al. 2010; Vranjkovic et al. 2012). Six ENV-3013 mouse 
CPP chambers from Med Associates, Inc. were used. The stainless-steel and polyvinyl 
chloride chambers consisted of three distinct compartments separated by 5 cm wide×5.9 
cm high manual guillotine doors. The two 46.5×12.7×12.7-cm side compartments 
consisted of a white compartment with a 6.35×6.35-mm stainless-steel mesh floor and a 
black compartment with a stainless-steel grid rod floor consisting of 3.2-mm rods spaced 
7.9 mm apart. The side compartments were attached via a gray colored 7.2-cm-long 
center compartment with a smooth floor. The clear tops of the compartments were hinged 
to permit placement and removal of the mice. Ceiling lights were attached to each top. To 
balance unconditioned side preferences, only the light in the black compartment was 
illuminated during the training, testing, and extinction phases. Automated data collection 
was accomplished by using photobeams (six beams for the white and black test areas and 
two beams for the center gray area) that were evenly spaced across the length of the 
chamber and interfaced with a computer containing MED-PC software (MED 
Associates). Using this automated photobeam system, entry into a side compartment was 
defined as consecutive breaks of the first two-photocell beams in that compartment 
located adjacent to the door separating that compartment from the center compartment. 
Exiting of a side compartment (and entry into the center compartment) was indicated by 
occlusion of the beams in the center compartment. 
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 Cocaine-induced conditioned place preference: Cocaine-induced conditioned 
place preference (CPP) was conducted using an unbiased approach by pairing one 
compartment with cocaine and the other with saline as previously described (Mantsch et 
al. 2010). These assignments were made randomly. On the first day of CPP, mice were 
placed into the center compartment of the chamber and given free access to all three 
compartments for 30 min in the absence of cocaine or saline to determine preconditioning 
preference. During the 8-day conditioning phase of the experiment, mice received 
cocaine (15 mg/kg, i.p.) on the odd days and saline injections on the even days. 
Immediately after the injection, mice were confined (guillotine door closed) to the drug-
appropriate compartment for 30 min. A day after the final conditioning session, the mice 
were tested for the expression of cocaine-induced CPP by placing them in the center 
compartment and allowing them full access to the apparatus for 30 min. CPP was defined 
as the change in time spent (in seconds) in the cocaine-paired compartment after 
conditioning compared with the initial preconditioning session. Mice were determined to 
exhibit a CPP if they spent more time in the cocaine-paired compartment during the post-
conditioning session compared to the preconditioning session. 
 Extinction: Daily extinction training was conducted after conditioning. During the 
extinction sessions, the mice had free access to the entire apparatus for 30 min following 
placement in the center compartment with both guillotine doors open. Mice underwent 
daily extinction training until the extinction criterion was met (50 % reduction in the 
preference for the cocaine-paired compartment). Mice were tested for reinstatement 24 h 
after this criterion was reached. 
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 Reinstatement: Aside from exposure to a reinstating stimulus, the reinstatement 
test sessions were identical to extinction conditions: mice were provided free access to 
the entire apparatus for 30 min following placement in the center compartment with both 
guillotine doors open. Most mice were tested multiple times for reinstatement. The 
sequence of reinstatement test conditions was counter-balanced using a Latin square 
design. The mice underwent additional extinction prior to each subsequent test and were 
not tested again until the criterion for extinction was once again reached. Reinstatement 
was defined as the difference in the time spent (in seconds) in the cocaine-paired 
compartment between the reinstatement test day and the prior extinction day. 
 Drugs: Cocaine HCl (15 mg/kg) was obtained from the National Institute on Drug 
Abuse (NIDA) through the NIDA Drug Supply Program. The CRF-R1 antagonist 
antalarmin (10 mg/kg), the beta 2-adrenergic receptor (AR) agonist clenbuterol (4 
mg/kg), and the beta 2-AR antagonist ICI-118,551 (1 mg/kg) were purchased from 
Sigma-Aldrich. Cocaine, clenbuterol, and ICI-118,551 were dissolved in saline (0.9 % 
bacteriostatic saline). Antalarmin was dissolved in 5 % DMSO. All drugs were 
administered i.p. in a volume of 0.1 ml per 25 g body weight. 
 
Experiment 1: role of beta-2 AR and CRF-R1 receptors in stress-induced 
reinstatement of CPP 
 
 Forced swim-induced reinstatement Stress-induced reinstatement was induced 
using a forced swim (FS) protocol as previously reported(Kreibich & Blendy 2004, 
Mantsch et al 2010). Briefly, mice were placed into a 30 cm high× 20 cm deep cylindrical 
polypropylene container filled with water (20–25 °C) for 6 min. After the forced swim, 
mice were placed back into their home cages for 3 to 4 min before being introduced into 
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the center compartment of the CPP apparatus with free access to the entire apparatus for 
reinstatement testing, as described above. 
 The role of beta 2-ARs and CRF-R1 receptors in swim-induced reinstatement We 
have previously reported that either pharmacological blockade of the β2-AR or genetic 
beta 2-AR deletion prevents stress-induced, but not cocaine-induced, reinstatement of 
extinguished cocaine-induced CPP in mice (Mantsch et al. 2010; Vranjkovic et al. 2012). 
To confirm the role of beta 2-ARs in swim-induced reinstatement and to determine the 
role of CRF-R1 receptors, mice (n = 8) underwent cocaine-induced CPP and extinction as 
described above before testing for swim-induced reinstatement following pretreatment 
with the beta 2-AR antagonist ICI-118,551 (1 mg/kg i.p.), the CRF-R1 antagonist 
antalarmin (10 mg/kg i.p.), or vehicle. The mice received injections 30 min prior to 
forced swim. The sequence of the treatments was counter-balanced using a Latin square 
design.  
 
Experiment 2: effects of CRF-R1 antagonism on beta 2-AR agonist-induced 
reinstatement 
 
  
We previously reported that the beta-2-AR agonist clenbuterol reinstates 
extinguished cocaine-induced CPP (Vranjkovic et al. 2012). To determine if the beta 2-
AR induces cocaine- conditioned reward via a CRF-dependent mechanism, the mice (n = 
12) were tested for reinstatement in response to administration of the beta 2-AR agonist 
clenbuterol (4 mg/kg, i.p.) or vehicle 30 min after pretreatment with CRF-R1 receptor 
antagonist antalarmin (10 mg/kg, i.p.; Kreibich et al., 2009) or vehicle. The mice were 
introduced into the experimental chambers 30 min after clenbuterol administration and 
tested for reinstatement. The sequence of the treatments was counter-balanced using a 
	   64	  
Latin square design. Notably, we have found that reinstatement of extinguished CPP by 
this dose of clenbuterol is not attenuated by pretreatment with the beta-1 AR antagonist, 
betaxolol (10 mg/kg, i.p.), suggesting that its agonist actions are selective for the beta-2 
AR and/or that beta-1 AR, if activated, do not con- tribute to reinstatement (Ext: 558.28 
± 72.45; Clen/Betax: 1075.11 ± 94.03; Significant reinstatement, paired t test; p < 0.001). 
 
Experiment 3: role of beta 2-ARs in swim-induced effects on crf mRNA in the BNST 
and amygdala 
 
  
In order to examine the role of beta 2-ARs on stress-induced CRF mRNA, mice 
received an injection of cocaine (15 mg/kg, i.p.) or saline on alternating days for 8 days. 
Following the cocaine treatment, mice were given an 8-day withdrawal period before 
exposure to the stressor. Mice were pretreated with either ICI- 118,551 (1 mg/kg, i.p.) or 
vehicle 30 min prior to forced swim. After forced swim, the mice were placed back in 
their home cages for 30 min prior to sacrifice. The remaining mice did not undergo 
forced swim but instead were euthanized 60 min after the ICI-118,551 or vehicle 
injection. The groups were as follows: vehicle, vehicle + forced swim, ICI, ICI + forced 
swim.  
Tissue extraction: Mice were killed by cervical dislocation and their brains were rapidly 
removed and flash frozen by submersion for 30 s in a beaker filled with 2-methylbutane 
sitting in dry ice and brains were then stored at −80 °C. A cryostat was used to cut one 
500-µm-thick coronal section from frozen brain tissue at the level of the BNST (+0.45 to 
−0.05 mm from Bregma; Fig. 2.3a), and tissue punches were taken from the BNST using 
a tissue punch kit (1.00 mm in diameter), with hemispheres pooled into one sample for 
each mouse. In the same brain, a cryostat was used to cut two 500-µm-thick coronal 
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sections from frozen brain tissue at the level of the amygdala (−0.82 to −1.82 mm from 
Bregma; Fig. 2.3b), and tissue punches were taken from the amygdala, with hemi- 
spheres pooled into one sample for each mouse. The tissue punches were stored at −80 ° 
C for later quantitative real-time polymerase chain reaction (qPCR) analysis.  
 RNA was extracted from frozen brain punches using a phenol: chloroform 
method. Due to the small amount of tissue, tissue from two mice was pooled for each 
sample. Briefly, tissue punches were homogenized in Trizol using a 20 ga. followed by a 
25 ga. needle. Homogenized samples were incubated at room temperature with 
chloroform and then centrifuged at 11,000×g for 15 min. The upper aqueous phase was 
separated into a new tube and isopropranolol was added. Following incubation at room 
temperature, samples were centrifuged at 12,000×g for 10 min. The isopropranolol was 
poured off and samples were washed twice in 70 % ethanol followed by centrifugation at 
12,000×g for 5 min. The pellet was finally stored in 70 % ethanol at −20 °C. 
 Reverse transcription and qPCR: For complementary DNA (cDNA) production, the 
ethanol was poured off and the RNA pellet was allowed to air dry before being re-
suspended in RNAse free water. Samples were then treated with DNAse (Invitrogen) to 
remove genomic DNA. Following DNAse treatment, cDNA was created using Oligo(dT) 
primers, and a Superscript II reverse transcription kit (Invitrogen). cDNA was diluted 1:3 
and stored at −20 °C for qPCR analysis. All qPCR was run using the StepOne real-time 
PCR sys- tem (Applied Biosystem). For qPCR analysis, reactions containing PerfeCTa 
SYBR Green FastMix with ROX (Quanta Biosciences), 20 µM of forward and reverse 
primers, and cDNA were loaded into the wells of a 48-well plate on ice. The cycling 
parameters were 95 °C for 30s followed by 40cycles of 95°C (5s), 60°C (15s), and 70°C 
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(10s) followed by a melting curve to ensure amplification of a single product. All 
reactions were performed in triplicate and the mean threshold cycle for each gene product 
for each sample was used for analysis. The mRNA levels of CRF were normalized to the 
housekeeping gene, TATA binding protein (TBP). Primer sequences were generously 
provided by Dr. Julie Blendy(Cleck et al 2008). 
Results 
Prior to testing for reinstatement, mice underwent CPP and extinction as 
previously described (Mantsch et al. 2010). All mice displayed cocaine-induced CPP and 
met criteria for extinction. Five mice were excluded from testing because they did not 
display CPP (two mice) or did not extinguish (three mice). The mean time spent in the 
cocaine-paired compartment prior to and after conditioning and during extinction for 
each CPP experiment (Exp. 1 and 2) is shown in Table 2.1.  
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Experiment 1: role of beta 2-AR and CRF-R1 receptors in stress-induced 
reinstatement of CPP 
 
For this experiment, mice (n=8) were tested for the effects of vehicle, the CRF-R1 
antagonist antalarmin, and the beta 2-AR antagonist ICI-118,551 on reinstatement of 
extinguished CPP following forced swim. The pretreatments in combination with forced 
swim were tested in counterbalanced sequence determined using a Latin square design. 
The effects are shown in Fig. 2.1. 
Table 2.1: Cocaine-induced conditioned place preference (CPP) and 
extinction. Mice underwent CPP using an unbiased 8-day (4 x alternating 15 
mg/kg, ip cocaine and vehicle administration) approach. Data represent the 
mean time (sec ± S.E.) spent in the cocaine compartment prior to conditioning 
(Pre-Cond.), after conditioning (Post-Cond.), and on the first and last (prior to 
the first reinstatement test) days of extinction (First and Last Ext) in mice used 
for Experiments 1 and 2. Mice used in both experiments displayed significant 
CPP (*p<0.01; paired t-test Post-Cond. vs. Pre-) and showed extinction 
(**p<0.001; paired t-test, First Ext. vs.  Last). 
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1.1: Effects of the beta 2-AR antagonist, ICI-118,551, on stress- induced reinstatement of 
CPP. We previously reported that the beta 2-AR antagonist, ICI-118,551, prevented 
swim-induced re- instatement of CPP in mice (Vranjkovic et al. 2012). This effect of ICI-
118,551 (1 mg/kg, i.p.) was also observed in the present study (Fig. 2.1a). Consistent 
with our earlier report, two- way repeated measures ANOVA showed significant overall 
effects of forced swim (F(1,7)=22.423; p<0.01) and ICI- 118,551 (F(1,7) = 8.829; p < 
0.05) and a significant interaction between swim-induced reinstatement and ICI-118,551 
pre- treatment (F(1,7) = 14.272; p < 0.01). ICI-118,551 prevented swim-induced 
reinstatement. Post hoc testing showed that significant reinstatement was observed in 
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FIGURE 2.1 : Stress- (swim-) induced reinstatement of extinguished cocaine-
induced CPP requires β-2 adrenergic and CRF-R1 receptor activation. Data 
represent the time spent in the compartment previously paired with cocaine (s ± 
S.E.) during the preceding extinction session (Ext) or during reinstatement testing 
following a 6-min forced swim (22°C) in mice (n=8) pretreated with the β-2 AR 
antagonist, ICI-118,551 (1 mg/kg, ip; 1A), the CRF-R1 receptor antagonist, 
antalarmin (10 mg/kg, ip; 1B) or Veh. Both ICI-118,551 and antalarmin prevented 
swim-induced reinstatement. In both cases, significant reinstatement was observed 
in vehicle- but not antagonist-pretreated mice (*p<0.01 vs. Ext) and reinstatement 
was significantly lower following antagonist pretreatment (#p<0.01 vs. Veh). 
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vehicle but not ICI-118,551 pretreated mice (p < 0.01 vs.the prior extinction session) and 
was significantly reduced following ICI-118,551 pretreatment (p<0.01 vs. vehicle).  
 
1.2: Effects of the CRF-R1 receptor antagonist, antalarmin on stress-induced 
reinstatement of CPP The neuropeptide CRF has also been implicated in stress-induced 
cocaine seeking (Erb et al 1998, Shaham et al 1998). To test for the involvement of CRF 
in swim-induced reinstatement of CPP, mice received pretreatment with the CRF-R1 
receptor antagonist, antalarmin (10 mg/kg, i.p.). Antalarmin prevented reinstatement 
following forced swim (Fig. 2.1b). Two-way repeated measures ANOVA showed 
significant overall effects of forced swim (F(1,7)= 5.710; p < 0.05) and antalarmin 
(F(1,7) = 13.642;p < 0.01) and a significant interaction between swim-induced 
reinstatement and antalarmin pretreatment (F(1,7)=67.375; p<0.01). Post hoc testing 
showed that significant reinstatement was observed in vehicle-pretreated but not 
antalarmin-pretreated mice (p<0.01 vs. extinction) and was significantly reduced 
following antalarmin pretreatment (p<0.01 vs. vehicle).  
 
Experiment 2: effects of CRF-R1 antagonism on beta 2-AR agonist-induced 
reinstatement 
 
 
We previously reported that the administration of beta 2-AR agonist, clenbuterol 
(4 mg/kg, i.p.), is sufficient to reinstate extinguished cocaine-induced CPP in mice 
(Vranjkovic et al. 2012). Here, we demonstrate that, like forced swim, clenbuterol-
induced reinstatement is blocked by pretreatment with the CRF-R1 receptor antagonist, 
antalarmin. Pretreatment with antalarmin (10 mg/kg, i.p.) prevented clenbuterol- induce 
reinstatement (Fig. 2.2).  
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Twelve mice were tested for reinstatement following vehicle pretreatment. Nine were 
tested for reinstatement following antalarmin. Since some mice were not tested for effects 
of both vehicle and antalarmin on clenbuterol-induced reinstatement, a mixed two-way 
clenbuterol reinstatement (repeated measure) × antalarmin pretreatment condition 
(between subjects measure) ANOVA was used. A significant overall effect of clenbuterol 
administration (F(1,19)=26.335; p<0.001) and a significant interaction be- tween 
antalarmin pretreatment and clenbuterol-induced rein- statement (F(1,19) =4.294; 
p=0.050) were observed. Antalarmin prevented clenbuterol-induced reinstatement. 
Significant reinstatement was observed in vehicle-pretreated but not antalarmin-
pretreated mice (p < 0.01 vs. extinction), and time spent in the cocaine-paired 
Veh Antalarmin
0
250
500
750
1000
1250
*
Clenbuterol
Ext
#
Tim
e S
pe
nt 
Co
c S
ide
 (s
)
FIGURE 2.2: Clenbuterol-induced reinstatement is 
significantly decreased by pretreatment with the CRF-R1 
receptor antagonist, antalarmin. Data represent the time 
spent in the compartment previously paired with cocaine (s ± 
S.E.) during the preceding extinction session (Ext) or during 
reinstatement testing following administration of clenbuterol (4 
mg/kg, ip) after pretreatment with the CRF-R1 receptor 
antagonist, antalarmin (10 mg/kg, ip; n=9) or vehicle (n=12). 
Significant reinstatement was observed in vehicle- but not 
antalarmin-pretreated mice (*p<0.01 vs. Ext) and reinstatement 
was significantly lower following antalarmin pretreatment 
(#p<0.05 vs. Veh). 
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compartment was increased in mice pretreated with vehicle compared to mice pretreated 
with antalarmin (p=0.05).  
 
Experiment 3: Role of beta 2-ARs in stress-induced effects on CRF mRNA in the 
BNST and amygdala 
 
Since reinstatement of CPP following administration of the beta 2-AR agonist, 
ICI-118,551, was dependent on CRF receptor activation, we hypothesized that beta 2-AR 
receptors regulate, either directly or indirectly, CRF-producing neurons in brain regions 
previously implicated in CRF-dependent stress- induced cocaine seeking. To test this 
hypothesis, we quantified CRF mRNA in the BNST and amygdala dissected from 
cocaine-treated mice 30 min following the termination of a 6- min forced swim using 
qPCR after pretreatment with ICI- 118,551 (1 mg/kg, i.p.) or vehicle. Schematics 
depicting the areas targeted for dissection are included in Fig. 2.3. 
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3.1: Effects on crf mRNA in the BNST: The BNST is involved in stress-induced 
cocaine seeking following SA in rats(Leri et al 2002, McFarland et al 2004), and both 
beta -AR signaling and CRF actions in the BNST are important for stress-induced 
reinstatement(Erb & Stewart 1999, Leri et al 2002, Wang et al 2006), suggesting that the 
BNST is a critical site in which beta 2-ARs can either directly or indirectly regulate CRF. 
Here, we examined the effect of pretreatment with the beta 2-AR antagonist ICI-118,551 
(1 mg/kg, i.p.) on swim-induced levels of CRF mRNA in the BNST following cocaine 
treatment and withdrawal (Fig. 2.4a). 
induced reinstatement of cocaine-induced CPP but it is also
necessary for reinstatement in response to the β2-AR agonist
clenbuterol, suggesting thatβ2-AR signaling is upstream from
CRF actions in the neural pathway responsible for stress-
induced reinstatement of cocaine-conditioned reward. In sup-
port of this hypothesis, we also found that forced swim can
significantly increase CRF mRNA levels in the BNST, a
region necessary for stress-induced reinstatement, and that
this effect can be prevented by pretreatment with the β2-AR
antagonist ICI-118,551. Surprisingly, this effect does not oc-
cur in the amygdala. Taken altogether, these data raise the
possibility that β2-AR-dependent activation of CRF-
expressing neurons in the BNST ediates stress-induced re-
instatement of cocaine-conditioned reward, a process that
likely contributes to relapse.
The BNST is an important site for integration of stress and
reward networks (Flavin and Winder 2013). The BNST re-
ceives heavy innervation from most subregions of the amyg-
dala (Dong et al. 2001a; Weller and Smith 1982), a structure
known to be involved in stress, fear and anxiety, and projects
to regions involved in neuroendocrine, autonomic and behav-
ioral control (Dong and Swanson 2006) such as the PVN and
the amygdala (Cullinan et al. 1993; Dong et al. 2001a; Dong
et al. 2001b). In addition to its connectivity with stress-related
structures, BNST efferent projections target regions involved
in motivation and reward, such as the nucleus accumbens
(Dong et al. 2001b) and the VTA (Georges and Aston-Jones
2001; 2002). The BNST is activated during stress-induced
reinstatement (Briand et al. 2010; Brown et al. 2011) and is
necessary for stress-induced reinstatement in mice and rats
(Briand and Blendy 2010; Erb and Stewart 1999; Leri et al.
2002; McFarland et al. 2004). In addition, it is an important
region for CRF actions that mediate stress-induced reinstate-
ment following SA, as CRF-R1 activation in the BNST is both
necessary (Erb et al. 2001; Erb and Stewart 1999) and suffi-
cient (Erb and Stewart 1999) for reinstatement, and stress can
increas CRF mRNA in the BNST in rats (Funk et al. 2006).
Indeed, our own findings support this hypothesis by demon-
strating that CRF-R1 receptor activation is necessary for
forced swim induced reinstatement of CPP in mice and that
the same stressor increases CRFmRNA levels in the BNSTof
mice with a prior history of cocaine, albeit in the absence of
CPP. These data suggest that the BNST is a major site of
regulation of CRF actions during stress-induced reinstatement
of cocaine-conditioned reward.
In addition to CRF, the noradrenergic system plays an
important role in reward and stress (Flavin and Winder
2013; Weinshenker and Schroeder 2007). In particular, this
Fig. 3 Tissue dissection schematic for qPCR analysis. (a) For the BNST,
a tissue punch (1.00 mm in diameter) was taken from one 500-μm
section. The punch site is shown in the shaded circle and both the dorsal
and ventral portions of the BNSTwere collected. (b) For the amygdala, a
tissue punch (1.00 mm in diameter) was taken from two 500-μm sections.
The punch site is shown in the shaded circle and the majority of the
amygdala was collected. For both regions, hemispheres were pooled into
one sample. Adapted from Franklin and Paxinos (2007)
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Fig. 2.3 Tissue dissection schematic for qPCR analysis. (a) For the 
BNST, a tissue punch (1.00 mm in diameter) was taken from one 500-µm 
section. The punch site is shown in the shaded circle and both the dorsal 
and ventr l portions of t e BNST were c llected. (b) For the amygd la, a 
tissue punch (1.00 mm in diameter) was taken from two 500-µm secti ns. 
The punch site is shown in the shaded circle and the majority of the 
amygdala was c llected. For both regions, hemispheres were pooled i to 
one sample. Adapted from Franklin and Paxi os (2007) 
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Two-way ANOVA did not show a significant main effect of forced swim 
(F(1,36)=3.737, p= 0.061) or ICI-118,551 (F(1,36)=1.919, p=0.174) on CRF mRNA 
levels in the BNST but did show a significant inter- action between forced swim and ICI-
118,551 (F(1,36)=4.851, p<0.05). Mice that received vehicle pretreatment and forced 
swim had significantly higher CRF mRNA levels in the BNST compared to the vehicle 
	  
FIGURE 2.4: Stress- (forced swim-) induced increases in crf mRNA in 
the BNST, but not the amygdala, are blocked by pretreatment with a 
beta-2 adrenergic receptor antagonist. Data represent the fold change in 
crf mRNA ± S.E. The mRNA changes were assessed using quantitative real-
time polymerase chain reaction (qPCR) on tissue from the BNST (A) and 
amygdala (B) of mice exposed to a 6-min forced swim (22°C) after cocaine 
treatment and withdrawal. The mean threshold cycle for crf was normalized 
to the endogenous control TATA binding protein (tbp). Forced swim 
significantly increased crf mRNA levels in the BNST in mice that received a 
vehicle pretreatment (*p<.05, compared to vehicle alone). However, in mice 
that received a pretreatment the beta-2 AR antagonist, ICI-118,551 (1 mg/kg, 
ip), forced swim no longer increased crf mRNA levels in the BNST while the 
pretreatment of ICI-118,551 alone had no effect on crf mRNA. In contrast, in 
the amygdala, neither forced swim nor ICI-118,551 had a significant effect 
on crf mRNA. 
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treatment alone (p < 0.05). However, when mice were pretreated with ICI-118,551, 
forced swim no longer increased CRF mRNA levels in the BNST (p>0.05 compared to 
vehicle treatment), while the treatment with ICI-118,551 alone had no significant effect 
on CRF mRNA levels (p>0.05, compared to vehicle treatment alone).  
 
3.2: Effects on crf mRNA in the amygdala Like the BNST, the amygdala has been 
implicated in stress-induced cocaine seeking following SA in rats(McFarland et al 2004). 
Moreover, beta-AR signaling in the central nucleus of the amygdala con- tributes to 
stress-induced reinstatement(Leri et al 2002) and forced swim following protracted 
withdrawal after binge cocaine access has been reported to increase CRF mRNA levels in 
the amygdala(Cleck et al 2008). Thus, the amygdala is a potential site at which CRF is 
either directly or indirectly regulated by beta 2-ARs to promote cocaine use. Here, we 
examined the effect of the beta 2-AR antagonist ICI-118,551 (1 mg/kg, i.p.) on swim-
induced levels of CRF mRNA in the amygdala following cocaine treatment and 
withdrawal (Fig. 2.4b). In contrast to the BNST, a two-way ANOVA did not show a 
significant main effect of forced swim (F(1,39) = 2.033, p = 0.162), ICI-118,551 
(F(1,39)=0.046, p=0.83), or an interaction between forced swim and ICI-118,551 on CRF 
mRNA in the amygdala (F(1,39)=0.558, p=0.459). 
 
Discussion 
 
The main finding of this study is that an interaction between beta 2-ARs and 
CRF-R1 receptors is critical for stress-induced reinstatement of extinguished cocaine-
induced CPP in mice. Additionally, beta 2-AR signaling is required for the stress- 
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induced regulation of CRF mRNA levels in the BNST. We found that not only is CRF-
R1 activation necessary for swim induced reinstatement of cocaine-induced CPP but it is 
also necessary for reinstatement in response to the beta 2-AR agonist clenbuterol, 
suggesting that beta 2-AR signaling is upstream from CRF actions in the neural pathway 
responsible for stress- induced reinstatement of cocaine-conditioned reward. In support of 
this hypothesis, we also found that forced swim can significantly increase CRF mRNA 
levels in the BNST, a region necessary for stress-induced reinstatement, and that this 
effect can be prevented by pretreatment with the beta 2-AR antagonist ICI-118,551. 
Surprisingly, this effect does not occur in the amygdala. Taken altogether, these data raise 
the possibility that beta 2-AR-dependent activation of CRF- expressing neurons in the 
BNST mediates stress-induced re- instatement of cocaine-conditioned reward, a process 
that likely contributes to relapse. 
 The BNST is an important site for integration of stress and reward networks 
(Flavin & Winder 2013). The BNST receives heavy innervation from most subregions of 
the amygdala(Dong et al 2001a, Weller & Smith 1982), a structure known to be involved 
in stress, fear and anxiety, and projects to regions involved in neuroendocrine, autonomic 
and behavioral control (Dong & Swanson 2006) such as the PVN and the 
amygdala(Cullinan et al 1993, Dong et al 2001a, Dong et al 2001b). In addition to its 
connectivity with stress-related structures, BNST efferent projections target regions 
involved in motivation and reward, such as the nucleus accumbens (Dong et al 2001b) 
and the VTA (Georges & Aston-Jones 2001, Georges & Aston-Jones 2002). The BNST 
is activated during stress-induced reinstatement (Briand et al 2010, Brown et al 2011) and 
is necessary for stress-induced reinstatement in mice and rats (Briand & Blendy 2010, 
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Erb & Stewart 1999, Leri et al 2002, McFarland et al 2004). In addition, it is an important 
region for CRF actions that mediate stress-induced reinstatement following SA, as CRF-
R1 activation in the BNST is both necessary (Erb et al. 2001; Erb and Stewart 1999) and 
sufficient (Erb and Stewart 1999) for reinstatement, and stress can increase CRF mRNA 
in the BNST in rats(Funk et al 2006). Indeed, our own findings support this hypothesis by 
demonstrating that CRF-R1 receptor activation is necessary for forced swim induced 
reinstatement of CPP in mice and that the same stressor increases CRF mRNA levels in 
the BNST of mice with a prior history of cocaine, albeit in the absence of CPP. These 
data suggest that the BNST is a major site of regulation of CRF actions during stress-
induced reinstatement of cocaine-conditioned reward.  
 In addition to CRF, the noradrenergic system plays an important role in reward 
and stress (Flavin & Winder 2013, Weinshenker & Schroeder 2007). In particular, this 
system is heavily involved in stress-induced reinstatement behaviors. For example, 
reducing norepinephrine levels through alpha 2-AR agonism blocks stress-induced 
reinstatement of cocaine seeking following SA in rats (Erb et al. 2000) and reinstatement 
of cocaine-conditioned reward in mice (Mantsch et al. 2010), as well as stress-associated 
cocaine craving in humans(Jobes et al 2011). Norepinephrine is also sufficient for 
reinstatement as elevation of norepinephrine levels through central administration of 
norepinephrine or alpha 2-AR antagonism promotes reinstatement behaviors in both rats 
and mice (Brown et al. 2011; Brown et al. 2009; Feltenstein and See 2006; Mantsch et al. 
2010). 
 We have previously demonstrated, using the mouse CPP/ reinstatement approach 
that, specifically, beta 2-ARs are required for stress-induced reinstatement (Mantsch et al. 
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2010; Vranjkovic et al. 2012). Reinstatement of CPP by either forced swim or yohimbine 
is blocked by the beta 2-AR-selective antagonist, ICI-118,551, but not the beta1-AR-
selective antagonist, betaxolol, while administration of the beta 2-AR-selective agonist, 
clenbuterol, is sufficient to reinstate CPP. Our current findings confirm this role for beta 
2-ARs. In rats, the BNST, which receives dense noradrenergic innervation through the 
ventral noradrenergic bundle (Ricardo & Koh 1978, Woulfe et al 1988) and displays 
increased norepinephrine levels following stress (Pacak et al 1995), appears to be a key 
site for beta-AR regulation of cocaine seeking during stress. Blockade of beta 1- and beta 
2-ARs in the BNST using a cocktail of ICI-118,551 and betaxolol prevents footshock-
induced reinstatement of cocaine seeking following SA in rats (Leri et al. 2002). 
 The precise mechanism through which beta 2-ARs regulate reinstatement of 
cocaine seeking and CPP is unclear, but we hypothesize that it involves effects on CRF 
neurons in the BNST. Beta-AR activation increases excitatory transmission in the BNST 
(Egli et al 2005), and these effects appear to be mediated in part via a CRF-R1-dependent 
mechanism(Nobis et al 2011). In addition, norepinephrine-induced reinstatement is 
prevented by CRF receptor antagonism, but CRF- induced reinstatement is not blocked 
by inhibition of noradrenergic neurotransmission(Brown et al 2009), suggesting that 
noradrenergic signaling is upstream from CRF in the chain of events that lead to 
reinstatement. Our own findings support this possibility, as we found that reinstatement 
of CPP induced by the beta 2-AR agonist clenbuterol is blocked by the CRF-R1 
antagonist antalarmin and that stress-induced increases in CRF mRNA in the BNST are 
prevented by the beta 2-AR antagonist ICI-118,551. CRF released into the BNST may 
originate from CRF-releasing afferent projections to the BNST or from local cell 
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populations(Veinante et al 1997). The latter possibility is supported by findings from 
Silberman et al. (2013) suggesting that norepinephrine depolarizes CRF- containing 
neurons intrinsic to the BNST, thereby releasing CRF locally, which then enhances 
glutamatergic neurotransmission via presynaptic effects. 
 CRF neurons in the BNST also send efferent projections to a number of brain 
regions, most notably the VTA (Rodaros et al. 2007). The VTA is a heterogeneous region 
that is the source of dopamine neurons that comprise the mesocorticolimbic system and 
has a well-established role in stress-induced cocaine seeking(Mantsch et al 2014, 
McFarland et al 2004). CRF actions in the VTA are necessary for stress-induced 
reinstatement and are mediated by activation of CRF-R1 receptors(Blacktop et al 2011). 
Emerging evidence suggests that the BNST-VTA pathway is essential for stress-induced 
cocaine seeking and reinstatement of CPP (Mantsch et al. 2014). For example, reinstating 
stimuli such as forced swim increase c-fos expression specifically in BNST neurons that 
project to the VTA (Briand et al. 2010). The BNST sends both glutamatergic and 
GABAergic projections to the VTA(Georges & Aston-Jones 2001, Kudo et al 2012), 
which appear to have distinct roles in reward and aversion(Jennings et al 2013). 
However, the relative roles of GABAergic vs. glutamatergic projections from the BNST 
to the VTA in the regulation of stress-induced reinstatement behaviors are not clear. 
Notably, withdrawal from chronic ethanol exposure enhances basal glutamatergic 
regulation of VTA-projecting BNST neurons in a CRF-R1 dependent manner (Silberman 
et al. 2013). Understanding how projections from the BNST to the VTA promote relapse 
to drug use during stress and delineation of the processes in the BNST that regulate these 
projections represent important goals for future research. 
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 In general, the role for CRF and NE in stress-induced reinstatement behaviors, as 
demonstrated in the present study, extends to other classes of abused drugs. Antagonism 
of CRF receptors prevents stress-induced reinstatement following alcohol (Le et al 2000), 
heroin(Shaham et al 1997) , and nicotine (Bruijnzeel et al 2009, Zislis et al 2007)SA, as 
does suppression of noradrenergic neurotransmission using alpha-2 AR agonist drugs(Le 
et al 2005, Shaham et al 2000, Zislis et al 2007). However, subtle differences in the 
mechanisms underlying stress- induced reinstatement appear to exist. For example, the 
alpha-1 AR antagonist, prazosin, blocks stress-induced reinstatement (Le et al 
2011),while the highly selective alpha-2 AR antagonist, RS-79948, fails to evoke 
reinstatement following alcohol SA in rats(Dzung Le et al 2009). Thus, application of the 
current findings to other drugs of abuse will require further investigation. 
 There is some evidence that suggests that targeting ARs in human cocaine addicts 
may be an effective treatment strategy. In humans, alpha 2-AR agonists, which 
functionally antagonize noradrenergic neurotransmission, reduce stress-induced (Jobes et 
al 2011)and cue-induced(Fox et al 2012) cocaine craving. The effectiveness of beta 
blockers in cocaine users classified as dependent has also been examined(Kampman et al 
2001). It is noteworthy that, while the beta-blocker propranolol did not universally 
improve treatment outcome measures, positive responses were observed in subjects who 
displayed more severe cocaine withdrawal symptoms. Considering that such symptoms 
are largely stress-related, we view these findings as supportive of a role for beta-ARs in 
stress-induced relapse. 
 Similar to the BNST, the amygdala is a region known to be involved in both 
reward and stress. The amygdala is comprised of a number of subnuclei that are highly 
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interconnected with regions involved in stress-related responses such as the PVN and 
BNST, as well those involved in reward-related processes, such as the NAc, the PFC, and 
the VTA(McDonald 1991a, McDonald 1991b, Rodaros et al 2007, Silverman et al 1981). 
As is the case for the BNST, it has been reported that the amygdala is essential for stress-
induced reinstatement (McFarland et al. 2004) and that the CeA sends CRF-positive 
projections to the VTA (Rodaros et al. 2007). Moreover, beta 2-AR signaling in the CeA 
(Leri et al. 2002) and a projection from the CeA that regulates CRF release in the BNST 
(Erb et al. 2001) have been reported to be necessary for stress-induced cocaine seeking 
following SA in rats, suggesting that beta 2-AR regulation of CRF neurons may occur in 
the amygdala as well. Surprisingly, we found that forced swim stress did not alter CRF 
mRNA levels in the amygdala. This is in contrast to a prior study demonstrating swim-
induced in- creases in CRF mRNA levels in the amygdala of mice with a prior history of 
cocaine(Cleck et al 2008). However, in that study, mice received greater amounts of 
cocaine and the increase in CRF mRNA levels was only observed following prolonged 
withdrawal (Cleck et al. 2008). Importantly, in the present study, mice were tested for 
CRF mRNA responses after repeated exposure to cocaine but in the absence of the CPP 
context. It is not clear how conditioning to cocaine and testing for swim effects on CRF 
mRNA measured following exposure to the CPP chambers could have influenced our 
results. It should also be noted that since our dissections were gross dissections of the 
amygdala due to the small amount of tissue yielded from a mouse brain, we cannot 
exclude the possibility that a more specific dissection of the CeA may yield different 
results. In contrast to its regulatory role in anxiety, CRF actions in the CeA do not appear 
to be necessary for stress-induced reinstatement following SA or CPP (Erb and Stewart 
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1999; Wang et al. 2006). Our findings also suggest that, while CeA regulation of CRF 
release into the BNST is necessary for stress-induced reinstatement behaviors (Erb et al. 
2001), the source of CRF may consist of CRF projections from regions other than the 
CeA or cells that intrinsic to the BNST and not CRF neurons originating in the CeA.  
 Our current findings support a hypothesis that places beta2- AR signaling 
upstream from CRF actions in the BNST in the neural pathway that mediates stress-
induced reinstatement of cocaine-conditioned reward. While there are long-established 
roles for AR and CRF individually in stress-induced reinstatement, it has become clear 
that an interaction between beta2-AR signaling and CRF producing neurons, possibly in 
the BNST is likely critical. For this reason, further investigation of the precise 
mechanisms through which beta2-ARs contribute to the stress-induced regulation of CRF 
neurons in the BNST is needed. Finally, our findings also suggest that medications 
targeting beta2-ARs hold some promise for potential treatment aimed at minimizing the 
contribution of stress to relapse.  
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Chapter III 
 
 
Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated 
pathway from the ventral bed nucleus of the stria terminalis that regulates CRF 
actions in the ventral tegmental area 
 
 
Abstract 
 
 
The ventral bed nucleus of the stria terminalis (vBNST) has been implicated in 
stress-induced cocaine use. Here we demonstrate that, in the vBNST, corticotropin 
releasing factor (CRF) is expressed in neurons that innervate the ventral tegmental area 
(VTA), a site where the CRF receptor antagonist antalarmin prevents the reinstatement of 
cocaine seeking by a stressor, intermittent footshock, following intravenous self-
administration in rats. The vBNST receives dense noradrenergic innervation and 
expresses β adrenergic receptors (ARs). Footshock-induced reinstatement was prevented 
by bilateral intra-vBNST injection of the β-2 AR antagonist, ICI-118,551, but not the β-1 
AR antagonist, betaxolol. Moreover, bilateral intra-vBNST injection of the β-2 AR 
agonist, clenbuterol, but not the β-1 agonist, dobutamine, reinstated cocaine seeking, 
suggesting that activation of vBNST β-2 AR is both necessary for stress-induced 
reinstatement and sufficient to induce cocaine seeking. The contribution of a β-2 AR-
regulated vBNST-to-VTA pathway that releases CRF was investigated using a 
disconnection approach. Injection of ICI-118,551 into the vBNST in one hemisphere and 
antalarmin into the VTA of the contralateral hemisphere prevented footshock-induced 
reinstatement, whereas ipsilateral manipulations failed to attenuate stress-induced cocaine 
seeking, suggesting that β-2 AR regulate vBNST efferents that release CRF into the 
VTA, activating CRF receptors, and promoting cocaine use. Last, reinstatement by 
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clenbuterol delivered bilaterally into the vBNST was prevented by bilateral vBNST 
pretreatment with antalarmin, indicating that β-2 AR-mediated actions in the vBNST also 
require local CRF receptor activation. Understanding the processes through which stress 
induces cocaine seeking should guide the development of new treatments for addiction. 
Introduction 
 
In many cocaine addicts, relapse to drug use is triggered by the onset of craving in 
response to episodes of stress. Due to the uncontrollable and often unavoidable nature of 
stress, its contribution to relapse is particularly problematic when managing cocaine 
addiction. 
Using rodent reinstatement models, preclinical researchers have begun to define 
the neurocircuitry that underlies stress-induced relapse. One prominent pathway that has 
been implicated consists of a dopaminergic projection from the ventral tegmental area 
(VTA) to the medial prefrontal cortex, where dopamine D1 receptor activation increases 
the activity of a glutamatergic pathway to the nucleus accumbens that is critical for 
cocaine seeking (Capriles et al 2003, McFarland et al 2004). During stress, the VTA is 
regulated by the neuropeptide corticotropin releasing factor (CRF; (Wang et al 2005), in 
part via CRF-R1 receptors (Blacktop et al 2011), to evoke cocaine seeking. 
The VTA receives inputs from brain regions involved in integration of the stress 
response, including those comprising the “extended amygdala”: the nucleus accumbens 
shell, central amygdala, and bed nucleus of the stria terminalis (BNST;(Phillipson 1979). 
Among these structures, the BNST, which serves as an interface between stress and 
motivational/reward systems, appears to be particularly important for stress-induced 
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cocaine seeking, in that its inactivation prevents stress-induced reinstatement in rodents 
((Briand et al 2010, McFarland et al 2004). A subgroup of neurons projecting from the 
BNST to the VTA express CRF (Rodaros et al 2007)and therefore may be responsible for 
stress-induced increases in VTA CRF and CRF-dependent cocaine seeking. However, 
CRF projections to the VTA from the ventral BNST (vBNST), the subregion implicated 
in stress-induced cocaine seeking (McFarland et al., 2004), have not been described. The 
BNST, particularly the vBNST, receives dense noradrenergic innervation (Phelix et al 
1992) and expresses β adrenergic receptors (ARs; (Cecchi et al 2007)), which have been 
reported to regulate efferent projections (Nobis et al 2011), including those that innervate 
the VTA (Dumont & Williams 2004, Silberman et al 2013). Both stress-induced 
reinstatement (Erb et al 2001, Erb & Stewart 1999) and noradrenergic regulation of 
BNST efferents to the VTA (Silberman et al., 2013) require BNST CRF receptor 
activation, suggesting that norepinephrine in the BNST promotes local CRF release, 
thereby activating a second CRF-releasing pathway to the VTA. 
Considering the important role for noradrenergic signaling in stress-induced 
reinstatement in rodents (Erb et al 2000, Mantsch et al 2010)and craving in human 
cocaine-dependent populations (Jobes et al 2011), AR regulation of a vBNST-to-VTA 
CRF-releasing pathway is a likely mechanism through which stress promotes cocaine 
seeking. We have found that β-2 AR activation is both necessary and sufficient for stress-
induced reinstatement in mouse models (Vranjkovic et al 2012). Moreover, it has been 
demonstrated that a mixture of β-AR antagonists, administered into the vBNST, prevents 
stress-induced reinstatement(Leri et al 2002). In this study, we demonstrate direct CRF 
neuronal projections from the vBNST to the VTA and examine the relationship between 
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stress-induced β-2 AR activation in the vBNST and CRF-R1 receptor-dependent actions 
in the VTA that lead to cocaine seeking. 
Materials and Methods: 
 
Subjects 
Male Sprague Dawley rats (Harlan Laboratories) ∼90-d-old at the time of delivery (325 
g) were used. Rats were housed singly in a temperature- and humidity-controlled, 
Association for Assessment and Accreditation of Laboratory Animal Care accredited 
facility under a 12 h light/dark cycle (lights off at 07:00 h) and had access to food and 
water at all times, except during the food training periods during which they were kept at 
90% of their free-feeding body weight. All procedures were performed in accordance 
with the NIH Guide for the Care and Use of Laboratory Animals. 
Drugs 
Cocaine HCl was acquired from the National Institute on Drug Abuse through its drug 
supply program. The selective β-1 AR antagonist betaxolol HCl, the selective β-2 AR 
antagonist (-)-(isopropylamino)-1-[(7-methyl-4-indanyl)oxy]butan-2-ol (ICI-118,551) 
HCl, the selective β-1 AR agonist dobutamine HCl, the selective β-2 AR agonist 
clenbuterol, and the axonal transport inhibitor colchicine HCl were purchased from 
Sigma-Aldrich. Cocaine was dissolved in bacteriostatic saline. Other drugs were 
dissolved in sterile water. Colchicine was delivered intra cerebroventricularly in a 
volume of 2 µl over a 5 min period. Intracranial drug injections occurred in a volume of 
0.2 µl/side over a 1 min period. 
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Catheter and cannula implantation 
For intravenous self-administration (SA) and reinstatement testing, rats were implanted 
with catheters into the jugular vein under ketamine HCl (100 mg/kg i.p.) and xylazine (2 
mg/kg, i.p.) anesthesia, as described previously (Blacktop et al 2011), along with 11 mm 
26-gauge guide cannulae aimed at the vBNST (0.6 mm posterior to bregma; 3.5 mm 
lateral to midline; 6.9 mm ventral to the skull surface at a 15° angle), and/or the VTA 
(5.6 mm posterior to bregma; 2.2 mm lateral to midline; 6.9 ventral to the skull surface at 
a 12° angle) for intracranial injections. The tips of the guide cannulae were aimed 0.5 mm 
above the target injection sites. 
Cocaine self-administration 
Following a 2 week recovery from surgery, rats were trained to self-administer cocaine 
(1.0 mg/kg/inf, i.v.) by pressing a response lever under an FR1 schedule in a computer-
interfaced operant conditioning chamber (Med Associates) during daily 2 h sessions. 
During these sessions, the active (front) lever was extended into the chamber and the 
corresponding stimulus light was illuminated. Pressing this lever resulted in a cocaine 
infusion (200 µl over 5 s), followed by a 25 s time-out period during which the stimulus 
light was extinguished but the lever remained extended. Responding on a second, inactive 
lever was recorded but had no programmed consequences. Once stable SA under the FR1 
schedule was observed (>15 infusions), the requirements for SA were gradually increased 
until rats displayed stable responding under ta FR4 schedule (<10% variation from the 
mean over 3 sessions), at which time daily access was increased to 6 h. Rat were 
permitted to self-administer daily under these conditions for 14 consecutive days after 
which they underwent extinction training. 
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Extinction training and reinstatement testing 
Extinction sessions were identical to SA conditions except that (1) the sessions were 2 h 
in duration and (2) the cocaine solution was replaced with saline. Daily extinction 
training sessions were conducted until rats displayed <15 cocaine lever responses for 
consecutive sessions (range, 6–10 d) at which time rats were tested for reinstatement. 
Reinstatement sessions were identical to extinction sessions except that they were 
preceded by exposure to shock and/or intracranial drug delivery. Shocks (0.5 mA, 0.5 s 
duration) were delivered on average every 40 s (range, 10–70 s) through the grid floors of 
the chambers over a 15 min period that immediately preceded the 2 h reinstatement test 
session (Blacktop et al 2011, Graf et al 2011). During the shock session, the levers were 
retracted and the stimulus lights were off, but a houselight in the chamber was 
illuminated. Reinstatement was defined as an increase in cocaine lever responding 
relative to the prior extinction session. When rats were tested multiple times for 
reinstatement, test sessions were separated by additional extinction session and were 
required to display <15 cocaine lever responses before retesting. 
Effects on food-reinforced lever pressing 
In most cases where significant reductions in shock-induced reinstatement were 
observed, the effects of the same manipulations on lever pressing reinforced by food 
delivery (45 mg sucrose-sweetened food pellets; BioServ) were also examined in separate 
rats to confirm that reduced reinstatement was not attributable to motor impairment that 
interfered with the ability of the rats to press the lever. Following surgical intracranial 
implantation of guide cannulae and recovery, these rats were maintained at 90% of their 
free-feeding body weights and trained to self-administer food pellets by pressing a lever 
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under a FR4 schedule. Effects on food-reinforced responding were tested after stable 
patterns of lever pressing were observed (<10% variation from the mean over 3 sessions). 
Histological confirmation of injection sites 
The accuracy of cannula implantation was confirmed postmortem in each rat after cardiac 
perfusion with 60 ml 0.15% NaCl followed by 60 ml of 2.5% buffered neutral formalin 
under sodium pentobarbital anesthesia (55 mg/kg). Brains were removed and stored in 
2.5% buffered formalin before vibratome sectioning (40 µm), slide mounting, and 
staining with cresyl violet for examination using a light microscope. Rats with injection 
sites outside of the VTA or the vBNST were excluded from data analysis. 
Experiment 1: effects of intra-BNST β AR antagonists on stress-induced reinstatement 
We initially examined the role of β-1 and β-2 AR activation in the vBNST in stress-
induced reinstatement by testing rats for shock-induced reinstatement following bilateral 
intra-vBNST injection of the β-1 AR selective antagonist, betaxolol (1 nmol/307 ng per 
side), the β-2 AR antagonist selective antagonist, ICI-118,551 (1 nmol/277 ng per side) 
or vehicle (sterile water). Concentrations were selected based on selectivity for human β 
receptor subtypes (Baker 2005). Moreover, the antagonist concentrations were previously 
used to selectively target brain β ARs(Cecchi et al 2007, Delfs et al 2000, LaLumiere et 
al 2010, Leri et al 2002). Rats received vBNST injections 15 min before shock. Nine total 
rats were used for this experiment. Five rats were tested for shock-induced reinstatement 
following pretreatment with vehicle, betaxolol, and ICI-118,551; two rats were tested 
following only vehicle and betaxolol; and two rats were tested for following only vehicle 
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and ICI-118,551. An additional group of rats (n = 6) was tested for the effects of ICI-
118,551 and vehicle on food-reinforced lever pressing. 
Experiment 2: reinstatement by intra-vBNST injection of β-AR agonists 
To further examine the role of vBNST β-1 and β-2 ARs in stress-induced cocaine 
seeking, a separate group of rats was tested for the ability of bilateral intra-vBNST 
injection of the β-1 AR selective agonist dobutamine (1 nmol/ 301 ng per side) or the β-2 
AR selective agonist clenbuterol (36 pmol/10 ng per side) to induce reinstatement. 
Concentrations were again chosen based on selectivity for human β receptor subtypes 
(Baker 2010). Further, the clenbuterol dose has been previously used to selectively target 
brain β-2 ARs(LaLumiere et al 2010, Roozendaal et al 2008). Ten total rats were used for 
this experiment. Seven rats were tested for reinstatement in response to dobutamine, 
clenbuterol, and vehicle. An additional three rats were tested only with clenbuterol and 
vehicle. 
Experiment 3: effect of VTA CRF receptor antagonism on stress-induced 
reinstatement 
 
To confirm our earlier finding that shock-induced reinstatement requires CRF receptor 
activation in the VTA (Blacktop et al., 2011), we also tested rats for the effects of intra-
VTA pretreatment with the CRF-R1 receptor antagonist, antalarmin ((Webster et al 
1996); 1.32 nmol/500 ng/side). We (Blacktop et al., 2011) and others (Lowery-Gionta et 
al 2012) have used this antalarmin dose to investigate CRF-R1 receptor-dependent 
contributions to behavior. Six rats were used for this experiment. Each of them was tested 
for the effects of both antalarmin and vehicle on shock-induced reinstatement. 
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Experiment 4: identification of CRF-positive neurons in the vBNST that project to the 
VTA 
 
Retrograde tracing using CTb. 
We used cholera toxin B subunit (CTb) as a retrograde tracer to identify neurons in the 
vBNST with direct efferent projections to the VTA. Rats were anesthetized with 
ketamine and xylazine and placed in a stereotaxic frame. Heat-sterilized Hamilton 
syringes were used to pressure inject 0.2 µl biotinylated CTb (List Biological 
Laboratories) unilaterally into the VTA over a 10 min period (posterior to bregma −5.6 
mm, lateral −2.6 mm, ventral −8.6 mm; Paxinos and Watson, 2006). Syringes were left in 
place for 20 min after injections and slowly removed from the brain over a 10 min period. 
Colchicine treatment. 
Because it has been reported that inhibition of axonal transport using pretreatment with 
the microtubule polymerization inhibitor colchicine is necessary for detection of CRF-
immunoreactive cell bodies within the vBNST (Sakanaka et al 1986) anesthetized rats 
received injections of colchicine (1.25 µmol/500 µg in 2 µl) into a lateral ventricle 
(posterior to bregma −1.0 mm, lateral 1.4 mm, ventral −5.3 mm) 10 d after injection with 
CTb, thus avoiding interference with retrograde transport of CTb. 
Tissue collection and preparation. 
Twenty-four hours after the colchicine injections, rats were anesthetized with sodium 
pentobarbital (55 mg/kg, i.p.) and perfused transcardially with 30 ml of 0.9% NaCl, 
followed by 60 ml of cold (4°C) 4% paraformaldehyde in 0.1 M phosphate buffer, pH 
7.0. Brains were quickly removed and immersed in fixative for 24 h at 4°C. Brains were 
washed twice in 0.1 Msodium phosphate buffer for 12 h each, after which they were 
	   91	  
cryoprotected in 30% sucrose in 0.1 M-phosphate buffer for 3 d at 4°C. Brains were 
rapidly frozen and serial coronal sections (30 µm) were cut on a cryostat. Sections were 
stored at −20°C until immunofluorescence procedures were conducted. 
Fluorescence immunocytochemistry. 
Immunofluorescence for CTb and CRF was conducted on free-floating 30 µm sections. 
Sections were rinsed three times for 10 min in 0.05 M KPBS and once for 10 min in 
0.1 M glycine in 0.05 KPBS, followed by blocking in 3% normal donkey serum in 0.4% 
Triton KPBS for 20 min. Sections were then incubated for 48 h at 4°C with rabbit anti-
CRF (supplied by Dr Wylie Vale, The Salk Institute) diluted 1:8000 in 0.1% Triton 
KPBS with 3% normal donkey serum. Sections were then rinsed 3× 10 min in 
0.05 M KPBS, followed by incubation with an AlexaFluor 488-conjugated donkey anti-
rabbit secondary antibody (Catalog #A11008; 1:500; Life Technologies) in 0.05 M KPBS 
for 2 h at room temperature, and rinsed three times for 10 min in 0.05 M KPBS. For 
detection of biotinylated CTb, sections were incubated for 24 h at 4°C in goat anti-biotin 
polyclonal antibody (Catalog # SP 3000; Vector Laboratories) diluted 1:30,000 in 0.1% 
Triton KPBS and 3% normal donkey serum. After rinsing, sections were incubated 2 h 
with AlexaFluor 598-conjugated donkey anti-goat IgG (Catalog #A-110581; 1:500; Life 
Technologies) and washed three times for 10 min in 0.05 M KPBS. Sections were briefly 
rinsed in distilled water and mounted onto gel-coated SuperFrost Plus slides and 
coverslipped using Vectashield mounting medium with DAPI (Catalog #H-1200; Vector 
Laboratories). Photomicrographs were acquired using a Retiga 2000R digital camera 
(QImaging) on a Nikon 80i microscope using NIS Elements software (Nikon 
Instruments). 
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Experiment 5: effects of vBNST and VTA disconnection on stress-induced cocaine 
seeking 
 
A disconnection approach was used to determine whether a β 2-AR activated, 
CRF-dependent pathway between the vBNST and the VTA is required for stress-induced 
cocaine seeking. At the time of catheterization, separate groups of rats were implanted 
with two cannulae aimed unilaterally at the vBNST and VTA in either the contralateral or 
the ipsilateral hemisphere(s) of the brain. The effect of pathway disconnection was 
examined in six rats by injection of the β-2 AR antagonist ICI 118,551 (1 nmol/277 ng) 
into the vBNST in one hemisphere and the CRF-R1 receptor antagonist antalarmin (1.32 
nmol/500 ng) into the VTA of the other before testing for shock-induced reinstatement. 
For comparison, the same rats were tested for shock-induced reinstatement following 
injection of vehicle into each region. As a control to ensure that reductions in 
reinstatement were attributable to disconnection, a second groups of rats (n = 7) received 
a unilateral injection of ICI 118,551 into the vBNST in one hemisphere and a unilateral 
injection of antalarmin into the VTA in the same hemisphere before testing for shock-
induced reinstatement. These rats were also tested for the effects of ipsilateral vehicle 
injections. For this experiment, the hemispheres into which cannulae were implanted 
were randomized across rats in each group such that in the contralateral treatment group, 
half of the rats received ICI 118,551 injections into the left vBNST and antalarmin 
injections into the right VTA, whereas the other half received ICI 118,551 injections into 
the right vBNST and antalarmin injections into the left VTA. Likewise, half of the rats in 
the ipsilateral treatment group received drug injections into sites in the right hemisphere, 
whereas the remaining rats received injections into sites in the left hemisphere. To 
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examine the potential contribution of nonspecific behavioral suppression to the effects on 
reinstatement, an addition group of rats (n = 6) was tested for the effects of contralateral 
drug and vehicle injections on food-reinforced lever pressing. 
 
Experiment 6: role of vBNST CRF-R1 receptors in cocaine seeking induced by 
vBNST β-2 AR activation 
 
It has been reported that CRF-R1 antagonist injections directly into the vBNST 
can also block stress-induced cocaine seeking (Erb et al 2001, Erb & Stewart 1999). To 
determine whether β-2 ARs in the vBNST regulate efferent pathways to the VTA to 
produce cocaine seeking via a mechanism that also involves local CRF actions, we tested 
for the ability of intra-BNST pretreatment with antalarmin to block reinstatement in 
response to local delivery of the beta2 AR agonist clenbuterol. Reinstatement in response 
to bilateral intra-BNST delivery of clenbuterol (36 pmol/10 ng per side) was examined 
following bilateral intra-BNST pretreatment with antalarmin (1.32 nmol/500 ng/side) or 
vehicle (10 min pretreatment) in counterbalanced sequence in six rats. To test the 
hypothesis that CRF-R1 receptor activation in the vBNST is downstream from β-2 AR 
activation in the sequence of events that mediate stress-induced cocaine seeking, a 
separate group of six rats was tested for reinstatement in response to bilateral intra-
vBNST CRF (63 pmol/300 ng/side; Erb and Stewart, 1999) following bilateral intra-
vBNST pretreatment with the selective β-2 AR antagonist, ICI-118,551 (1 nmol/277 ng 
per side) or vehicle (10 min pretreatment). 
Statistical analyses 
Statistical analyses were conducted using Predictive Analytics SoftWare statistics 
software (SPSS). Statistical significance was determined using ANOVA followed, when 
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appropriate, by further analyses of main effects using ANOVA and/or post hoc testing 
using Bonferroni-corrected t tests. 
 
Results 
 
Cocaine SA and extinction in rats used for the various reinstatement experiments are 
shown in Table 3.1 and did not differ across experiments.  
 
 
 
In general, each group of rats displayed escalation, as previously demonstrated 
under these conditions, and showed reduced cocaine seeking across extinction testing, 
which consisted of an average of 8.24 (±0.28) sessions before extinction criteria were 
met. The injection sites for rats used for each experiment are depicted in Figure 3.1. A 
Table 1: Cocaine SA and extinction.  Data represent cocaine SA (infusions/6-h 
session ± S.E) on days 1 and 14 of SA testing and cocaine lever responding 
(responses/2-h session ± S.E.) on the first day of extinction training (First Ext) 
and the last day of extinction training prior to reinstatement testing (Last Ext) in 
rats from each of the reinstatement experiments  
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total of 11 rats were excluded from analyses due to cannula misplacement. In all cases, 
drug effects were not observed with inaccurate injection.  
 
 
 
 
Experiment 1: effects of intra-BNST β AR antagonists on stress-induced 
reinstatement 
 
 
The effect of bilateral intra-vBNST injection of the β-1 AR antagonist betaxolol 
(1 nmol/307 ng per side) on shock-induced reinstatement was examined in seven rats and 
is shown in Figure 3.2A. Two-way repeated measures (reinstatement × betaxolol) 
Figure3.1: Intracranial injection sites. Representative atlas diagrams (Paxinos 
and Watson, 2006) of injection sites within the vBNST and the VTA. A, Rats 
from Experiments 1, 2 and 5; vBNST hits are depicted as circles and misses as 
triangles. B, Food control rats for Experiment 1; hits are depicted as squares and 
misses as triangles. C, Rats from Experiment 3; VTA hits are depicted as circles 
and misses as triangles. D, Rats used for the Experiment 4; contralateral hits are 
depicted as circles, ipsilateral hits are depicted as squares and food-controls are 
depicted as triangles. 
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ANOVA showed a significant overall reinstatement effect (F(1,6) = 65.437; p < 0.001) but 
no main effect of betaxolol pretreatment or interaction between betaxolol treatment and 
reinstatement. Shock produced robust reinstatement regardless of whether rats were 
pretreated with betaxolol or vehicle. The effects of bilateral intra-vBNST injection of the 
β-2 AR antagonist ICI-118,551 (1 nmol/277 ng per side) pretreatment on shock-induced 
reinstatement were also examined in seven rats and are shown in Figure 3.2B. Two-way 
repeated-measures ANOVA showed a significant reinstatement effect (F(1,6) = 
52.475; p < 0.001) and a significant main effect of ICI-118,551 pretreatment (F(1,6) = 
10.224; p < 0.05), as well as a significant reinstatement × ICI-118,551 pretreatment 
interaction (F(1,6) = 20.213; p < 0.01). Shock reinstated cocaine seeking in vehicle but not 
ICI-118,551 pretreated rats (p < 0.01 vs extinction; Ext) and reinstatement was reduced in 
ICI-118,551 pretreated versus vehicle pretreated rats (p < 0.01). To assess potential motor 
impairment resulting from intra-vBNST ICI-118,551 delivery that may have 
nonspecifically interfered with reinstatement responding, a separate group of six rats was 
tested for effects of intra-vBNST ICI-118,551 on sucrose pellet-reinforced responding. 
ICI-118,551 pretreatment failed to alter lever pressing under these conditions (Fig. 3.2C). 
In three of the rats that were tested, guide cannulae were misplaced such that they 
received injections into areas that comprise the dorsal BNST. Notably, in these rats, 
shock-induced reinstatement was observed in both vehicle-pretreated (Ext: 8.67 ± 1.76 
responses vs shock: 32.33 ± 2.03) and ICI-118,551-pretreated (Ext: 12.67 ± 1.76 
responses vs shock: 28.33 ± 4.81) rats. Effects of shock were specific to the previously 
active lever as shock failed to increase responding on a previously inactive lever in 
vehicle-pretreated rats (Ext: 1.37 ± 0.51 responses vs shock: 1.02 ± 0.44). Neither 
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betaxolol nor ICI-118,551 affected inactive lever responding during reinstatement testing 
(vehicle: 1.02 ± 0.44 responses; betaxolol: 1.00 ± 0.33; ICI-118,551: 0.75 ± 0.31). 
 
 
 
Experiment 2: reinstatement by intra-vBNST injection of β-AR agonists 
 
Following SA and extinction, bilateral intra-vBNST delivery of clenbuterol (36 
pmol/10 ng per side) but not dobutamine (1 nmol/ 301 ng per side), reinstated cocaine 
seeking (Fig. 3.3). A paired t test showed that, compared with vehicle, pretreatment with 
clenbuterol significantly increased previously active lever pressing (t(9) = 11.156; p < 
0.001). Neither dobutamine (0.88 ± 0.22 responses) nor clenbuterol (0.83 ± 0.55 
responses) increased responding on a previously inactive lever relative to vehicle 
Figure3.2: Footshock-induced reinstatement of cocaine seeking is blocked 
by intra-vBNST injection of the β-2 AR antagonist, ICI-118,551, but not the 
β-1 AR antagonist, betaxolol. Data represent the effects of bilateral intra-
vBNST injections of betaxolol (1 nmol/307 ng per side; A; n = 7) or ICI-118,551 
(1 nmol/277 ng per side; B; n = 7) or vehicle on reinstatement (responses/2 h 
session ± SE) by electric footshock. Significant reinstatement was observed 
following intra-vBNST pretreatment with vehicle or betaxolol (*p < 0.05 vs 
Ext), but not ICI-118,551. Likewise, responding following ICI-118,551, but not 
betaxolol, was significantly reduced compared with vehicle pretreatment (
#
p < 
0.05 vs vehicle). By contrast, intra-vBNST ICI-118,551 failed to altered food-
reinforced lever pressing (C; n = 6). 
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pretreatment (0.63 ± 0.18) responses. Guide cannulae were misplaced in three rats such 
that they received injections into sites within the dorsal BNST. In contrast to rats that 
received intra-vBNST injections, neither clenbuterol (Ext: 8.67 ± 1.99 vs clenbuterol: 
5.33 ± 5.95) nor dobutamine (Ext: 10.00 ± 2.07 vs dobutamine: 9.33 ± 7.60) produced 
reinstatement in these rats. 
 
 
Experiment 3: effect of VTA CRF receptor antagonism on stress-induced 
reinstatement 
 
 
As previously reported (Blacktop et al., 2011), bilateral injection of the CRF-R1 receptor 
selective antagonist, antalarmin (1.32 nmol/500 ng per side) into the VTA prevented 
reinstatement. The effect of bilateral intra-VTA antalarmin pretreatment on shock-
induced reinstatement was examined in six rats as shown in Figure 3.4. Two-way 
Figure3.3: Reinstatement of extinguished cocaine seeking by 
bilateral injection of the β-2 AR selective agonist, clenbuterol, but 
not the β-1 AR selective agonist, dobutamine, into the vBNST. Data 
represent responding on the cocaine lever (responses/2 h session ± SE; 
active) or a previously inactive lever. Intra-vBNST clenbuterol (36 
pmol/10 ng per side; n = 10), but not dobutamine (1 nmol/301 ng per 
side; n = 7) reinstated extinguished cocaine seeking (*p < 0.05 vs 
vehicle). Neither dobutamine nor clenbuterol increased “inactive” lever 
responding 
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repeated-measures ANOVA showed a significant reinstatement effect (F(1,5) = 
12.971; p < 0.05) and a significant main effect of antalarmin pretreatment (F(1,5) = 
9.175; p < 0.05), as well as a significant reinstatement × antalarmin pretreatment 
interaction (F(1,5) = 8.461; p < 0.05). As previously reported, shock reinstated cocaine 
seeking in vehicle but not antalarmin pretreated rats (p < 0.05 vs Ext) and reinstatement 
was reduced in antalarmin pretreated versus vehicle-pretreated rats (p < 0.05). As we 
have already demonstrated that intra-VTA antalarmin delivery does not alter food-
reinforced lever pressing (Blacktop et al., 2011), we did not test for these effects in this 
study. In two of the rats that were tested, guide cannulae were misplaced such that they 
received injections outside of the VTA. Notably, in these rats, shock-induced 
reinstatement was observed in both vehicle-pretreated (Ext: 13 and 12 responses vs 
shock: 35 and 29 responses) and antalarmin-pretreated (Ext: 5 and 12 responses vs shock: 
39 and 41 responses) rats.  
 
Figure3.4: Bilateral injection of the 
CRF receptor antagonist, 
antalarmin, into the VTA prevents 
shock-induced reinstatement of 
cocaine seeking. Data represent the 
effects of bilateral intra-vBNST 
delivery of antalarmin (1.32 nmol/500 
ng per side; Fig. 2A; n = 6) or vehicle 
on reinstatement (responses/2 h session 
± SE) following electric footshock. 
Significant reinstatement was observed 
after intra-vBNST pretreatment with 
vehicle (*p < 0.05 vs Ext) but not 
antalarmin. Likewise, responding 
following antalarmin was significantly 
reduced compared with vehicle 
pretreatment (
#
p < 0.05). 
	  
	   100	  
 
Effects of shock were specific to the previously active lever as shock failed to 
increase responding on a previously inactive lever in vehicle-pretreated rats (Ext: 1.12 ± 
0.29 responses vs shock: 0.89 ± 0.65). Antalarmin did not affect inactive lever 
responding during reinstatement testing (vehicle: 0.89 ± 0.65 responses; antalarmin: 0.81 
± 0.52). 
 
Experiment 4: identification of CRF-positive neurons in the vBNST that project to 
the VTA 
 
To determine whether CRF-positive neurons within the vBNST project to the 
VTA, we injected CTb unilaterally into the VTA and looked for the presence of 
CTb/CRF double-labeled perikarya in the vBNST in four rats. Representative 
photomicrographs from one rat are shown in Figure 5. CTb-immunoreactive (CTb-ir) 
perikarya were observed in the vBNST ipsilateral, to the VTA injection site (average of 
45 CTb-ir perikarya/ipsilateral vBNST). By contrast, and consistent with a previous 
report (Dong & Swanson 2006)CTb immunoreactivity in the vBNST contralateral to the 
VTA injection site was minimal (average of four immunoreactive cells/contralateral 
vBNST). CRF-like-immunoreactive (CRF-ir) perikarya and fibers were observed in the 
vBNST (Fig. 3.5). Under higher-magnification, three cell types were observed in the 
vBNST: CTb-ir/CRF-immunonegative, CTB-ir/CRF-ir, and CTb-immunonegative/CRF-
ir cells. Notably, most CRF-positive cells in the ipsilateral vBNST were also CTb-
immunoreactive (∼80%). By contrast, dual-labeled CRF- and CTb-positive cells were not 
observed in the contralateral vBNST. 
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Figure3.5: CRF neurons within the vBNST project to the VTA. A, Line drawing 
(adapted from Paxinos and Watson, 2006) of a coronal section containing the area of 
the VTA targeted for CTb microinjections and depicted in B. B, Representative 
photomicrograph depicting the VTA in brightfield, and CTb immunofluorescence in 
red. C, Line drawing of a coronal section containing the vBNST used for 
immunostaining of CRF and CTb. D–G, Representative photomicrographs depicting 
immunostaining for CRF (green) and CTb (red) in the BNST ipsilateral to the VTA 
injection site. Rectangle in D indicates area shown at higher-magnification in E. E, 
White arrowheads indicate CRF-ir/CTb-ir (VTA-projecting) neurons; white arrows 
indicate CTb-ir/CRF-immunonegative neurons; black arrowhead indicates a CRF-
ir/CTb-immunonegative cell. Rectangles in E represent areas shown at higher-
magnification in indicated panels. F, CRF-ir/CTb-ir neurons in vBNST. G, CRF-
positive/CTb-immunonegative cell in BnST. Scale bars: B, D, 500 µm; E, 100 µm; F, 
G, 33 µm. ac, Anterior commissure; Aq, cerebral aqueduct; f, fornix; fr, fasciculus 
retroflexus; Fu, bed nucleus of the stria terminalis, fusiform part; PAG, 
periaqueductal gray; PBP, parabrachial pigmented nucleus of the VTA; SN, 
substantia nigra; STLV, bed nucleus of the stria terminalis, lateral division, ventral 
part; STMV, bed nucleus of the stria terminalis, medial division, ventral part. 
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Experiment 5: effects of vBNST and VTA disconnection on stress-induced cocaine 
seeking 
 
 
To determine the role of a β-2 AR regulated pathway originating in the vBNST 
that releases CRF into the VTA in stress-induced cocaine seeking, we used a 
disconnection approach in which we delivered ICI-118,551 (1 nmol/277 ng) into the 
vBNST of one hemisphere and antalarmin (1.32 nmol/500 ng) into the contralateral VTA 
(n = 6 rats). To confirm that any effect on reinstatement was attributable to pathway 
disconnection, a second group of rats (n = 5) received ICI-118,551 into the vBNST of 
one hemisphere and antalarmin into the ipsilateral VTA. Contralateral but not ipsilateral 
antagonist delivery prevented shock-induced reinstatement (Fig. 3.6A), suggesting that, 
during stress, β-2 AR in the vBNST regulate one or more pathways that release CRF into 
the VTA to induce cocaine seeking. A three-way ANOVA showed a significant 
interaction between reinstatement test condition (shock vs extinction; repeated measure), 
antagonist pretreatment (ICI-118,551/antalarmin vs vehicle/vehicle treatment; repeated 
measure), and injection site (contralateral vs ipsilateral; between-subjects; F(1,9) = 
7.169; p < 0.05). Further analysis revealed a significant interaction between antagonist 
treatment and shock-induced reinstatement only in rats that received contralateral 
antagonist injections (F(1,5) = 25.851; p < 0.01).Post hoc testing showed that significant 
shock-induced reinstatement was observed following vBNST/VTA vehicle 
(contralaterally or ipsilaterally) and following ipsilateral intra-vBNST ICI-118,551 and 
intra-VTA antalarmin pretreatments (p< 0.05 for each comparison) but not following 
contralateral antagonist delivery. Furthermore, shock-induced reinstatement was 
significantly reduced following contralateral antagonist injections relative to either 
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vehicle pretreatment or ipsilateral antagonist delivery (p < 0.05 for each comparison). To 
assess potential motor impairment resulting from the disconnection approach that may 
have nonspecifically interfered with reinstatement responding, a separate group of six rats 
were tested for effects on sucrose pellet-reinforced responding. Contralateral intra-
vBNST ICI-118,551 and intra-VTA antalarmin delivery failed to alter lever pressing 
under these conditions (Fig. 3.6B).  
 
 
 
Figure	   3.6:	   Disconnection	   of	   a	   β-­‐2	   AR-­‐regulated	   vBNST-­‐to-­‐VTA	   CRF-­‐
releasing	   pathway	   prevents	   stress-­‐induced	   cocaine	   seeking.	   To	  
determine	   the	   role	   of	   a	  β-­‐2	  AR	   regulated	   pathway	  originating	   in	   the	  
vBNST	   that	   releases	  CRF	  into	  the	  VTA	  in	  stress-­‐induced	  cocaine	  seeking,	  we	  used	  a	  disconnection	  approach	   in	  which	  we	  delivered	  ICI-­‐118,551	   into	  the	  vBNST	  of	  one	  hemisphere	  and	  antalarmin	  into	  the	  contralateral	  VTA	  (n	  =	  6	  rats)	  and	  tested	  for	  shock-­‐induced	  cocaine	  seeking.	  To	  confirm	  that	  any	  effect	   on	   reinstatement	   was	   attributable	   to	   pathway	   disconnection,	   a	  second	   group	   of	   rats	   (n	   =	   5)	   received	   an	   ICI-­‐118,551	   injection	   into	   the	  vBNST	  of	   one	  hemisphere	   and	   an	   antalarmin	   injection	   into	   the	   ipsilateral	  VTA.	   Significant	   shock-­‐induced	   reinstatement	   was	   observed	   following	  vBNST/VTA	   vehicle	   (contralaterally	   or	   ipsilaterally)	   and	   following	  ipsilateral	  intra-­‐vBNST	  ICI-­‐118,551/intra-­‐VTA	  antalarmin	  pretreatment	  (*p	  <	   0.05	   vs	   Ext)	   but	   not	   following	   contralateral	   antagonist	   delivery	   (A).	  Furthermore,	   shock-­‐induced	   reinstatement	   was	   significantly	   reduced	  following	   contralateral	   antagonist	   injections	   relative	   to	   either	   vehicle	  pretreatment	   or	   ipsilateral	   antagonist	   delivery	   (#p	   <	   0.05	   for	   each	  comparison).	   By	   contrast,	   contralateral	   antagonist	   injections	   failed	   to	  altered	  food-­‐reinforced	  lever	  pressing	  (B;	  n	  =	  6).
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Effects of shock were specific to the previously active lever as shock failed to 
increase responding on a previously inactive lever in vehicle/vehicle-pretreated rats (Ext: 
0.88 ± 0.35 responses vs shock: 1.11 ± 0.27). Neither ipsilateral nor contralateral 
manipulations affected inactive lever responding during reinstatement testing 
(vehicle/vehicle: 1.11 ± 0.27 responses; ipsilateral: 0.97 ± 0.66; contralateral: 0.93 ± 
0.66). 
Experiment 6: role of vBNST CRF-R1 receptors in cocaine seeking induced by 
vBNST β-2 AR activation 
 
 
Because it has been reported that CRF receptors in the BNST are also required for 
stress-induced cocaine seeking (Erb and Stewart, 1999; Erb et al., 2001), and because 
BNST β ARs have been proposed to modulate efferent projections to the VTA via 
regulation of local CRF actions (Silberman et al., 2013), we hypothesized that 
reinstatement induced by vBNST β-2 AR activation requires local CRF receptor 
activation. To test this hypothesis we delivered antalarmin (1.32 nmol/500 ng per side) 
bilaterally into the vBNST before bilateral vBNST injection of clenbuterol (36 pmol/10 
ng per side). As shown in Figure 3.7, intra-vBNST antalarmin delivery prevented intra-
vBNST clenbuterol-induced cocaine seeking (n = 7). Two-way repeated-measures 
ANOVA showed a significant reinstatement effect (F(1,6) = 25.910; p < 0.01) and a 
significant main effect of antalarmin pretreatment (F(1,6) = 29.883; p < 0.01), as well as a 
significant reinstatement × antalarmin pretreatment interaction (F(1,6) = 35.968; p < 0.01). 
Clenbuterol reinstated cocaine seeking in vehicle but not antalarmin-pretreated rats (p < 
0.01 vs Ext) and reinstatement was reduced in antalarmin- versus vehicle-pretreated rats 
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(p < 0.01). By contrast, bilateral intra-vBNST pretreatment with the β-2 AR antagonist, 
ICI-118,551 (1 nmol/277 ng per side) failed to attenuate reinstatement in response to 
intra-vBNST CRF delivery (63 pmol/300 ng per side).  
 
 
Two-way repeated-measures ANOVA showed an overall effect of CRF (F(1,5) = 46.925) 
but no overall effect of ICI-118,551 pretreatment or no CRF × ICI-118,551 interaction. 
Altogether, these findings indicate that CRF receptor activation is likely downstream 
from β-2 AR activation in the sequence of events responsible for stress-induced 
reinstatement. Effects of intra-BNST clenbuterol (2.14 ± 0.67 responses vs 1.38 ± 0.73 
Figure3.7: Reinstatement of cocaine seeking by intra-vBNST clenbuterol 
injection requires activation of vBNST CRF-R1 receptors. Data represent the 
effects of A: bilateral intra-vBNST pretreatment with antalarmin (1.32 nmol/500 ng 
per side) or vehicle on reinstatement (responses/2 h session ± SE) in response to 
bilateral intra-vBNST clenbuterol injection (36 pmol/10 ng per side), or B: bilateral 
intra-vBNST pretreatment with ICI-118,551 (1 nmol/277 ng per side) or vehicle on 
reinstatement in response to bilateral intra-vBNST CRF injection (63 pmol/300 ng 
per side). Significant clenbuterol-induced reinstatement was observed in vehicle 
but not antalarmin pretreated rats (*p < 0.05 vs Ext). Responding following 
antalarmin was significantly reduced compared with vehicle pretreatment (
#
p < 
0.05). By contrast, significant CRF-induced reinstatement was observed in both 
vehicle and ICI-118,551 pretreated rats (*p < 0.05 vs Ext) and did not significantly 
differ between the two pretreatment conditions. 
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responses during extinction) and CRF (0.66 ± 0.42 vs 0.00 ± 0.00 responses during 
extinction) on previously inactive lever responding were not observed. Likewise, neither 
intra-BNST antalarmin (antalarmin/clenbuterol: 1.16 ± 0.16 responses) nor intra-BNST 
ICI-118,551 (ICI/CRF: 2.5 ± 1.93 responses) significantly altered inactive lever pressing 
during reinstatement.  
Discussion 
 
Our results extend earlier findings that the reinstatement of cocaine seeking by a 
stressor, electric footshock, requires CRF actions in the VTA (Wang et al., 
2005; Blacktop et al., 2011) and vBNST β AR activation (Leri et al., 2002) by showing 
that vBNST β-2 AR activation is both necessary and sufficient for stress-induced 
reinstatement. Moreover, using a disconnection approach in which we block β-2 ARs in 
the vBNST of one hemisphere and VTA CRF-R1 receptors in the contralateral 
hemisphere, we demonstrate that vBNST β-2 ARs regulate a CRF-releasing pathway to 
the VTA that is necessary for stress-induced cocaine seeking. As VTA CTb delivery 
labels CRF-positive cells in the ipsilateral vBNST, it is likely that this pathway consists 
(at least partly) of vBNST CRF neurons that project directly to the VTA. Consistent with 
reports that CRF actions in the BNST are required for stressor-induced cocaine seeking 
(Erb and Stewart, 1999; Erb et al., 2001), we demonstrate that vBNST CRF-R1 activation 
is necessary for reinstatement induced by local delivery of the β-2 AR agonist, 
clenbuterol, suggesting that β-2 AR-mediated activation of this BNST-to-VTA pathway 
also requires local CRF receptor activation. 
Findings from laboratory studies in human cocaine addicts (Jobes et al., 2011) and 
preclinical experiments in rodents (Erb et al., 2000; Mantsch et al., 2010) point to a role 
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for noradrenergic signaling in the stress-induced relapse to cocaine use. Specifically, our 
studies in mice suggest that β-2 ARs are critical for stress-induced cocaine seeking 
(Vranjkovic et al., 2012). As a target for ascending noradrenergic projections(Ricardo & 
Koh 1978, Weller & Smith 1982, Woulfe et al 1990) and a key site for integration of 
stress and reward networks (Flavin & Winder 2013, Stamatakis et al 2014), the BNST is 
a likely location at which stress-induced increases in norepinephrine regulate drug use. 
Although shock-induced increases in norepinephrine have not been reported, a variety of 
distinct stressors, including immobilization(Pacak et al 1995), visceral pain(Deyama et al 
2009), and exposure to a shock-conditioned stimulus(Onaka & Yagi 1998) ,fox odor 
(Fendt et al 2005), or an aversive tastant (Park et al 2012), have been demonstrated to 
increase noradrenergic neurotransmission in the BNST. In particular, the vBNST receives 
very dense noradrenergic innervation (Egli et al 2005, Georges & Aston-Jones 2001, 
Woulfe et al 1990). Moreover, delivery of a mixture of β-1 and β-2 AR antagonists into 
the vBNST has been reported to prevent shock-induced reinstatement in rats (Leri et al., 
2002). Our data extend these findings by demonstrating that β-2 but not β-1 AR 
activation in the vBNST is necessary for shock-induced cocaine seeking and that intra-
vBNST injection of a β-2 AR- but not a β-1 AR-selective agonist is sufficient to reinstate. 
Beta-2 ARs are expressed throughout the BNST (Cecchi et al., 2007). Whereas in 
the dorsal BNST β AR activation can have either excitatory or inhibitor effects on 
synaptic transmission, β AR effects in the vBNST are predominantly inhibitory (Egli et 
al., 2005) and include inhibition of neurons that project directly to the VTA (Dumont and 
Williams, 2004). In the dorsal BNST, β-AR regulation of neuronal activity requires CRF-
R1 activation (Nobis et al., 2011). Although the involvement of CRF in norepinephrine-
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dependent effects in the vBNST has not been established, our finding that local 
antalarmin pretreatment blocks reinstatement by intra-vBNST clenbuterol delivery 
supports a role for local CRF actions in the regulation of cocaine seeking by 
norepinephrine and β-2 AR activation. Consistent with this possibility, previous studies 
demonstrated that (1) noradrenergic terminals synapse on the dendrites of CRF-positive 
neurons in the vBNST(Phelix et al 1994)  (2) β-2 AR-mediated reinstatement requires 
CRF-R1 activation(McReynolds et al 2014), and (3) the β-2 AR antagonist, ICI-118,551, 
blocks stress-induced increases of BNST CRF mRNA (McReynolds et al., 2014). 
Overall, the findings are consistent with reports that cocaine seeking induced by central 
norepinephrine delivery is blocked by CRF receptor antagonism, whereas suppression of 
noradrenergic function using the α-2 AR agonist, clonidine, does not affect reinstatement 
in response to central CRF delivery(Brown et al 2009). 
Notably, the magnitude of cocaine seeking in response to intra-vBNST 
clenbuterol was lower than that observed following either shock or CRF. This could be 
attributed to (1) secondary effects of BNST β-2 AR activation that are not engaged by 
shock or CRF and offset responding, (2) unique attributes of clenbuterol itself (e.g., 
pharmacokinetics, ligand-specific receptor desensitization), or (3) the requirement for 
additional stress-responsive mediators to fully engage the processes that lead to cocaine 
seeking. 
Our findings suggest that the vBNST influences cocaine seeking via regulation of 
the VTA. Consistent with this possibility, stress-induced reinstatement in mice is 
associated with activation of VTA-projecting BNST neurons (Briand et al., 2010) and a 
role for a vBNST-VTA pathway in the expression of cocaine seeking has been reported 
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(Sartor & Aston-Jones 2012). In light of these findings, it is surprising that vBNST β-
ARs have been found to exert inhibitory effects on neurons that project to the VTA, 
likely via stimulation of local GABA release (Dumont and Williams, 2004). Both 
GABAergic and glutamatergic projections from the BNST to the VTA have been 
identified (Georges & Aston-Jones 2001, Georges & Aston-Jones 2002, Jennings et al 
2013, Kudo et al 2012, Sartor & Aston-Jones 2012). Moreover, CRF-positive terminals 
within the VTA coexpress either the glutamatergic neuronal marker, vesicular glutamate 
transporter 2, or the GABAergic neuronal marker, glutamic acid decarboxylase, and 
make contacts that have morphological characteristics of either excitatory or inhibitory 
synapses, suggesting that CRF can be coreleased into the VTA along with either GABA 
or glutamate (Tagliaferro & Morales 2008) .Further investigation is needed to (1) confirm 
the neurochemical phenotype of VTA-projecting vBNST CRF-positive neurons, (2) 
clarify the mechanism through which β-2 ARs regulate these neurons and determine how 
this regulation might change following cocaine exposure, and (3) examine the likelihood 
that β-2 AR in the vBNST may also regulate CRF and/or CRF actions in the VTA via 
parallel multisynaptic pathways. Consistent with the last possibility, BNST efferents can 
influence the VTA through multisynaptic pathways that include regions, such as the 
lateral habenula and rostromedial tegmental area(Dong & Swanson 2006, Kaufling et al 
2009, Lammel et al 2012). 
It has been found that (1) shock elevates VTA CRF levels (Wang et al., 2005), (2) 
intra-VTA CRF delivery is sufficient to induce cocaine seeking (Wang et al., 
2005; Blacktop et al., 2011), and (3) VTA CRF receptor activation is required for stress-
induced reinstatement (Wang et al., 2005; Blacktop et al., 2011) in rats. Our 
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demonstration that intra-VTA antalarmin delivery prevents shock-induced reinstatement 
is consistent with these reports. As the antalarmin dose used may also block CRF-R2 
receptors, our findings are not definitive regarding which CRF receptor subtype is 
involved. However, we have reported that, in rats tested under identical conditions, intra-
VTA delivery of a CRF-R2-selective antagonist does not prevent shock-induced 
reinstatement, whereas intra-VTA injection of a CRF-R1 but not a CRF-R2-selective 
agonist is sufficient to induce cocaine seeking (Blacktop et al., 2011). 
CRF actions in the VTA are complex and involve both excitatory and inhibitory 
effects that vary depending on the receptor and site(Beckstead et al 2009, Hahn et al 
2009, Riegel & Williams 2008, Ungless et al 2003, Wanat et al 2013, Wanat et al 2008). 
Likely VTA targets for CRF include mesocortical DA cells, which are activated during 
stress(Deutch et al 1991). Elevated medial prefrontal cortex DA, via activation of DA 
receptors, is necessary for stress-induced reinstatement (Capriles et al., 2003; McFarland 
et al., 2004). We demonstrate that the mechanisms through which vBNST β-2 ARs 
regulate this CRF projection to the VTA requires local CRF actions, likely at CRF-R1. 
This finding is consistent with reports that (1) depolarization of BNST neurons by the 
nonselective β-AR agonist, isoproterenol, is CRF-dependent (Nobis et al., 2011), (2) CRF 
in the BNST depolarizes neurons that project to the VTA (Silberman et al., 2013), and (3) 
stress-induced increases in CRF mRNA in the BNST in mice are β-2 AR-dependent 
(McReynolds et al., 2014). Moreover it is consistent with reports that intra-BNST 
antalarmin delivery prevents stress-induced cocaine seeking (Erb and Stewart, 1999; Erb 
et al., 2001). Although the requirement for vBNST CRF is evident, the source of this 
CRF has not been identified and could include intrinsic cell populations within the BNST 
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and/or CRF-releasing projections originating in other regions (e.g., the central amygdala). 
A clearer mechanistic understanding awaits determination of BNST β-2 AR receptor 
localization as it relates to that of CRF and CRF-R1. 
Although it is likely that the mechanisms through which stress promotes relapse 
are not identical across drug classes, both CRF-R1 receptor activation(Bruijnzeel et al 
2009, Deutch et al 1991, Le et al 2000, Shaham et al 1997) and central noradrenergic 
signaling(Erb et al 2000, Le et al 2005, Shaham et al 2000, Yamada & Bruijnzeel 2011) 
are necessary for stress-induced reinstatement of heroin-, nicotine-, and alcohol-seeking 
in rats. Moreover, in the case of heroin, stress-induced drug seeking requires CRF (Wang 
et al 2006) and noradrenergic (Wang et al 2001)signaling within the BNST. Notably, 
similar processes in the BNST may be engaged during withdrawal from ethanol 
(Francesconi et al 2009, Huang et al 2010, Silberman et al 2013)and opioids(Delfs et al 
2000, Fuentealba et al 2000), suggesting that this pathway to the VTA, or parallel 
pathways originating in other BNST subregions may also contribute to withdrawal-
related drug seeking.  
To summarize, we report that, during stress, norepinephrine released into the 
vBNST activates β-2 ARs, which via a CRF-dependent process, activate neurons that 
release CRF into the VTA, thereby leading to cocaine seeking. Identification of the 
processes responsible for stress-induced cocaine seeking should guide the development of 
new treatment approaches aimed at managing relapse, particularly in individuals whose 
use is stress-related. 
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Chapter IV 
 
Enhanced CRFR1 receptor-dependent regulation of a ventral tegmental area 
to prelimbic cortex projection establishes susceptibility to stress-induced cocaine 
seeking 
 
ABSTRACT 
The ability of stress to trigger cocaine seeking in humans and rodents is variable 
and is determined, in part, by the amount and pattern of prior drug use.  This study 
examined the role of a corticotropin releasing factor- (CRF-) regulated dopaminergic 
projection from the ventral tegmental area (VTA) to the prelimbic cortex in shock-
induced cocaine seeking and its recruitment under self-administration conditions that 
establish relapse vulnerability.  Rats with a history of daily long-access (LgA; 14 x 6 
hrs/day) but not short-access (ShA; 14 x 2 hrs/day) self-administration showed robust 
shock-induced cocaine seeking.  This was associated with a heightened shock-induced 
prelimbic cortex Fos response and activation of VTA neurons that project to the 
prelimbic cortex, as defined by Fos co-labeling with the retrograde tracer, cholera toxin 
B.  Both shock-induced reinstatement and the prelimbic cortex Fos response were 
prevented by bilateral intra-VTA injections of the CRFR1 receptor antagonist, 
antalarmin.  Pharmacological disconnection of the CRF-regulated dopaminergic 
projection to the prelimbic cortex by injection of antalarmin into the VTA in one 
hemisphere and the D1R antagonist SCH23390 into the prelimbic cortex of the 
contralateral hemisphere prevented shock-induced cocaine seeking, while antagonist 
administration within the same hemisphere or disconnection of the VTA projection to 
infralimbic cortex was without effect.  LgA, but not ShA, cocaine self-administration 
resulted in increased CRFR1 mRNA levels in the VTA as measured using in situ 
	   114	  
hybridization.  Altogether, these findings suggest that excessive cocaine use establishes 
susceptibility to stress-induced relapse by recruiting CRF regulation of a key stressor-
responsive mesocortical dopaminergic pathway.  
INTRODUCTION 
Relapse to drug use remains a barrier to the effective treatment of cocaine addiction. 
While a number of stimuli can elicit relapse, stress is a particularly problematic relapse 
trigger due to its unpredictable and often unavoidable nature.  Stress-induced relapse is 
studied in rats using the self-administration (SA)/reinstatement approach in which the 
ability of a stressor, most commonly electric footshock, to re-establish extinguished 
cocaine-directed lever pressing is assessed (Mantsch et al., 2015).  Studies using this 
approach have begun to define the neurocircuitry and mechanisms that contribute to 
stress-related relapse and have demonstrated involvement of dopamine D1 receptor 
activation in the prelimbic cortex (Capriles et al 2003; McFarland et al 2004) and 
corticotropin releasing factor (CRF) activation of CRFR1 receptors in the ventral 
tegmental area (VTA; Blacktop et al 2011).  Based on these findings, a role for a CRF-
regulated dopamine projection from the VTA to the prelimbic cortex in stress-induced 
cocaine seeking has been proposed but has not been directly demonstrated. 
The mesocortical dopamine system has long been known to be highly responsive 
to stress (Thierry et al., 1976; Reinhard Jr et al 1982; Deutch et al 1985; Speciale et al 
1986).  Moreover, VTA dopamine cells that project to the prelimbic cortex are activated 
by stressors, as measured ex vivo using Fos immunoreactivity or slice electrophysiology 
in neurons labeled by retrograde tracers injected into the prelimbic cortex (Deutch et al 
1991; Lammel et al 2011).  Although studies examining the regulation of mesocortical 
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dopamine by VTA CRF have produced mixed results (see e.g., Kalivas et al., 1987), 
reports that icv CRF increases dopaminergic neurotransmission in the prefrontal cortex 
(Dunn and Berridge, 1987; Lavicky and Dunn, 1993) and that CRF promotes excitation 
of VTA dopamine neurons via both pre- and post-synaptic mechanisms (Ungless et al 
2003; Korotkova et al 2006; Riegel and Williams 2008; Wanat et al 2008, Beckstead et al 
2009; Hahn et al 2009, Williams et al 2014) suggest that stress-induced CRF release into 
the VTA may underlie increases in mesocorticolimbic dopamine release.  Consistent with 
this possibility, Refojo et al (2011) reported that selective deletion of CRFR1 receptors in 
VTA dopamine neurons significantly reduced stress-induced increases in dopamine in the 
prefrontal cortex in mice. 
Evidence that CRF regulation of mesocortical dopamine is responsible for stress-
induced cocaine seeking is indirect.  Stress-induced reinstatement is associated with 
elevated extracellular CRF in the VTA (Wang et al., 2005) and extracellular dopamine in 
the prelimbic cortex (McFarland et al 2004) and VTA (likely reflecting somatodendritic 
release; Wang et al, 2005).  Moreover, CRF receptor antagonism in the VTA prevents 
both stress-induced cocaine seeking (Wang et al, 2005; Blacktop et al 2011) and 
increases in VTA dopamine (Wang et al, 2005), while stress-induced cocaine seeking is 
prevented by D1 receptor antagonism in the prelimbic cortex (Capriles et al 2003; 
McFarland et al 2004).  In this study we more directly test the hypothesis that stress-
induced reinstatement requires CRF regulation of a dopaminergic pathway from the VTA 
to the prelimbic cortex. 
We have found that stress-induced cocaine seeking depends on the prior history of 
cocaine use.  Under our experimental protocol, footshock induces reinstatement in rats 
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with a history of long-access (LgA; 14 x 6 hrs/day) but not short-access (ShA; 14 x 2 
hrs/day) cocaine SA (Mantsch et al 2008).  Moreover, cocaine seeking in response to 
intra-VTA CRF delivery is also only observed following SA under LgA conditions 
(Blacktop et al., 2011), suggesting that cocaine use promotes stress-induced cocaine 
seeking by recruiting CRF regulation of the mesocortical pathway.  Although a role for 
VTA CRF-R2 receptors in stress-induced cocaine seeking has been reported (Wang et al 
2005), we and others have demonstrated a role for CRFR1 receptors (Blacktop et al 2011; 
Chen et al 2014).  Therefore, in the present study we also test the hypothesis that stress 
regulation of the mesocortical dopamine pathway is recruited following LgA SA as a 
result of increased VTA CRFR1 receptor expression. 
MATERIALS AND METHODS 
Subjects 
Adult male Sprague Dawley rats (Harlan Laboratories) ~ 90-d old at the time of 
delivery (325g) were housed individually in a temperature- and humidity-controlled, 
Association for Assessment and Accreditation of Laboratory Animal Care accredited 
facility under a 12 h/12h dark/light cycle (lights off at 700h) and had access to food and 
water at all times, except during food training periods during which they were maintained 
at 90% of their free-feeding body weight. All procedures were performed in accordance 
with NIH Guide for the Care and Use of Laboratory Animals.    
Drugs 
Cocaine HCl was acquired from the National Institute on Drug Abuse through its 
Drug Supply Program. The selective dopamine D1 receptor antagonist SCH-23390 and 
the CRFR1 receptor antagonist antalarmin were purchased from Sigma-Aldrich. All 
drugs were dissolved in bacteriostatic saline. Intracranial drug doses were selected based 
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on previously published results (Blacktop et al 2011; Capriles et al 2003; Vranjkovic et al 
2014). 
Self-Administration and Extinction 
All rats in the study underwent cocaine or saline self-administration followed by 
extinction training.  Rats self-administered cocaine/saline through indwelling jugular 
catheters implanted under ketamine HCl (100mg/kg i.p.) and xylazine (2mg/kg, i.p.) 
anesthesia, as described previously (Blacktop et al., 2011; Vranjkovic et al., 2014).  
Following a 5-day post-surgery recovery period, rats were trained to self-administer 
cocaine (0.5 mg/kg/inf, i.v.) by pressing a lever under a FR1 schedule of reinforcement in 
computer-interfaced operant conditioning chambers (Med Associates) during daily 2-h 
sessions. During these sessions, the active lever was extended into the chamber and the 
corresponding light was illuminated. Pressing this lever resulted in activation of a pump, 
which infused cocaine (200µl over 5 sec) followed by a 5-sec time-out phase during 
which the stimulus light was extinguished, but the lever remained extended. Responding 
during the time-out phase did not activate the pump. Responding on a second (inactive) 
lever was also recorded but had no consequences. Once stable self-administration under 
the FR1 schedule was observed (>15 infusions for three consecutive days), the criterion 
for self-administration was gradually increased until rats displayed stable responding 
under a FR4 schedule (within 10% of the 3-session mean) at which time they entered into 
self-administration testing.  Depending on the experiment and experimental group, the 
conditions under which self-administered cocaine during the 14-day testing phase varied.  
Some rats continued to have access to cocaine (0.5 mg/kg/inf) during 2-h daily sessions 
(short-access; ShA rats).  Some rats were provided daily access to cocaine (0.5 
mg/kg/inf) during 6-h sessions (long-access; LgA rats).  Saline control rats were provided 
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daily access to saline during 2-h sessions (Sal rats).  Following completion of the 14-day 
self-administration phase, rats underwent extinction training.  During the 2-h extinction 
training sessions, the cocaine solution was replaced with saline (saline control rats 
continued to have access to saline).  The experimental conditions were otherwise 
identical to those during self-administration.  Depending on the experiment, extinction 
training either continued for ten days (Experiments 1, 2, 3, and 5) or until a response 
based criterion was reached (<15 active lever responses two consecutive sessions; 
Experiment 4).   Following extinction training, rats were tested for shock-induced 
reinstatement of cocaine seeking and/or were killed and their brains processed for 
immunohistochemistry or in situ hybridization.   
Shock-Induced Reinstatement 
With the exception of rats in Experiment #5, all rats were tested for shock-
induced reinstatement of extinguished lever pressing.  The 2-hr reinstatement sessions 
were identical to the extinction sessions except that they were preceded by the delivery of 
intermittent mild non-noxious footshock, in some cases following intracranial drug 
injections.  Shocks (0.5mA, 0.5sec duration) were delivered on average every 40 seconds 
(range 10- 70 sec) throughout the grid floors of the self-administration chambers over a 
15 min period that immediately preceded the 2hr reinstatement test session (Blacktop et 
al., 2011; Vranjkovic et al., 2014). During the shock period, the levers were retracted and 
the stimulus lights were not illuminated; the levers were extended into the chamber and 
the lights turned on immediately following the shock period. Reinstatement was defined 
as an increase in active lever responding relative to the prior extinction session.  
Statistical Analyses 
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Statistical analyses were conducted using Predictive Analytics SoftWare statistics 
software (SPSS, Inc.). Statistical significance was determined using ANOVA followed, 
when appropriate, by further analyses of main effects using ANOVA and/or post-hoc 
testing using Bonferroni-corrected t-tests. 
Experiment #1: Relationship between prefrontal cortical Fos immunoreactivity and 
shock-induced reinstatement of cocaine seeking. 
We have previously shown that robust shock-induced reinstatement of 
extinguished cocaine seeking is observed following daily long-access (LgA; 6 hrs) but 
not short-access (ShA; 2 hrs) cocaine self-administration (Mantsch et al., 2008).  To 
examine the relationship between shock-induced cocaine seeking and activation of the 
prelimbic and infralimbic regions of the prefrontal cortex, separate groups of rats 
underwent 14 days of self-administration testing under ShA (14 x 0.5 mg/kg/inf cocaine; 
2 hrs/day) or LgA (14 x 0.5 mg/kg/inf cocaine; 6 hrs/day) conditions or were provided 
access to saline for two hours daily (14 x saline; 2 hrs/day; Sal).  Following self-
administration, rats received extinction training (2 hrs daily, as described above).  As it 
has been reported that many cocaine-induced neurobiological alterations that contribute 
to drug seeking depend on the time period that has elapsed following self-administration 
(Grimm et al., 2001; Conrad et al., 2009; Ma et al., 2014), for these experiments we 
chose not to use extinction criteria for reinstatement testing/Fos determination.  Rather, 
all rats underwent extinction training for ten consecutive days.  Following extinction, all 
rats were tested for reinstatement in response to shock (ShA rats, n=8; LgA rats, n=7; Sal 
rats, n=10) or under shock-free conditions (ShA rats, n=10; LgA rats, n=10; Sal rats, 
n=10) and, immediately after the 2-h reinstatement session, were anesthetized with 
sodium pentobarbital (55 mg/kg, i.p.) and perfused transcardially with 0.9% NaCl, 
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followed by 60 ml of cold (4°C) 4% paraformaldehyde in 0.1 M phosphate buffer, pH 
7.0. Brains were removed and post-fixed in paraformaldehyde over-night at 4°C. Brains 
were then washed twice in 0.1M sodium phosphate buffers for 12 hrs. Afterwards, brains 
were cryoprotected in 30% sucrose in 0.1 M phosphate buffer for 3 days at 4°C. Brains 
were frozen and serial coronal sections (25 µm) containing the prelimbic and infralimbic 
cortices (+3.24 to 2.54) were cut at 200 µm intervals on a freezing microtome and placed 
in cryoprotectant. Sections were stored at -20°C until immunohistochemistru procedures 
were conducted.  Immunohistochemical analysis of Fos expression was performed on 
free-floating sections by using an avidin-biotin peroxidase protocol (Hoffman et al., 
2008). Fos immunolocalization was visualized using the primary polyclonal rabbit anti-
Fos antibody (sc-52, Santa Cruz Biotechnology; 1:10,000). Free-floating sections were 
washed 3 times for 5 min in 0.5M KPBS and then incubated in 2% hydrogen peroxide in 
0.5MKPBS containing 0.4% triton for 15 min to block endogenous peroxidase activity. 
Sections were washed three more times and then incubated in 3% natural donkey serum 
for one hour. Afterwards the sections were incubated in the primary antibody containing 
0.4% triton X-100 for 24 hours in 4°C. Next, sections were washed again, and then 
incubated for one hour in biotinalyed horse anti-rabbit IgG secondary antibody (PI-
1000;Vector Laboratories; 1:600). Sections were washed once again and then incubated 
for one hour in ABC solution (PK-4000; Vectastain Elite ABC kit; Vector Laboratories). 
After another series of washes, sections were incubated 3 times for 5min each in 0.175 M 
sodium acetate (7.0 pH). Sections were treated with a nickel-enhanced diaminobenzide 
method (black-nuclear reaction) (SK-4100 DAB; Vector Laboratories) and the sections 
were again incubated in 0.175 M sodium acetate and then washed in KPBS. Tissue was 
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then mounted on super-frost slides and dehydrated the next day. Fos immunoreactivity 
was quantified using Image J software.  The total numbers of Fos-positive cells within 
each cortical region (i.e., the sum across regions all sections) were determined and 
compared across groups. 
Experiment #2: Role of VTA CRFR1 receptors in shock-induced cocaine seeking 
and cortical subregion activation 
Rats were implanted with jugular catheters bilateral cannula (11-mm, 22-gauge) 
aimed at the caudal VTA (5.6 mm posterior to bregma; 2.2 mm lateral to midline; 6.9 
ventral to skull surface at a 12° angle; Paxinos and Watson, 2006) and underwent cocaine 
self-administration under LgA conditions and extinction prior to testing for reinstatement 
in response to shock or under shock-free conditions.  Prior to the 2-hour reinstatement 
session, rats received bilateral intra-VTA injections with the CRFR1 receptor antagonist, 
antalarmin (1.32 nmol/500 ng/side; n=9) or vehicle (n=8).  We (Blacktop et al., 2011; 
Vranjkovic et al., 2014) and others (e.g., Lowery-Gionta et al., 2012) have used this 
antalarmin dose to investigate CRF-R1 receptor-dependent contributions to behavior.  
Microinfusions were delivered in a volume of 0.25 µl/side over a 1-min period followed 
by an additional 1-min period to allow for drug diffusion, ten minutes prior to the 15-min 
shock or shock-free period.  Immediately after the 2-hr session, rats were processed (as 
described for Exp #1) for immunohistochemical analysis of Fos expression in the 
prelimbic and infralimbic cortices.   The accuracy of cannula implantation into the VTA 
was confirmed post-mortem following staining of sections containing VTA with cresyl 
violet for examination using a light microscope. Rats with injection sites outside of the 
targeted regions were excluded from data analysis. 
Experiment #3: Relationship between Fos immunoreactivity in VTA neurons that 
project to the prelimbic cortex and shock-induced reinstatement of cocaine seeking. 
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To determine if activation of VTA neurons that project to the prelimbic cortex is 
associated with shock-induced reinstatement of extinguished cocaine seeking, rats 
underwent LgA self-administration for 14 days and received bilateral injections with the 
retrograde tracer cholera toxin b subunit (CTb) into the prelimbic cortex.  Rats were 
anesthetized with ketamine and xylazine and placed in a stereotaxic frame. Heat-
sterilized Hamilton syringes were used to pressure inject 0.2µl biotinylated CTb (10%; 
List Biological Laboratories; #104; Campbell, CA) unilaterally into the prelimbic cortex 
over a 10-min period ( at a 6 degree angle anterior to Bregma 3.2 mm; lateral 0.4 mm; 
ventral 3.2 mm; Paxinos and Watson, 2006). Syringes were left in place for 20 min after 
injections and slowly removed from the brain over a 10-min period.  Following 
injections, rats were allowed to recover for seven days prior to undergoing daily 
extinction training until the extinction criterion was reached (<15 responses for 3 
consecutive sessions) at which point they were tested for cocaine seeking in response to 
shock (n=6) or under shock-free conditions (n=5).  Immediately following the 2-h 
reinstatement session, rats were processed (as described above) for CTb/Fos labeling of 
VTA neurons using dual immunohistochemistry.  Fos was visualized using a nickel-
enhanced DAB reaction as described above. CTb was visualized by similar methods 
except for the addition of an avidin-biotin blocking step (SP-2100) prior to incubation 
with the CTb primary antibody (List Biology #703; 1:8000).  After the 24-hour 
incubation period, sections were washed and incubated in horse anti-goat secondary 
antibody (PI-9500; Vector Laboratories; 1:1,000). Sections were washed again and 
incubated for one hour in ABC solution. Sections were then washed and treated with 
sodium acetate and were treated using the DAB method (brown cytoplasmic staining) for 
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visualization of CTb. Sections were washed and then mounted on super-frost slides and 
dehydrated the next day. Photomicrographs were acquired using a Retiga 2000R digital 
camera (QImaging) on a Nikon 80i microscope using NIS Elements software (Nikon 
Instruments).  Fos-, CTb- and dual Fos/CTb- immunoreactive cells were identified and 
counted using Image J software.  Using a similar approach, it has been previously 
reported that restraint stress selectively increases Fos expression in VTA neurons that 
project to the prelimbic cortex in rats (Deutch et al., 1991).   
Experiment #4: Effect of pharmacological disconnection of the CRF-regulated 
dopaminergic pathway from the VTA to the prelimbic cortex on shock-induced 
cocaine seeking. 
A disconnection approach was used to determine whether a CRFR1 receptor-activated 
dopaminergic projection from the VTA to the prelimbic cortex is required for stress-
induced cocaine seeking.  At the time of catheterization, separate groups of rats were 
implanted with two cannulae each aimed unilaterally at the VTA (at a 12 degree angle 
posterior to Bregma -5.6 mm; lateral 2.2 mm; ventral -6.9 mm; Paxinos and Watson, 
2006) or the prelimbic cortex (at a 6 degree angle anterior to Bregma 3.2 mm; lateral 0.4 
mm; ventral 3.2 mm; Paxinos and Watson, 2006) in either the contralateral or ipsilateral 
hemisphere(s) of the brain.  The effect of pathway disconnection was examined by 
injection of the CRF-R1 receptor antagonist antalarmin (1.32 nmol/500 ng) into the VTA 
in one hemisphere and the dopamine D1 receptor antagonist SCH23390 (1.38mM/200 
ng) into the prelimbic cortex of the other prior to testing for shock-induced reinstatement 
(n=5).  For comparison, the same rats were tested for shock-induced reinstatement 
following injection of vehicle into each region.  As a control to ensure that reductions in 
reinstatement were attributable to disconnection, a second groups of rats (n=4) received a 
unilateral injection of antalarmin into the VTA in one hemisphere and a unilateral 
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injection of SCH23390 into the prelimbic cortex in the same hemisphere prior to testing 
for shock-induced reinstatement.  These rats were also tested for the effects of ipsilateral 
vehicle injections.  For this experiment, the hemispheres into which cannulae were 
implanted were randomized across rats in each group such that in the contralateral 
treatment group, half of the rats received antalarmin injections into the left VTA and 
SCH23390 injections into the right prelimbic cortex, while the other half received 
antalarmin injections into the right VTA and SCH23390 injections into the left prelimbic 
cortex.  Likewise, half of the rats in the ipsilateral treatment group received drug 
injections into sites in the right hemisphere, while the remaining rats received injections 
into sites in the left hemisphere.  A third group of rats (n=4) were implanted with 
cannulae for disconnection of CRFR1-regulated VTA dopaminergic inputs into the 
infralimbic cortex.  As with the prelimbic cortex disconnection experiment, these rats 
received an antalarmin injection into the VTA of one hemisphere and a SCH23390 
injection into the infralimbic cortex of the other.  The accuracy of cannula implantation 
was confirmed post-mortem in each rat after cardiac perfusion with 60-ml 0.15% NaCl 
followed by 60-ml 2.5% buffered neutral formalin under sodium pentobarbital anesthesia 
(55 mg/kg). Brains were removed and stored in 2.5% buffered formalin prior to 
vibratome sectioning (40 µm), slide mounting, and staining with cresyl violet for 
examination using a light microscope. Rats with injection sites outside of the targeted 
regions were excluded from data analysis. 
Experiment #5: Effects of cocaine self-administration under conditions that promote 
shock-induced cocaine seeking on CRFR1 mRNA in the VTA 
We previously reported that intra-VTA CRF injections reinstate cocaine seeking in rats 
with a history of LgA, but not ShA self-administration (Blacktop et al., 2011).  To 
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determine if LgA self-administration recruits CRFR1-dependent regulation of VTA 
dopamine neurons that project to the prelimbic cortex to increase susceptibility to shock-
induced cocaine seeking, we used in situ hybridization to examine differences in the 
expression of CRFR1 mRNA within the VTA resulting from self-administration under 
ShA (n=8), LgA (n=8) and saline control (n=8) conditions.  All rats were tested under 
their respective conditions and underwent ten days of extinction. 24 hrs after the final 
extinction session brains were extract following rapid decapitation in the absence of 
anesthesia and were placed in methyl-2-butane for one minute at a temperature between -
25 and -35°C, and placed in a -80°C freezer until sectioning. The tissue was sectioned on 
a cyrostat to 14 µm thickness and placed onto superfrost plus slides and stored in a -80 °C 
freezer until in situ hybridization analysis was conducted.  A 1138 bp fragment of the rat 
CRF-R1 cDNA (NCBI NM_030999, nucleotides 99-1236) was isolated by PCR from rat 
cortex cDNA and subcloned into pCRII-TOPO (Invitrogen) to create pCRII-TOPO-
rCRHR1-1. For antisense riboprobe synthesis, the pCRII-TOPO-rCRHR1-1 plasmid was 
linearized with BamHI and transcribed with T7 RNA polymerase (Promega). The 
riboprobe was double labeled with 35S-CTP and 35S-UTP (Perkin-Elmer; 1250 Ci/mmol) 
and free nucleotides were removed using a Micro Bio-Spin column (Bio-Rad). In situ 
hybridization was performed as previously described with minimal modifications (Speert 
et al, 2002, Westphal et al 2010). Briefly, slides were post-fixed for 1 h in 4% phosphate-
buffered paraformaldehyde and washed three times in 2X SSC.  Sections were incubated 
in 0.1M triethanolamine containing 0.25% acetic anhydride for 10 minutes with stirring, 
rinsed in dH2O, dehydrated and air-dried.  Slides were then hybridized overnight at 55C 
with the 35S-labeled CRHFR1 riboprobe (2x106 cpm/slide) in 50% formamide 
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hybridization cocktail (Ameresco) containing 10 mM DTT. After hybridization, excess 
unhybridized probe was removed by 2X SSC washes and by incubating slides in RNase 
A (37 C, 1 h). Slides were then washed in decreasing salt solutions (2x, 1x, and 0.5x 
SSC) before a final high-stringency wash in 0.1x SSC (65 C, 1 h). Slides were then 
dehydrated in ethanol, air-dried, and apposed to Kodak BioMax MR autoradiography 
film (Carestream) for 7 days.  Four to five slides (1 slide/series with 4 sections/slide) 
from each rat were included and were processed simultaneously to allow direct 
comparisons in the same regions and minimize variation. Autoradiography films were 
scanned and analyzed using densitometry in ImageJ (Version 1.48g5). Signal pixels 
within the area of interest were defined as having a gray value of 3.5 standard deviations 
above the mean gray value of the background region.  Both the number of pixels (area) 
and average gray values (mean optic density/OD) above background were determined 
and multiplied to generate an integrated densitometric measurement (integrated OD).   
CRFR1 signal from multiple sections (spanning bregma -5.2 to -6.4) was analyzed and 
averaged to generate one single integrated OD per region per rat/per rat. Based on prior 
functional/anatomical distinctions (Oades et al., 1987), the VTA was subdivided into 
rostral (-5.2 to -5.6 mm bregma) and caudal regions (-5.6 to -6.2 bregma).  The caudal 
VTA did not include the VTA tail (rostromedial tegmental area; -6.6 to -6.9 mm bregma  
(Jhoun et al., 2009; Matsui and Williams, 2011; Barrot et al., 2012).   
 
RESULTS 
 
 
Cocaine self-administration and extinction 
Self-administration (infusions on days 1 and 14 of self-administration testing and total 
mg/kg cocaine intake across all sessions) and extinction data (responses during the final 
2-h session prior) for each experiment are shown in Table 1. 
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Table 1 
 
 
Experiment #1: Relationship between prefrontal cortical Fos immunoreactivity and 
shock-induced reinstatement of cocaine seeking 
 
 
Rats underwent daily cocaine self-administration for 14 days under ShA (2 
hrs/day; total intake ~359.4 mg/kg) or LgA (6 hrs/day; total intake ~1045 mg/kg) or were 
provided access to saline for self-administration, prior to undergoing ten days of 
extinction after which they were tested for cocaine seeking under shock-free conditions 
or following shock exposure and their brains were processed for cortical Fos analysis.  
Shock-induced cocaine seeking is shown in Figure 1A.  Similar to previous reports 
(Mantsch et al., 2008), robust shock-induced reinstatement was observed in rats 
Exp. Group  SA (infusions/session ± S.E.) Total Intake 
(mg/kg) 
Last Ext 
(resp/session ± S.E.) SA Day 1 SA Day 14 
Exp. 1  
 
Saline/No Shock  
Saline/Shock  
ShA Coc/No Shock 
ShA Coc/Shock 
LgA Coc/No Shock 
LgA Coc/Shock 
14.2 ± 3.5 
9.9 ± 1.2 
27.9 ± 1.5 
27.7 ± 1.3 
79.3 ± 3.9 
75.1 ± 3.5 
4.3 ± 0.9 
3.8 ± 6.7 
18.4 ± 4.7 
22.7 ± 4.7 
82.8 ± 9.2 
83.7 ± 7.7 
--- 
--- 
354.9 ± 19.8 
363.8 ± 31.4 
1062.3 ± 83.1 
1027.0 ± 77.2 
6. ± 1.58 
5.3 ± 1.2 
9.4 ± 2.8 
5.1 ± 1.4 
11.7 ± 2.3 
11.5 ± 3.0 
Exp. 2  Vehicle/No Shock 
Vehicle/Shock 
Antalarmin/No Shock 
Antalarmin/Shock 
83.6 ± 4.3 
76.0 ± 9.1 
78.0 ± 9.0 
90.0 ± 5.0 
91.6 ± 6.3 
94.0 ± 4.9 
105.0 ± 11.2 
94.0 ± 4.9 
1007.0 ± 48.0 
1092.3 ± 107.5 
1076.3 ± 109.4 
1126.6 ± 115.1 
8.0 ± 1.8 
8.0 ± 1.8 
6.8 ± 2.4 
8.0 ± 2.8 
Exp. 3  Shock 
No Shock 
58.4 ± 8.2 
71.8 ± 9.0 
80.4 ± 9.4 
88.0 ± 10.6 
887.2 ± 98.7 
1086.6 ± 60.0 
2.8 ± 1.8 
9.3 ± 2.4 
Exp. 4  Prelimbic/contralateral 
Prelimbic/ipsilateral 
Infralimbic/contralateral 
62.6 ± 4.6 
68.0 ± 5.9 
68.5  ± 3.1 
74.8 ± 5.3 
92.3  ± 3.5 
77.8 ± 3.7 
907.6 ± 77.8 
1063.75 ± 94.2 
959.8 ± 67.5 
5.8 ± 2.2 
8.3 ± 1.9 
7.3 ± 3.3 
Exp. 5  Saline 
ShA Coc 
LgA Coc 
3.6 ± 1.8 
28.7 ± 2.6 
79.3 ± 5.9 
3.3 ± 0.8 
21.2  ± 4.0 
77.6 ± 10.8 
--- 
348.2 ± 52.5 
994.1 ± 69.5 
3.2 ± 0.9 
26.7 ± 7.7 
20.2 ± 6.6 
!
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following LgA cocaine self-administration but not following ShA self-administration and 
shock did not increase lever-pressing in control rats provided access to saline.  A 3-way 
ANOVA reinstatement testing (extinction vs. reinstatement test; repeated measure) x 
self-administration (ShA, LgA, vs. Sal) x shock condition (shock vs. no shock) ANOVA 
showed a significant interaction among all three variables (F2,38= 12.67; p<0.001).  Post-
hoc testing showed that shock-induced cocaine seeking, as defined by increased lever 
pressing relative to the prior extinction session and compared to non-shock controls, was 
only observed following long-access/high-intake self-administration (p<0.01 for each 
comparison).  Moreover, cocaine seeking following shock was significantly higher 
following LgA self-administration than it was after ShA self-administration or in saline 
controls (p<0.01 for each comparison).  
The numbers of Fos-positive cells in the prelimbic and infralimbic cortex 
following behavioral testing under shock and shock-free conditions were recorded in 
each group and are shown in Figures 1C (prelimbic cortex) and 1D (infralimbic cortex).  
Figure 1E represents a schematic identifying the regions in which Fos immunoreactivity 
was analyzed (Paxinos and Watson, 2013).  Representative immuno-labeled sections 
including the cortical regions of interest from each condition/group are shown in Figures 
1E-1L.  A 2-way shock x SA condition ANOVA showed a significant overall effect of 
shock (F1,45=51.08; p<0.001) and self-administration condition on the number of Fos-
positive cells in the prelimbic cortex (F2,45=8.310; P=0.001) and a significant shock x 
self-administration condition interaction (F2,46=12.828; p<0.001).  Post-hoc testing 
showed that shock increased the number of Fos-positive cells in rats tested under each 
condition (p<0.05 vs. No Shock).  This increase was significantly greater in rats tested 
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under longer-access/high-intake conditions (p<0.001 vs. Sal and ShA).  Shock also 
modestly but significantly increased the number of Fos immunoreactive cells in the 
infralimbic cortex (2-way ANOVA; overall effect of shock; F1,45=28.08; p<0.001).  
However, no overall effect of SA condition or SA condition x shock interaction was 
observed. 
 
 
 
 
Figure 1: Stress-induced cocaine seeking is associated with a heightened Fos 
response in the prelimbic cortex.  Data in Figures 1A and 1B represent lever pressing 
during extinction (Ext) and reinstatement testing either following either shock delivery or 
in the absence of shock in rats with a history of self-administration under short-access 
(ShA; 0.5 mg/kg/infusion cocaine; 14 x 2 hrs/daily), long-access (LgA; 0.5 
mg/kg/infusion cocaine; 14 x 6 hrs/daily), or saline control (Sal; 14 x 2 hrs/daily) 
conditions.  Shock only increased lever pressing during reinstatement testing following 
LgA SA (*p<0.01 vs. prior Ext, responding in No Shock controls, and reinstatement in 
Sal/ShA rats).  Data in Figures 1C and 1D represent the corresponding Fos responses in 
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the prelimbic cortex and infralimbic cortex.  Shock produced overall increases in the 
number of Fos-positive cells in each region (#p<0.05; overall effect of Shock) and, in the 
prelimbic cortex, this response was heightened following LgA self-administration 
(*p<0.01 vs. No Shock controls and Sal/ShA rats).  A schematic and image illustrating 
the analyzed regions (1E and 1F) and representative images depicting Fos 
immunoreactivity in the prelimbic cortex in each group comprise Figures 1G-L. 
 
 
 
 
 
Figure 2: CRFR1 receptor antagonism in the VTA prevents shock-induced cocaine 
seeking and the corresponding Fos response in the prelimbic cortex.  Bilateral intra-
VTA injection sites for the CRFR1 receptor antagonist, antalarmin, are shown in 2A.  
Shock reinstated cocaine-seeking in vehicle control rats (*p<0.01 vs. prior Ext and No 
Shock controls) and intra-VTA antalarmin prevented shock induced cocaine seeking 
following LgA self-administration (2B; #p<0.01 vs. intra-VTA Veh controls) and the 
corresponding Fos response in the prelimbic cortex (2C; *p<0.01, Fos increase vs. No 
Shock controls in Veh rats; #p<0.01, Fos reduction intra-VTA antalarmin vs. veh 
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pretreatment) without affecting Fos in the infralimbic cortex (2D).  Representative 
images showing the Fos responses in the prelimbic cortex following intra-VTA vehicle or 
antalarmin injections are shown in Figures 2E and 2F. 
   
 
Experiment #2: Role of VTA CRFR1 receptors in shock-induced cocaine seeking 
and cortical subregion activation 
 
Bilateral intra-VTA injections of the CRFR1 receptor antagonist, antalarmin, prevented 
shock-induced cocaine seeking rats following LgA cocaine self-administration and 
extinction and eliminated the corresponding increase in the number Fos immunoreactive 
neurons in the prelimbic cortex.  Antalarmin/vehicle injection sites in the posterior VTA 
are shown in Figure 2A.  Figure 2B shows the effects of intra-VTA antalarmin on shock-
induced cocaine seeking.  A 3-way reinstatement (extinction vs. reinstatement test; 
repeated measure) x shock condition (shock vs. no shock) x antalarmin pretreatment 
(VTA antalarmin vs. veh) ANOVA showed a significant interaction among all three 
variables (F1,12=10.79; p<0.01).  Post-hoc testing revealed that shock-induced cocaine 
seeking was observed following intra-VTA vehicle injections (p>0.01 vs. the prior 
extinction session or shock-free controls) but not after intra-VTA antalarmin delivery.  
Moreover, cocaine seeking in rats that received intra-VTA antalarmin injections prior to 
shock delivery was significantly lower than in intra-VTA vehicle controls (p<0.01).  
Figure 2C shows the effects of intra-VTA antalarmin on the Fos response to 
shock in the prelimbic cortex.  A 2-way antalarmin x shock-induced reinstatement 
ANOVA showed significant overall effects of shock (F1,17=77.86; p<0.001) and intra-
VTA antalarmin (F1,17=61.36; p<0.001) on the number of Fos-positive cells in the 
prelimbic cortex and a significant shock x antalarmin interaction (F1,17=73.47; p<0.001).  
Shock increased the number of Fos-immunoreactive cells in the prelimbic cortex in 
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vehicle- but not antalarmin-pretreated rats (p<0.01 vs. no shock controls) and the number 
of Fos-positive cells in prelimbic cortex following antalarmin was significantly lower 
than in rats pretreated with vehicle (p<0.01).  By contrast, neither shock nor intra-VTA 
antalarmin altered Fos-positive cell numbers in the infralimbic cortex (Figure 2D).  
Immuno-labeled sections including the prelimbic cortex from representative rats that 
received VTA vehicle or antalarmin are shown in Figures 2E and 2F. 
Figure 3: Shock-induced cocaine seeking induces Fos expression in VTA neurons 
that project to the prelimbic cortex.  To determine if shock-induced cocaine seeking is 
associated with activation of VTA neurons that project to the prelimbic cortex, cholera 
toxin b subunit (CTb) was injected bilaterally into the prelimbic cortex and Fos 
expression in CTb-labeled cells in the VTA was quantified.  Cocaine seeking was 
increased when rats received shock (*p<0.01 vs. prior Ext and No Shock controls; Fig 
3A).  There was no difference in CTb labeling between rats that underwent shock-
induced reinstatement and non-shock controls, but the total number of cells expressing 
Fos was increased by shock (Fig 3B; *p<0.05 vs. No Shock Controls).  Moreover, the 
percentage of CTb-labeled cells expressing Fos was increased in rats tested for shock-
induced reinstatement relative to controls (Fig 3C; *p<0.05 vs. No Shock Controls).   The 
CTb injection site and CTb, Fos and CTb/Fos-labeled cells in the VTA in brain 
representative sections from each group are shown in Figure 3D-F. 
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Experiment #3: Relationship between Fos immunoreactivity in VTA neurons 
that project to the prelimbic cortex and shock-induced reinstatement of cocaine 
seeking 
 
  
To determine if shock-induced cocaine seeking was associated with activation of 
VTA neurons that project to the prelimbic cortex, rats were injected bilaterally with the 
retrograde tracer, CTb, into the prelimbic cortex and Fos expression in CTb-labeled cells 
in the VTA was assessed following testing for shock-induced reinstatement or under 
shock-free conditions.  As expected, footshock reinstated extinguished cocaine seeking 
(Fig 3A).  A 2-way shock condition (shock vs. no shock) x reinstatement condition 
(extinction vs. test session) ANOVA revealed a significant shock condition x 
reinstatement testing interaction (F1,11=20.24; p=0.001).  Post-hoc testing showed that 
cocaine seeking was increased after exposure to shock compared to the preceding 
extinction session and non-shocked controls (p<0.01). 
Shock-induced reinstatement was associated with an increase in the total number 
of Fos-positive cells in the VTA (2-tailed t11=2.63; p<0.05), while the number of CTb-
labeled VTA neurons did not differ between shocked and non-shocked rats (Fig 4B).  
Moreover, the percentage of CTb-positive neurons in the VTA that were co-labeled for 
Fos was significantly increased in rats tested for shock-induced reinstatement compared 
to rats tested in the absence of shock (2-tailed t11=2.95; p<0.05), suggesting that shock-
induced cocaine is associated with activation of VTA neurons that project to the 
prelimbic cortex(Fig. 4C).  The CTb injection site and CTb, Fos and CTb/Fos-labeled 
cells in the VTA in brain representative sections from each group are shown in Figure 
4D-F. 
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Figure 4: A CRFR1 receptor-regulated dopaminergic projection to the 
prelimbic cortex is required for stress-induced cocaine seeking.   
 
 
To determine the role of a CRFR1 receptor-regulated dopaminergic projection 
from the VTA to the prelimbic cortex in stress-induced cocaine seeking, we used a 
disconnection approach in which we delivered antalarmin into the VTA of one 
hemisphere and SCH23390 into the contralateral prelimbic cortex (n=5 rats) and tested 
for shock-induced cocaine seeking.  To confirm that any effect on reinstatement was 
attributable to pathway disconnection, a second group of rats (n=4) received an 
antalarmin injection into the VTA of one hemisphere and a SCH23390 injection into the 
ipsilateral prelimbic cortex.  Significant shock-induced reinstatement was observed 
following VTA/prelimbic cortex vehicle (contralaterally or ipsilaterally) and following 
ipsilateral intra-VTA antalarmin/prelimbic SCH23390 pretreatment (*p<0.05 vs. Ext) but 
not following contralateral antagonist delivery (Fig 4A).  Furthermore, shock-induced 
reinstatement was significantly reduced following contralateral antagonist injections 
relative to either vehicle pretreatment or ipsilateral antagonist delivery (#p<0.05 for each 
comparison).  By contrast, disconnection of the VTA pathway to the infralimbic cortex 
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failed to alter cocaine seeking (4B; n=4).  Intra-VTA and cortical injection sites for rats 
used for analysis are shown in Figure 4C. 
 
Experiment #4: Effect of pharmacological disconnection of the CRF-regulated 
dopaminergic pathway from the VTA to the prelimbic cortex on shock-induced 
cocaine seeking. 
 
 
To determine the role of a CRFR1 regulated pathway originating in the VTA that 
releases dopamine into the prelimbic cortex in stress-induced cocaine seeking, we used a 
disconnection approach in which we delivered antalarmin (250 ng) into the VTA of one 
hemisphere and the dopamine D1 receptor antagonist, SCH 23390 (200 ng) into the 
contralateral prelimbic (Figure 4A; n=5 rats).    A 3-way repeated measures reinstatement 
condition (extinction vs. reinstatement test) x shock condition (shock vs. no shock) x 
disconnection (antalarmin/SCH 23390 vs. veh/veh) ANOVA revealed a significant 
interaction among all three variables (F1,4=29.02; p<0.01).  Post-hoc testing showed that 
significant shock-induced cocaine seeking as defined as an increase relative to the prior 
extinction session and responding by shock-free controls, was observed in vehicle control 
rats but not in rats that underwent pharmacological disconnection (p<0.01/comparison).   
Moreover, cocaine seeking following shock was significantly lower in rats that received 
contralateral VTA antalarmin/prelimbic SCH 23390 relative to vehicle/vehicle controls 
(p<0.01).   
To confirm that the effects of contralateral drug delivery on cocaine seeking were 
attributable to pathway disconnection, a second group of rats (Figure 4A; n=4) received 
antalarmin into the VTA of one hemisphere and SCH 23390 into the ipsilateral prelimbic 
cortex.  In contrast to rats that received antagonists into the contralateral regions, 
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administration of antalarmin and SCH23390 to the VTA/prelimbic cortex within the 
ipsilateral hemisphere did not prevent shock-induced cocaine seeking.  A 3-way repeated 
measures reinstatement condition (extinction vs. reinstatement test) x shock condition 
(shock vs. no shock) x ipsilateral drug treatment (antalarmin/SCH 23390 vs. veh/veh) 
ANOVA revealed a significant shock x reinstatement condition interaction (F1,3=56.72; 
p<0.01).  However, no main effect of or interactions involving antagonist administration 
were observed.  Overall shock produced cocaine seeking as defined by significant shock-
induced increases in all groups relative to extinction and non-shock controls (p<0.05 for 
each comparison) 
In contrast to the prelimbic cortex, disconnection of the pathway from the VTA to 
the infralimbic cortex through antalarmin delivery into the VTA in one hemisphere and 
SCH 23390 delivery into the infralimbic cortex of the other hemisphere failed to alter 
shock-induced cocaine seeking (Figure 4B; n=4).  A 3-way repeated measures 
reinstatement condition (extinction vs. reinstatement test) x shock condition (shock vs. no 
shock) x disconnection (antalarmin/SCH 23390 vs. veh/veh) ANOVA revealed a 
significant shock x reinstatement condition interaction (F1,3=82.78; p<0.01).  However, 
no main effect of or interactions involving antagonist administration were observed.  
Overall shock produced cocaine seeking as defined by significant shock-induced 
increases in all groups relative to extinction and non-shock controls (p<0.05 for each 
comparison). 
VTA antalarmin/veh and cortical SCH 23390/veh injection sites are shown in Figure 4C.   
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Figure 5:  Cocaine self-administration under conditions that establish CRF-
dependent shock-induced cocaine seeking and corresponding activation of the 
prelimbic cortex increases CRFR1 mRNA in the caudal VTA.  CRFR1 receptor 
mRNA levels in the VTA were quantified by in situ hybridization using a 35S-labeled 
CRFR1 riboprobe.  Representative images of film exposed to hybridized sections 
containing VTA from rats following self-administration under ShA, LgA, or saline 
control conditions are shown in Figure 5A.  Rostral (-5.2 to -5.6 mm bregma) and caudal 
(-5.6 to -6.2 bregma) VTA were analyzed separately and mean integrated optical 
densities (IODs) in each region are shown in Figure 5B.  No alterations in the rostral 
VTA were observed.  However, CRFR1 mRNA levels were significantly increased in the 
caudal VTA following LgA self-administration (*p<0.05 vs. saline controls).  
 
 
Experiment #5: Effects of cocaine self-administration under conditions that promote 
shock-induced cocaine seeking on CRFR1 mRNA in the VTA 
 
 
To determine if the recruitment of the CRF-regulated pathway from the VTA to 
the prelimbic cortex was the result of increased CRFR1 receptor expression, in situ 
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hybridization was used to quantify VTA CRFR1 mRNA levels following self-
administration and extinction in rats provided access to cocaine under ShA and LgA 
conditions and saline controls (Fig 5).  The VTA is a complex heterogeneous structure 
with anatomically defined subregions that have distinct functionality (Kaufling et al; 
Lammel et al).  The tail of the VTA notwithstanding, a key anatomical demarcation is the 
division of the VTA into rostral (anterior to -5.6 mm bregma) and caudal (posterior to -
5.6 bregma) regions (ref).  Specifically, our work examining shock-induced cocaine 
seeking has focused on CRF effects in the caudal VTA (ref).  Thus, in this experiment, 
CRFR1 receptor mRNA levels were analyzed separately in the rostral (-5.2 mm to -5.6 
mm bregma) and caudal (-5.6 mm to -6.2 mm bregma).  Representative images of films 
exposed to CRFR1 riboprobe hybridized brain sections from each group containing the 
caudal VTA are shown in Figure 5A.  Mean integrated optical rostral and caudal film 
densities (IOD) are shown in Figures 5B and 5C.  Separate one-way ANOVAs were used 
to compare CRFR1 mRNA in rostral and caudal VTA across self-administration 
conditions.  A significant overall effect of access condition was found in the caudal, but 
not rostral, VTA (F2,23=5.53; p<0.05).  Post-hoc testing showed that CRFR1 mRNA was 
increased relative to saline controls following LgA, but not ShA self-administration and 
extinction (p<0.05).   
 
DISCUSSION 
 
 
Although stress has been identified as a key contributor to relapse, the 
relationship between stress and drug-seeking behavior is complex and it has been 
reported that the onset of stress does not always serve as a reliable trigger for cocaine use 
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(Preston and Epstein, 2011; Furnari et al., 2015).  A key determinant of stress-induced 
cocaine seeking appears to be the extent/pattern of prior use.  High-frequency cocaine 
abusers display increased drug craving, anxiety and associated cardiovascular and 
hypothalamic-pituitary-adrenal responses upon exposure to stress imagery when 
compared to lower-frequency abusers (Fox et al., 2005).  Consistent with this 
observation, we have found that reliable stress-induced reinstatement of cocaine seeking 
is observed in rats with a history of cocaine self-administration under conditions of long 
access (LgA)/high cocaine intake but not under conditions of short access (ShA) drug 
availability where intake is lower (Mantsch et al., 2008).   
The glutamatergic projection from the prelimbic cortex to the nucleus accumbens 
core has been shown to be critical for cocaine seeking.  Pharmacological inhibition of this 
pathway using baclofen/muscimol (McFarland et al., 2004) or TTX (Capriles et al., 2003) 
delivery into the prelimbic cortex prevents stress-induced cocaine seeking and associated 
increases in nucleus accumbens core glutamate levels (McFarland et al., 2004).  Here we 
demonstrate that stress-induced reinstatement is associated with a heightened Fos 
response in the prelimbic and the infralimbic cortex.  
The mesocortical dopamine projection, via dopamine D1 receptor activation in 
the prelimbic cortex, is a key regulator of this cortico-accumbens pathway.  Injections of 
the D1 receptor antagonist SCH23390 (Capriles et al 2003) or the non-selective 
dopamine receptor antagonist fluphenazine (McFarland et al., 2004) but not the D2-like 
receptor antagonist raclopride (Capriles et al., 2003) injected into the prelimbic but not 
infralimbic cortex prevent stress-induced cocaine seeking.   D1 receptors in the prelimbic 
cortex are predominantly expressed post-synaptically on pyramidal neurons where they 
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promote excitability (Seamanns et al., 2001; Gonzalez-Islas and Hablitz, 2003; Tseng and 
O’Donnell, 2004; Sun et al., 2006).  Not only do our present findings confirm that D1 
receptors in the prelimbic cortex are required for shock-induced reinstatement, but they 
suggest that stress-induced cocaine seeking is associated with activation of VTA 
dopamine neurons that project to the prelimbic cortex.  These findings are consistent with 
an earlier report by Deutch et al (1991) demonstrating a similar stress-induced response 
in cocaine-naïve rats.  Notably, in that study, shock selectively activated VTA neurons 
that project to the prelimbic cortex without activating VTA neurons that project to the 
nucleus accumbens, consistent with reports that the mesocortical dopamine pathway is 
selectively activated by aversive stimuli (Lammel et al 2012).   
Much evidence points to CRF in the VTA as a key regulator of the mesocortical 
dopamine pathway and stress-induced drug seeking.  Shock-induced reinstatement of 
cocaine seeking is associated with increased CRF levels in the VTA (Wang et al., 2005) 
and intra-VTA CRF injections are sufficient to reinstate (Wang et al., 2005; Blacktop et 
al., 2011).  Moreover, pharmacological antagonism of (Blacktop et al., 2011; Vranjkovic 
et al 2014) or shRNA-mediated knockdown of (Chen et al., 2014) of the CRFR1 receptor 
in the VTA prevents stress-induced cocaine seeking.  Although studies examining the 
regulation of mesocortical dopamine by VTA CRF have produced mixed results (see e.g., 
Kalivas et al., 1987), reports that icv CRF increases dopaminergic neurotransmission in 
the prefrontal cortex (Dunn and Berridge, 1987; Lavicky and Dunn, 1993) and that CRF 
promotes excitation of VTA dopamine neurons via both pre- and post-synaptic 
mechanisms (Ungless et al 2003; Korotkova et al 2006; Riegel and Williams 2008; 
Wanat et al 2008, Beckstead et al 2009; Hahn et al 2009; Williams et al 2014) suggest 
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that stress-induced release of CRF into the VTA may underlie increases in 
mesocorticolimbic dopamine release.  Consistent with this possibility, Refojo et al (2011) 
reported that selective deletion of CRFR1 receptors in VTA dopamine neurons 
significantly reduced stress-induced increases in dopamine in the prefrontal cortex in 
mice while Wang et al (2005) have demonstrated that increases in VTA dopamine levels 
associated with shock-induced reinstatement are CRF-dependent. 
Here we report that the increase in Fos in the prelimbic cortex associated with 
shock-induced reinstatement of cocaine is prevented by intra-VTA delivery of the 
CRFR1 receptor antagonist, antalarmin.  Further, we directly tested the role of CRFR1 
regulation the mesolimbic dopamine pathway in stress-induced cocaine seeking using a 
pharmacological disconnection approach.  Bilateral disconnection of the proposed 
pathway by injection of antalarmin into the VTA of one hemisphere and the D1R 
antagonist SCH23390 into the prelimbic cortex of the contralateral hemisphere prevented 
shock-induced reinstatement.  By contrast administration of VTA antalarmin and PL 
SCH23390 in the ipsilateral hemisphere or disconnection of the CRF regulated pathway 
to the infralimbic cortex failed to block shock-induced reinstatement.  These data suggest 
that, during stress, CRF released into the VTA, possibly from neurons that originate in 
the BNST (Rodaros et al 2007; Silberman et al 2013; Vranjkovic et al 2014), activates 
CRFR1 receptors on mesocortical neurons thereby promoting prelimbic dopamine release 
and D1 receptor activation to induce drug seeking behavior. 
Consistent with other reports that CRF actions in the VTA depend on a prior 
history of cocaine exposure (Wang et al, 2005; Beckstead et al 2009; Hahn et al 2009; 
Williams et al 2014), we have found that intra-VTA CRF-induce reinstatements is only 
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observed in rats with a prior history of cocaine SA under daily extended-access/high-
intake conditions.  Thus, the observed heightened sensitivity to stress-induced cocaine 
seeking (Mantsch et al., 2008 and current findings) and the corresponding enhancement 
of stress regulation of the mesocortical pathway to stress can likely be attributed to 
increased CRFR1 receptor responsiveness at the level of the VTA.  In support of this 
possibility, we found that CRFR1 mRNA in the posterior VTA (the site at which CRF 
regulates cocaine seeking) is increased following long-access SA.  Notably, it has 
previously been reported that repeated cocaine administration increases CRF binding in 
the VTA (Goeders et al., 1990) and establishes CRFR1 regulation of excitatory 
transmission (Hahn et al., 2009).  Although we assume that alterations in CRFR1 mRNA 
are localized to dopaminergic neurons, confirmation of this requires further investigation. 
To summarize, the present findings demonstrate that 1) stress-induced cocaine 
seeking requires the activation of a CRFR1-regulated dopaminergic pathway from the 
VTA to the prelimbic cortex and 2) repeated cocaine use under patterns/intake levels 
observed in many cocaine abusers can establish stress-reactivity of this pathway via 
upregulation of CRFR1.  Further understanding the regulation of this pathway and how it 
is recruited with excessive cocaine use (e.g., elevated glucocorticoid levels; Graf et al., 
2011) should provide important insight into the addiction process. 
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General Discussion 
 
 
Addiction is a tremendous health and financial burden on our society. Our current 
understanding of the brain circuitries involved in addiction is far from complete. Drug 
use is a stress-driven behavior partially because of the unpredictable and often 
uncontrollable nature of stress. The work in this dissertation will hopefully aid in the 
development of new and more effective treatment strategies aimed at either preventing 
stress-induced relapse or minimizing the role of stress in the addiction cycle. Research in 
our lab has focused on the idea that chronic cocaine use, as displayed by the long-access 
self-administration paradigm (Ahmed and Koob, 1998), increased the vulnerability to 
relapse during periods of stress (Mantsch et al., 2008) in a manner dependent on an 
escalating pattern of cocaine use, which may be dependent on the interactions of 
glucocorticoids and epinephrine (Mantsch et al., 2008). Findings within this dissertation 
will hopefully aid in the development of better treatment options. To summarize, we have 
found that stress-dependent relapse occurs through a corticotropin releasing factor (CRF) 
pathway from the bed nucleus of the stria terminalis (BNST) to the ventral tegmental area 
(VTA) that activates dopamine (DA) neurons that project into the prelimbic cortex to 
precipitate cocaine use (figure 4.1). In addition, we have found that CRF expression is 
increased within the BNST following a stressor that is dependent on beta-2 adrenergic 
receptor (AR) activation. Furthermore, long-access cocaine use significantly increased 
the expression of CRFR1 within the caudal VTA. This increase in CRFR1 expression 
primes the activity of VTA neurons that specifically project into the prelimbic cortex, and 
therefore causes an increase of prelimbic pyramidal activity through a dopamine receptor 
1 (D1R) mechanism. 
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Beta-noradrenergic receptors within the BNST regulate relapse of cocaine 
seeking during periods of stress 
 
 
Clinical and preclinical research has determined that inhibition of the 
noradrenergic system, through the actions of alpha-2 AR agonists such as clonidine and 
guanfacine, can block stress-induced craving of opiates (Sinha et al., 2007), cocaine 
(Jobes et al., 2011, Mantsch et al., 2010), and nicotine (Fox et al. 2012, McKee at., 2014).  
These studies are based on the assumption that alpha-2 ARs are presynaptic autoreceptor, 
although post-synaptic alpha-2 AR effects that could interfere with cocaine seeking in 
regions such as the prefrontal cortex have been reported.  Based on these studies, we have 
focused our research on determining the contribution of the noradrenergic system to 
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 Neuroanatomical projections involved in stress-induced cocaine seeking figure 4.1: An electric footshock stressor will 
activate a noradrenergic projection from the ventral noradrenergic bundle into the ventral bed nucleus of the stria terminalis. 
Here norepinephrine will activate beta-2AR receptors and release corticotropin releasing factor (CRF). CRF will increase the 
drive on CRF ventral tegmental area (VTA)  projecting neurons. A CRF projection from the vBNST into the VTA will be 
activated, and CRF will be released within the VTA. CRF will activate CRFR1 on VTA dopamine neurons that project into 
the prelimbic cortex. DA within the prelimbic cortex will activate D1R and increase the firing rate of pyramidal neurons that 
project into the core of the nucleus accumbens. This will activate sub-motor circuits to engage in drug seeking behavior. 
(Figure adapted from Mantsch et al., 2015)     
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stress-related relapse to cocaine use. Earlier studies have indicated that a cocktail 
antagonism of both beta-1 and beta-2 ARs within the bed nucleus of the stria terminalis 
(BNST), and the central nucleus of the amygdala (CeA) blocks footshock-induced 
reinstatement of cocaine seeking (Leri et al 2002). Based on these results, our lab has 
tested the sufficiency and necessity of activation of the individual beta-AR receptors for 
stress-induced relapse in both the self-administration and conditioned place preference 
models.  
Our results indicate that the beta-2 AR is both necessary and sufficient in 
mediating forced swim-induced drug seeking in extinguished conditioned place 
preference mice (Mantsch et al 2010, McReynolds et al 2014, Vranjkovic et al 2012). 
Specifically, we showed that the beta-2 AR antagonist ICI 118,551 blocked forced swim-
induced reinstatement (Chapter 2; Mantsch et al 2010, McReynolds et al 2014) while the 
non-selective beta-AR agonist isoproterenol was sufficient to induce drug seeking 
(Vranjkovic et al 2012), and the selective beta-2 AR agonist clenbuterol was also 
sufficient to induce drug-seeking behavior (McReynolds et al 2014, Vranjkovic et al 
2012). In addition, using footshock-induced reinstatement in our rat self-administration 
model, we have shown that stress-induced reinstatement is specific to beta-2 ARs in the 
ventral BNST (vBNST) as intra-vBNST administration of the beta-2 AR antagonist ICI 
118,551 blocked stress-induced drug seeking and intra-vBNST administration of the 
beta-2 AR agonist clenbuterol was sufficient to evoke stress-induced reinstatement 
(Chapter 3; Vranjkovic et al 2014).   
 Interestingly, we were able to block isoproterenol-induced reinstatement with 
both the selective beta-1 AR antagonist betaxolol, and the selective beta-2 AR antagonist 
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ICI 118,551 (Vranjkovic et al 2012). It is also important the signal redundancy in that 
both receptors signal through Gs. This indicates that beta-AR receptors may exert their 
affects on different cell types. This was interesting because antagonism of the beta-1 AR 
failed to block forced swim-induced reinstatement, in the CPP model, and footshock-
induced reinstatement, in the self-administration model, when administered into the 
vBNST. This indicates that either the drugs bind to other receptors, or that there is an 
unknown role for beta-1 ARs in stress-induced reinstatement. Studies have shown that 
stress can increase the expression of both beta-1 and beta-2 ARs within the BNST 
(Cecchi et al 2007), and that chronic cocaine administration can decrease the beta-1 AR-
mediated excitatory post-synaptic potential within the BNST (Nobis et al 2011). Our 
results indicate that beta-2AR receptors are important in contributing to stress-induced 
relapse; however, their localizations within the central nervous system is not clear. 
Unfortunately, beta-AR antibodies have been extremely unreliable in determining the 
cellular localization; however studies employing electrophysiology have determined that 
beta-ARs are located on glutamatergic terminals within the BNST to enhance the 
excitatory drive of these neurons through a CRF-dependent mechanism (Nobis et al 2011; 
Silberman et al 2013). In addition, experiments using HA-tags mutated onto the C-
terminus of the alpha-2 AR have been used to localize the alpha-2 AR (Flavin et al 2014). 
This technique can be used to identify the localization of the beta-1 and beta-2-ARs 
within the synapse.  
It is interesting that both beta-1 ARs and beta-2ARs work through the same 
second messenger system. Both beta-1 and beta-2 ARs are Gs-coupled receptors 
suggesting that downstream activation of cAMP, PKA, or CREB are involved in the 
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reinstatement process during stress. Interestingly, studies have shown that cAMP and 
CREB activation are required for forced swim- but not cocaine-induced reinstatement of 
conditioned place preference (Kreibich and Blendy, 2004). Therefore, it is necessary to 
understand the localization of these receptors within the synapse, and how their 
trafficking, expression, or down-stream mechanisms may change due to chronic drug use 
or during periods of stress. 
Moreover, beta-1 ARs have a higher affinity for norepinephrine than beta-2 ARs, 
but here we show that the effect of stress on reinstatement is dependent upon the beta-2 
AR specifically. This may be attributed to elevated norepinephrine levels during periods 
of stress (Pacak et al 1995), during which it is possible that the high affinity beta-1 AR is 
saturated and therefore is either internalized, or non-functional. This would allow for the 
low affinity beta-2 AR to be activated. In support of this, a similar type of affinity is seen 
with glucocorticoid receptors within the stress circuit as high affinity mineralocorticoid 
receptors are saturated under basal cortisol levels whereas low affinity glucocorticoid 
receptors are activated by cortisol during periods of elevated cortisol levels that are 
typically observed during stress. In addition, beta-2 ARs seem to have both genomic and 
non-genomic effects within the BNST. Electrophysiology studies have indicated that 
beta-ARs enhance excitatory transmission within the BNST (Nobis et al 2011), possibly 
through a CRF-releasing event (Silberman et al., 2013). However, we have shown that a 
forced swim stressor increases crf mRNA within the BNST, and that this increase can be 
blocked with antagonism of the beta-2 AR(McReynolds et al., 2014). This suggests that 
beta-2 ARs serve as a mechanism to reload CRF pools either within local CRF-positive 
neurons in the BNST or CRF-projecting neurons that originate within the BNST, and 
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beta-2AR receptors may also stimulate the release of CRF within the BNST. This is 
important because it shows that beta-ARs and CRF have a crucial interaction within the 
BNST.      
Beta-2 ARs act upstream from CRFR1 to mediate stress-induced drug 
seeking 
 
 
Data from our lab and others has suggested that norepinephrine drives 
reinstatement through a beta-AR dependent engagement of the CRF system within the 
BNST (Brown et al 2009, Erb et al 2000, McReynolds et al 2014, Vranjkovic et al 2014). 
In this dissertation we have shown this in mice wherein administration of a beta-2 AR 
antagonist blocked stress-dependent increases of crf mRNA within the BNST, and the 
CRFR1 antagonist antalarmin blocked clenbuterol-induced reinstatement. In addition, 
using the rat self-administration model, we have shown that intra-BNST clenbuterol-
induced reinstatement is blocked by pretreatment with the CRFR1 antagonist antalarmin 
(Chapter 3; Vranjkovic et al 2014). Furthermore, we have shown that intra-BNST CRF 
administration induces drug-seeking behavior, and this effect is not blocked by 
administration of the beta-2 AR antagonist ICI 118,551 (Vranjkovic et al 2014).  
This strongly suggests that beta-2 AR activation releases CRF within the BNST. 
This data is consistent with other studies that have shown that beta-AR activation within 
the BNST produces an enhancement of excitatory synaptic mechanisms (Egli et al., 2005; 
Nobis et al., 2011) that was dependent upon CRFR1 activation (Silberman et al., 2013). It 
is important to note that even though CRF signaling in the BNST is necessary for relapse 
(Chapter 3; Erb et al., 2001; Vranjkovic et al 2014), the source of this CRF is not know as 
it could be released from local CRF neurons (Veinante & Freund-Mercier 1997) or from 
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CRF-ergic afferents from other regions (Rodaros et al., 2007). In addition, our own data 
suggest that beta-2 ARs regulate CRF release within the BNST though a more direct 
examination of this effect is still needed.   
Several different methods can be employed to study whether beta-2 AR activation 
is necessary for direct CRF signaling in stress-induced reinstatement in the different 
reinstatement models. Studies have started employing the human diphtheria toxin (toxic 
to humans, but not mice) receptor to selectively destroy cell bodies in a cre-depndent 
manner (Silberman et al., 2015). For this example, CRF-cre mice would be injected with 
a cre-dependent virus expressing the diphtheria toxin receptor and this virus could be 
specifically injected into either the BNST or CeA to produce the receptor on CRF-
positive cells. Subsequently, mice would be chronically injected with the diphtheria toxin 
to destroy any cells expressing the diphtheria toxin receptor (Silberman et al., 2015). 
Using this, studies could examine whether depletion of CRF by diphtheria toxin could 1) 
induce forced-swim dependent reinstatement of CPP in mice; this study could examine 
whether CRF in cells in either the CeA or the BNST is necessary for stress-induced 
reinstatement. 2) This study could be used to confirm a relationship between beta-2 AR 
and CRFR1 activation in stress-induced reinstatement; injections of the beta-2 AR 
agonist clenbuterol should not be sufficient in reinstating drug-seeking behavior. 3) 
Electrophysiology studies could be conducted to determine whether beta-AR activation 
within the BNST still causes enhancement of glutamatergic transmission within the 
BNST that is dependent on CRFR1 activation. Beta-AR and CRFR1 could be working 
separately to enhance glutamatergic signaling independent from each other. In addition, 
injections of an AAV virus containing shRNA for CRF (Grieder et al 2014) could be 
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used to test whether local or CeA CRF input into the BNST regulates reinstatement. In 
addition, microdialysis studies may be employed to directly measure CRF release within 
the BNST during either a footshock stressor, or through reverse dialyzing the beta-2 AR 
agonist clenbuterol. These studies would be crucial in understanding the direct interaction 
of beta-2AR receptors and CRFR1; and their relationship in stress-induced drug seeking.   
 
Excitatory input onto CRF neurons within the BNST 
 
 
A major challenge in the field of neuroscience research on affective disorders is 
identifying the signaling pathways and neural circuits involved in the complex 
mechanisms that underlie stress-induced reinstatement. Very little studies have been done 
to examine the excitatory afferents that project onto CRF neurons within the BNST. 
Optogenetic and genetically encodable reporter strategies may be used to map excitatory 
afferents that directly synapse onto CRF neurons within the BNST. Anatomical studies 
have suggested that the BNST receives a major glutamatergic input from the infralimbic 
cortex, however it is important to understand the upstream structures that activate CRF 
neurons within the BNST, or more importantly CRF-positive BNST neurons that project 
to downstream structures such the VTA. Currently, the anterior insular cortex, medial 
prefrontal cortex, and the parabrachial nucleus have been suggested to send glutamatergic 
signaling onto CRF-positive cells within BNST (Swanson et al., 1982).  
 
 
Activation of beta-2 AR within the BNST activates a CRF projection into the VTA. 
  
 
 Many studies have indicated that a CRF projection into the VTA mediates stress- 
induced reinstatement, however, no studies have shown a neuronal mechanism or a 
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functional location. A major finding in our lab is that beta-2 ARs within the vBNST 
recruit a CRF-projecting pathway from the vBNST to the VTA, and this pathway, in part, 
mediates stress-induced drug seeking (Chapter 3; Vranjkovic et al., 2014). In addition, 
animals that received an intra-VTA cholera toxin subunit b injection (CTb; retrograde 
tracer), and underwent dual immunofluorescence for CTb and CRF within the vBNST, 
showed that CRF-positive cells within the vBNST project to the VTA (Chapter 3; 
Vranjkovic et al., 2014). This directly suggests that activation of the vBNST result in 
release of CRF within the VTA, which will bind to CRFR1 to promote drug use during 
times of stress. However, data in this dissertation suggests that CRF release within the 
VTA is mediated by a beta-2AR, and CRFR1 interaction within the vBNST.  
 
CRF cells that project into the VTA are either glutamatergic or GABAergic 
 
 
 Our studies suggest that CRF-positive neurons originate from the BNST and 
project into the VTA, though we did not confirm a direct CRF-releasing pathway 
projection. Studies stimulating the BNST through a beta-2 AR mechanism and measuring 
CRF release within the VTA in animals that have a knockdown of CRF, and proper 
controls, within the vBNST need to be conducted to confirm our theory. Furthermore, 
CRF-positive neurons could regulate glutamatergic or GABAergic cells within the 
BNST; therefore, one possibility is that CRF-positive projecting neurons could make a 
relay projection to another area, from which CRF is coreleased with GABA or glutamate 
into the VTA. Furthermore, it is not well known whether the BNST sends a 
predominately glutamatergic or GABAergic input into the VTA during periods of stress. 
Studies have shown that the majority of BNST neurons that project into the VTA are 
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GABAergic (Kudo et al 2012) and it is predicted that they disinhibit VTA dopaminergic 
neurons by synapsing onto VTA GABA neurons as studies have shown that BNST to 
VTA projections formed symmetric terminals that co-expressed vesicular inhibitory 
amino acid transporter (Kudo et al 2012). However, other studies have found that BNST 
glutamatergic and GABAergic projections preferentially innervate non-dopaminergic 
VTA neurons, and that BNST glutamatergic projection activation resulted in aversive and 
anxiogenic behavioral phenotypes, while BNST GABAergic projections produced 
rewarding and anxiolytic behavior (Jennings et al 2013). More studies need to be 
conducted to understand the regulation of the VTA by BNST glutamatergic/GABAergic 
neurons and CRF-projecting neurons, and its involvement in stress-induced 
reinstatement.  
Studies have shown that CRF-positive terminals within the VTA synapse onto 
DA cells that have asymmetric projections, indicating that they are glutamatergic 
(Tagliaferro & Morales 2008). However, this study failed to discuss the CRF terminals 
that do not synapse onto DA cells. It is my strong opinion that a subset of CRF-positive 
terminals originating from the BNST synapse onto either GABAergic interneurons, or 
other GABAergic neurons where they act to disinhibit DA neurons. In addition, it is 
important to note that studies have shown that both presynaptic and postsynaptic CRFR1 
activation can reduce the activity of VTA DA neurons (Wanat et al., 2013; Beckstead et 
al., 2008). This indicates that CRF within the VTA can either enhance or inhibit VTA DA 
firing. Therefore, it is important to understand under what conditions CRF is released 
within the VTA, because CRF undergoes volume transmission, and therefore a single 
CRF release event within the VTA may act to activate and inhibit VTA DA neurons.   All 
	   153	  
in all, others and we have suggested a beta-2 AR-driven CRF pathway within the BNST 
that activate a CRF projection in to the VTA. This is depicted in figure 4.2. This pathway 
will act to engage VTA DA cells projecting to the prelimbic cortex.    
 
 
 
 
 
 
 
 
 
Significance/Progress Relapse to drug-seeking behavior remains a major therapeutic barrier in the treatment 
of addiction, with relapse rates in the 80-90% range for most illicit drugs1, 2, 33.  While several stimuli can elicit 
drug-craving responses and relapse, stress is most frequently cited1, 2, 33.  NE ligands, particularly the !-AR 
blocker propranolol, and the "2a-AR agonist guanfacine, have been explored as potential prophylactic 
treatments in abstinent cocaine addicts, because of the known roles of NE in stress responses and the 
compounds are generally well tolerated12-14, 17, 34, 35.  While not producing outright improvements in long-term 
abstinence, these studies suggest that they do improve drug-craving symptoms. We propose that a better 
understanding of the specific mechanisms controlled by these receptors to regulate stress-induced relapse will 
spur the development of more effective therapeutics. 
Rodent models point to the extended amygdala as a key site of NE function in stress-induced drug seeking.  
 NE plays a key role in reinstatement of drug seeking36, 37 38. Intracerebroventricular injection of NE 
reinstates cocaine seeking behavior 39, and NE inputs to the BNST are activated during withdrawal from drugs 
of abuse40, 41, leading to increased extracellular levels of NE40-42. Lesioning of the ventral NE bundle to the 
extended amygdala blocks stress induced reinstatement of morphine seeking43.  !1- and !2-AR antagonists 
administered peripherally or directly into the CeA or BNST block stress-induced reinstatement of cocaine 
seeking28, 44, 45 as well as anxiogenesis46.  Conversely, !-AR agonists induce reinstatement of cocaine 
seeking28.  Activation of "2-ARs has repeatedly been shown to block stress induced reinstatement43, 45, 47, 48.  
Further, administration of an "2-AR agonist directly into the BNST blocks foot shock induced reinstatement of 
morphine seeking43.  In addition, systemic administration of the "2A-AR agonist 
guanfacine reduces withdrawal induced anxiety and attenuates reinstatement 
behavior 49.  In addition to withdrawal induced anxiety, "2A-ARs have been linked to 
anxiety disorders 50.   
Actions of !-ARs in extended amygdala point to CRF-dependent and independent 
mechanisms.  NE signaling produces a constellation of actions within the extended 
amygdala8.  As evidence indicates that glutamatergic inputs into the BNST drive 
stress-related behaviors51, 52, in the previous funding cycle we focused on the 
actions of NE and CRF on excitatory transmission in both the BNST and CeA.  In 
the BNST, we found that !-ARs enhance spontaneous excitatory postsynaptic 
currents (sEPSCs) in a CRF-dependent and cocaine-sensitive fashion3, 7, 8, 53.  We 
found that this enhanced excitatory drive can be elicited on BNST neurons that 
project to the VTA, and that the !-AR agonist isoproterenol (iso) depolarizes CRF 
neurons in BNST3, 53, suggesting a model whereby NE elicits the local release of 
CRF from interneurons to increase the activity of VTA-projecting BNST neurons 
(see model fig. 1).  A series of studies indicate that VTA-projecting neurons in the 
BNST play an important role in reinstatement behavior9, 45, 51, 54-56.  In contrast, in 
the CeA, we found that !-ARs also increase excitatory transmission, but that this 
enhancement was not dependent on CRF signaling29.  Our initial 
electrophysiological characterization of CRF neurons in the CeA and BNST 
suggested a greater diversity of phenotypes in the BNST3. Thus one possibility is 
that CRF neurons in the CeA are projection neurons rather than interneurons.  As 
shown in fig. 4 below, at least a portion of CRF neurons in BNST are projection 
neurons. 
Actions of "2-ARs in extended amygdala point to complex regulatory mechanisms. 
"2-AR agonists block stress-induced reinstatement8, 43, 45, 47, 48.  This has 
been assumed to occur largely via activation of autoreceptors to limit NE release.  
However, in other regions such as prefrontal cortex, "2-ARs play a postsynaptic 
role57.  In initial studies we found that "2-ARs suppress BNST activity8, 22, 58, and that these receptors appeared 
to be widely expressed in BNST beyond autoreceptor sites58.  Consistent with this idea, we utilized an ex vivo 
optogenetic-based mapping strategy to identify the PBN as a BNST afferent inhibited by the "2a-AR agonist 
guanfacine18.  This is consistent with previous data using electrical stimulation in the CeA59.  Surprisingly, we 
also determined that in other contexts, "2a-ARs have excitatory actions in the BNST, such as increasing 
responses optogenetically-elicited in a Thy1-COP4 (channelrhodopsin, ChR2-expressing) transgenic line, 
increasing postsynaptic ERK phosphorylation and Fos expression when guanfacine is administered 
systemically (fig. 8-10)18, 60.  These data suggest that "2a-ARs filter excitatory input into the BNST.   
The potential role of the PBN in stress-induced reinstatement.  The guanfacine-sensitive PBN glutamatergic 
input to the BNST is an ascending input61-63 that forms axosomatic synapses primarily onto anterolateral BNST 
Fig. 1.  Model of NE 
recruitment of BNST VTA 
projection neurons We 
propose that NE depolarizes 
CRF neurons in the BNST to 
promote CRF release, which 
then activates presynaptic 
CRFR1 on glutamate 
terminals on VTA-projecting 
BNST neurons (gold)3, 6, 7.  
We propose a series of 
studies in Aim 1 to test and 
extend this model, and to 
begin to test the role of this 
pathway in stress-induced 
cocaine reward behavior. 
Research Strategy                                                                                             Page 26
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Figure 4.2: Model of NE recruitment of BNST VTA 
projection neurons We propose that NE activation of beta2-
ARs depolarizes CRF neurons in the B ST to promote CRF 
release, which then activates presynaptic CRFR1 on glutamate 
terminals on VTA CRF-projecting BNST neurons  
Beta-2AR!
CRFR1!
CRF!
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Susceptibility to stress-induced drug seeking is dependent on CRFR1 expression 
levels within the caudal VTA 
 
 
Stress-induced reinstatement to a footshock stressor requires a history of extended 
access to cocaine. Different neurobiological mechanisms may contribute to the 
susceptibility to relapse during periods of stress. We have shown that CRFR1 activation 
is both necessary and sufficient for stress-induced drug seeking (Blacktop et al., 2011). In 
this dissertation we have shown that within the caudal VTA, CRFR1 expression is 
increased. In addition, a footshock stressor increases Fos immunoreactivity within the 
VTA compared to no shock controls. Furthermore, shock increased the activity of 
neurons that project to the prelimbic cortex.  Moreover the prelimbic Fos response to 
shock is dependent on CRFR1 activation in the VTA (Chapter 4). These data suggests 
that a footshock stressor recruits a VTA projection, likely dopaminergic, to the prelimbic 
cortex via CRFR1 activation within the VTA as we have shown that a disconnection 
between VTA CRFR1 and prelimbic D1R prevents footshock-induced reinstatement. 
This is interesting because inhibiting dopamine signaling, with either a D1R specific 
antagonist, or a non-specific dopamine antagonist, within the prelimbic cortex prevents 
footshock-induced drug seeking (Capriles et al 2003, McFarland et al 2004). While we 
found that CRFR1 expression is increased within the VTA as a result of long-access 
cocaine self-administration, other mechanisms could be recruited to prime the activity of 
mesocortical neurons.  
Cocaine intake-dependent neuroplastic changes within the VTA can increase the 
susceptibility to relapse of cocaine use during a stressor. While stress has been shown to 
promote CRF release within the VTA that is not dependent on a history of cocaine intake 
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(Wang et al., 2005), no studies have examined whether CRF release is increased within 
the VTA in animals with a history of extended drug use. Our data from chapter 2 
suggests that CRF production is increased within BNST, and that the BNST sends a 
direct projection of CRF to the VTA. Therefore, CRF release within the VTA may be 
augmented as a result of long-access cocaine use. However, the increase in crf mRNA 
observed in chapter 2 may be a reloading effect. Specifically, the beta-2 AR-mediated 
increase in CRF production may restore the pools of CRF in VTA terminals that have 
been released due to prior stressors. In addition, our lab has shown that bilateral delivery 
of CRF directly into the VTA fails to induce drug seeking in rats with a history of short-
access self-administration (2hr/day) but produced robust drug seeking under long-access 
conditions suggesting that some neuroadaptation are needed. We have shown that this 
occurs as an increase of CRFR1 expression, but we cannot rule out other processes 
downstream (such as changes in the cortico-accumbens pathway), or upstream (such as 
actions within the BNST) from the site of CRF actions within the VTA.    
Studies have shown that repeated cocaine administration has been shown to 
increase CRF receptor binding in the VTA (Goeders et al 1990) and also alter CRF 
responsiveness. Repeated cocaine administration has been shown to attenuate CRFR1-
induced enhancement of GIRK channel-mediated inhibitory post-synaptic currents 
(Beckstead et al 2009) and establishes CRFR1-mediated regulation of glutamatergic 
synaptic transmission within the VTA (Hahn et al 2009). In addition, a history of cocaine 
use is required for CRF regulation of DA and glutamate release within the VTA (Wang et 
al., 2005).      
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We observed a gross increase in CRFR1 expression throughout the caudal VTA. 
However, the VTA consists of not only dopaminergic cells, but also GABAergic and 
glutamatergic cells. It would be interesting to see whether the increase in CRFR1 
expression occurs in any specific cell type. Furthermore, it is important to determine 
whether the increase in CRFR1 expression is observed in any specific cell type that 
projects to either the prelimbic cortex, or the nucleus accumbens. While we did not 
explore specific projecting patterns, we did observe an increase that was specific to the 
caudal VTA. This is important because recent research has suggested that the caudal 
medial VTA contains DA neurons that specifically project into the prelimbic cortex 
(Lammel et al 2014, Lammel et al 2012). Recent research has shown that CRF expression 
is increased in the caudal, but not rostral, VTA of nicotine-dependent mice (Grieder et al 
2014). In addition, the RMTg, or the tail of the VTA, has a stress-specific GABAergic 
input onto caudal VTA DA neurons that project into the ventral striatum (Barrot et al 
2012). However, very little research has been done examining the rostral-caudal axis as it 
pertains to cocaine seeking during periods of stress. Studies have suggested that the 
rostral VTA is necessary for cocaine-taking behavior (Lee et al 2007). However, recent 
breakthroughs in rat and mouse genetics will allow us to specifically target VTA DA 
neurons that project to the prelimbic cortex, and therefore determine whether CRFR1 
activation enhances the dopaminergic projection during periods of stress. Finally, other 
factors may mediate the heightened stress-induced cocaine seeking observed following 
LgA self-administration on CRFR1 function, such as downstream signaling pathways.    
 
A VTA CRF-mediated DA projection to the prelimbic cortex is required for stress-
induced drug seeking 
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Studies have shown that dopamine receptor antagonism within the prelimbic 
cortex is necessary for stress-induced reinstatement (Capriles et al., 2003; McFarland et 
al., 2004) and that this may be due to activation of CRFR1 (Refojo et al 2011). However, 
no direct evidence has indicated that stress-induced reinstatement is dependent on 
CRFR1 activation of the mesocortical dopamine pathway or that the stress-induced 
activity within the prelimbic cortex is dependent on CRFR1 activation within the VTA. 
In chapter 4, we show that inhibition of CRFR1 within the VTA and D1 receptor 
inhibition within the prelimbic, but not infralimbic, cortex is sufficient in blocking 
footshock-induced drug seeking through a disconnection approach. While it has been 
known that stressors increase the activity of the prelimbic and the infralimbic cortex 
(Felice et al 2014, Morrow et al 2000) we have shown that a footshock stressor 
significantly augments Fos reactivity within the prelimbic cortex in long-access animals 
compared to saline and short-access animals, and this effect was not observed in the 
infralimbic cortex. Interestingly, the stress-induced increase in Fos activity was blocked 
by administration of an intra-VTA CRFR1 antagonist.  
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This suggests that during periods of stress, CRFR1 activation within the VTA 
recruits a subset of VTA neurons to enhance the activity of prelimbic cortex (Figure 4.4)	  . 
This is similar to an early finding that showed that a restraint stress specifically increased 
Fos activity in DA neurons that project into the prelimbic cortex (Deutch et al 1991). 
Unfortunately, we cannot definitively state that VTA DA neurons are the sole driving 
force for the increase in prelimbic Fos reactivity. VTA GABAergic neurons may be 
driving the stress-dependent effect. In addition, studies have suggested that CRF may also 
decrease the activity of VTA DA neurons that project into the accumbens (Twining et al., 
2015), possibly through an interaction between CRFR1 and GABAB mediated inhibition 
by activating GIRK channels (Blacktop et al., 2015; Beckstead et al., 2009) (figure 4.3).  
 
The role of the prelimbic and infralimbic cortex in relapse 
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Figure 4.3: CRF enhances excitatory neurotransmission within the VTA. CRF 
has been shown to directly excite dopamine neurons in the VTA by either 
direct or indirect mechanism through post-synaptic trafficking of NMDA and 
AMPA receptors. Furthermore, repeated cocaine exposure has been shown to 
enhance AMPA mediated spontaneous miniature EPSC. Furthermore, CRF 
promotes GABA release via a presynaptic CRFR1 activation as well as 
exciting intrinsic GABA interneurons. In addition, through a CRFR1/GABAB 
receptor interaction, CRF promotes IPSC currents in VTA DA cells that we 
think project into the nucleus accumbens, because antagonism of CRFR1 
prevented a stress-induced drop in accumbal DA release.      !
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 Although shock increased Fos in the infralimbic cortex, the Fos response in the 
prelimbic cortex was much more robust and was more pronounced in long-access rats 
that displayed stress-induced reinstatement of cocaine seeking. This is not surprising 
because previous studies have suggested that prelimbic glutamate input into the nucleus 
accumbens core is involved in extinguished drug seeking to drugs, cues, and a footshock 
stressor (Capriles et al 2003, Cornish et al 1999, LaLumiere & Kalivas 2008, McFarland 
et al 2004). The infralimbic cortex sends a glutamatergic projection into the shell of the 
nucleus accumbens that is thought to be involved in extinction learning (LaLumiere et al 
2010, LaLumiere et al 2012). Furthermore, it has been shown that the glutamatergic 
projection from the infralimbic cortex to the shell of the accumbens regulates suppression 
of drug seeking (Peters et al 2009, Peters et al 2008). Specifically, inactivation of the 
infralimbic cortex, or the shell of the nucleus accumbens reinstates drug seeking in the 
absence of drugs, cue, or stressful triggers (Peters et al 2008). This is surprising because 
we show that a footshock stressor increases the activity of the infralimbic cortex, though 
to a lesser degree than the prelimbic cortex.  
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The role of the infralimbic cortex as a stop pathway has been recently challenged 
(Moorman et al 2014). Studies have shown that both the infralimbic and prelimbic cortex 
display rapid, stimulus-evoked activity changes that are closely linked to contextually 
appropriate behaviors. This was shown to be independent of whether the behavior 
involved execution or inhibition (Moorman & Aston-Jones 2015). Other studies have 
shown that activity is increased in the infralimbic cortex following both cue- and context-
induced cocaine, and heroin seeking (Moorman et al 2014). Therefore, our results may 
Core!
VTA!
Prelimbic !
Figure 4.4: D1R activation enhances the likelihood of pyramidal 
neuron activation by increasing the NMDA/AMPA ratio. During 
periods of stress, D1R activation will lead to activation of the 
cortico accumbens pathway which mediates stress-induced 
relapse.   !
!"#"$%
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suggest that within extended access cocaine use, the activity within the infralimbic cortex 
may be changed as well. However, our results from chapter 4 have indicated that D1R-
mediated DA activity within the infralimbic cortex, as it relates to CRFR1-dependent 
activation of VTA DA neurons, is not involved in stress-induced reinstatement since a 
disconnection between VTA CRFR1 and infralimbic D1R did not block stress-induced 
reinstatement.     
 
Conclusion 
  
 
The impact of stress on cocaine relapse is very complex. Not only do we report a 
beta-2 AR-mediated CRF-dependent activation of a CRFergic afferent pathway from the 
bed nucleus of the stria terminalis to the ventral tegmental area is necessary for stress-
induced relapse, we also report that animals with a history of extended access cocaine use 
are susceptible to reinstatement to a stressor by the recruitment of the mesocortical DA 
pathway to the prelimbic cortex. This recruitment may be partially due to an increase in 
CRFR1 expression within in the VTA that is specific to extended cocaine use. Human 
studies have already shown that clonidine can prevent cocaine craving during periods of 
stress in humans (Jobes et al 2011). While other studies have shown that polymorphisms 
in genes that encode the CRF receptors is associated with exacerbated stress responses 
and the propensity to develop drug addiction (Blomeyer et al 2008, Clarke & Schumann 
2009, De Luca et al 2007, Enoch et al 2008, Treutlein et al 2006), we still do not 
understand the microcircuitry of CRF signaling within the VTA. Thus, future directions 
for investigating the mechanisms by which CRF controls stress-related drug use should 
focus on mapping CRF circuitry within the VTA to determine the mechanism by which 
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CRF may activate, or inhibit specific dopaminergic projections. This can be achieved by 
determining the cellular location of CRFR1 and CRFR2 receptors within the VTA in 
animals with a history of extended cocaine access. Currently, novel tools are being 
developed to determine the microcircuitry within the VTA.       
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APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drug	  	   Action	  	  
Antalarmin	  	   Antagonist	  at	  CRFR1	  
Antisauvagine	   Antagonist	  at	  CRFR2	  
Betaxolol	  	   Antagonist	  at	  Beta-­‐1AR	  
BRL	  44408	   Antagonist	  at	  Alpha-­‐2AR	  (2α)	  
Clenbuterlol	  	   Agonist	  at	  Beta-­‐2AR	  
Clonidine	  	  	   Agonist	  at	  Alpha-­‐2AR	  
CP	  154,526	   Antagonist	  at	  CRFR1	  
Dobutamine	  	   Agonist	  at	  Beta-­‐2AR	  
Guanfacine	  	   Agonist	  at	  Alpha-­‐2A	  (2α)	  
ICI	  118,551	   Antagonist	  at	  Beta-­‐2AR	  
Isoproterenol	   Agonist	  at	  Beta-­‐1AR	  and	  Beta-­‐2AR	  	  
Kynurenic	  Acid	  	   Antagonist	  at	  AMPA,	  NMDA,	  and	  Kianate	  Receptors	  	  
Prazosin	   Antagonist	  at	  Alpha-­‐1AR	  	  
Propranolol	  	   Antagonist	  at	  Beta-­‐1AR	  and	  Beta-­‐2AR	  
SCH	  23390	   Antagonist	  at	  D1R	  	  
Yohimbine	  	  
Antagonist	  at	  Alpha2-­‐AR	  
	  (2α,	  alpha1αAR,	  5HT:	  1A,1,B,1D,1F,2B	  and	  D2)	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List of abbreviations  
 
Abbreviations Name 
AC Anterior Commissure  
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AR Adrenergic Receptor  
BNST Bed Nucleus of the Stria Terminalis  
CPP Conditioned place preference 
CRF Corticotropin releasing factor 
CRFR Corticotropin releasing factor receptor 
CTb Cholera Toxin B 
DA Dopamine  
EPSC Excitatory Postsynaptic Current 
GABA Gamma -Aminobutyric Acid 
IL Infralimbic Cortex 
IPSC Inhibitory Postsynaptic Current 
MSN Medium spiny neurons 
Nacc Nucleus Accumbens 
NE Norepinephrine 
NMDA N-methyl-D-aspartate receptor  
PFC Prefrontal Cortex 
PL Prelimbic Cortex 
SA Self-Administration  
VP Ventral Pallidum  
VTA Ventral Tegmental Area 
 
 
 
